<!DOCTYPE article
 PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="preprint"><?all-math-mml yes?><?use-mml?><?origin ukpmcpa?><front><journal-meta><journal-id journal-id-type="nlm-ta">bioRxiv</journal-id><journal-title-group><journal-title>bioRxiv : the preprint server for biology</journal-title></journal-title-group><issn pub-type="epub">2692-8205</issn></journal-meta><article-meta><article-id pub-id-type="manuscript">EMS200181</article-id><article-id pub-id-type="doi">10.1101/2024.11.16.623933</article-id><article-id pub-id-type="archive">PPR940980</article-id><article-version-alternatives><article-version article-version-type="status">preprint</article-version><article-version article-version-type="number">1</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Connectivity Map and perturbation-based sensitivity analysis identifies MEK inhibitors as senolytics in human lung fibroblasts</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Rad</surname><given-names>Amirhossein Nayeri</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="corresp" rid="CR1">*</xref></contrib><contrib contrib-type="author"><name><surname>Sperger</surname><given-names>Simon</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Marsh</surname><given-names>Leigh M.</given-names></name><xref ref-type="aff" rid="A3">3</xref><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>Hoetzenecker</surname><given-names>Konrad</given-names></name><xref ref-type="aff" rid="A5">5</xref></contrib><contrib contrib-type="author"><name><surname>Lämmermann</surname><given-names>Ingo</given-names></name><xref ref-type="aff" rid="A6">6</xref></contrib><contrib contrib-type="author"><name><surname>Grillari</surname><given-names>Johannes</given-names></name><xref ref-type="aff" rid="A2">2</xref><xref ref-type="aff" rid="A7">7</xref><xref ref-type="aff" rid="A8">8</xref><xref ref-type="corresp" rid="CR1">*</xref></contrib></contrib-group><aff id="A1"><label>1</label>Pharmaceutical Sciences Research Center, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/01n3s4692</institution-id><institution>Shiraz University of Medical Sciences</institution></institution-wrap>, <addr-line>P.O. Box 71468-64685</addr-line>, <city>Shiraz</city>, <country country="IR">Iran</country></aff><aff id="A2"><label>2</label>Ludwig Boltzmann Institute for Traumatology, The Research Center in Cooperation with AUVA, Vienna, Austria</aff><aff id="A3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/009r5p347</institution-id><institution>Ludwig Boltzmann Institute for Lung Vascular Research</institution></institution-wrap>, <city>Graz</city>, <country country="AT">Austria</country></aff><aff id="A4"><label>4</label>Otto Loewi Research Centre, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/02n0bts35</institution-id><institution>Medical University of Graz</institution></institution-wrap>, <city>Graz</city>, <country country="AT">Austria</country></aff><aff id="A5"><label>5</label>Department of Thoracic Surgery, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/05n3x4p02</institution-id><institution>Medical University of Vienna</institution></institution-wrap>, <city>Vienna</city>, <country country="AT">Austria</country></aff><aff id="A6"><label>6</label>Rockfish Bio, Vienna, Austria</aff><aff id="A7"><label>7</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/052f3yd19</institution-id><institution>Austrian Cluster for Tissue Regeneration</institution></institution-wrap>, <city>Vienna</city>, <country country="AT">Austria</country></aff><aff id="A8"><label>8</label>Institute of Molecular Biotechnology, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/057ff4y42</institution-id><institution>BOKU University</institution></institution-wrap>, <addr-line>Vienna, Muthgasse 18</addr-line>, <city>Vienna</city>, <country country="AT">Austria</country></aff><author-notes><corresp id="CR1">
<label>*</label><bold>Co-corresponding authors:</bold> Amirhossein Nayeri Rad, PharmD Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, P.O. Box 71468-64685, Shiraz, Iran. address: <email>psrc_ra@sums.ac.ir</email>; <email>amirhosseinnayerirad@yahoo.com</email>. Mobile phone: +989383118015</corresp><corresp>Johannes Grillari, PhD Associate Professor Ludwig Boltzmann Institute for Traumatology, AUVA Research Center, Donaueschingenstraße 13, 1200 Vienna, Austria address: <email>johannes.grillari@lbg.ac.at</email> Tel: +435939341961</corresp></author-notes><pub-date pub-type="nihms-submitted"><day>19</day><month>11</month><year>2024</year></pub-date><pub-date pub-type="preprint"><day>17</day><month>11</month><year>2024</year></pub-date><permissions><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">CC BY-NC-ND 4.0 International license</ext-link>.</license-p></license></permissions><abstract><p id="P1">Recently, the elimination of the disease-associated accumulation of senescent cells using senolytics has been shown to exert health benefits in animal studies. However, due to the heterogeneity of cell senescence and its unrecognized master regulators, drug development faces a complexity that must be handled. Bioinformatic elucidation of genes and pathways involved in senolysis and prediction of senolytic activity of compounds can cut costs and facilitate faster achievements in the field. In the present investigation, after obtaining the consensus gene signature of senescent fibroblasts of lung origin and deriving its anti-apoptotic module, we utilized Connectivity Map (CMap) alongside small molecule and genetic perturbation sensitivity data in cancer cell lines to identify drugs and genetic interventions that might induce apoptosis or sensitize senescent cells to apoptosis. Through bioinformatic evaluations, we speculate that activation of early stages of autophagy which contributes to the formation of autophagosomes, concurrent with the activation of waste protein concealment system by the mean of p62 and chaperoning system alongside an increase in JUNB gene expression can secure the survival of the senescent cells even when homeostasis of different cellular processes is disrupted. Moreover, our bioinformatic evaluation proposed selumetinib, a MEK inhibitor, as a senolytic against senescent lung fibroblasts. The senolytic activity of a variety of MEK inhibitors in senescent lung fibroblasts was confirmed using human lung fibroblasts in vitro.</p></abstract><kwd-group><kwd>Aging</kwd><kwd>Cellular senescence</kwd><kwd>senolytics</kwd><kwd>MEK inhibitors</kwd><kwd>Connectivity Map</kwd><kwd>Sensitivity</kwd></kwd-group></article-meta></front><body><sec id="S1" sec-type="intro"><title>Introduction</title><p id="P2">Nowadays cancer, aging, and many hyper-inflammatory diseases have been revealed to be linked to cellular senescence [<xref ref-type="bibr" rid="R1">1</xref>]. Thereby, understanding senescence and its underlying signaling pathways might become one of the game-changers in the therapy of a vast range of diseases termed ‘senopathies’ [<xref ref-type="bibr" rid="R2">2</xref>], in which senescent cells are causally involved in the pathogenesis. It has been indicated that the genetics of senescence, depending on the cell origin, is heterogenous and involves different elements [<xref ref-type="bibr" rid="R3">3</xref>, <xref ref-type="bibr" rid="R4">4</xref>]. This heterogeneity has also contributed to a hurdle in universal therapeutic targeting of these cells. A class of these drugs, called senolytics, which induce apoptosis in senescent cells, e.g., dasatinib+quercetin [<xref ref-type="bibr" rid="R5">5</xref>], fisetin [<xref ref-type="bibr" rid="R6">6</xref>], navitoclax [<xref ref-type="bibr" rid="R7">7</xref>], and others [<xref ref-type="bibr" rid="R8">8</xref>] have been shown to exert their effect in a cell-type specific manner. In a previous study, we integrated a set of bioinformatic measurements including transcriptional connectivity attained from Connectivity Map (CMap) and network proximity scores to discover another class of senotherapeutics [<xref ref-type="bibr" rid="R4">4</xref>], called senomorphics, which attenuate the detrimental functions of senescent cells like their inflammatory secretions, named senescence-associated secretory phenotype (SASP) [<xref ref-type="bibr" rid="R9">9</xref>].</p><p id="P3">CMap is a large-scale compendium of the cellular effects of small-molecule and genetic perturbations that calculates the connectivity of the perturbations’ effect with the signature which can be requested through the CLUE Query online platform [<xref ref-type="bibr" rid="R10">10</xref>]. While CMap data are abundantly related to cancer cell lines (not normal cells), a variety of studies have used CMap negative connections to repurpose drugs for a wider range of diseases rather than cancer, like aging [<xref ref-type="bibr" rid="R11">11</xref>], Alzheimer’s disease [<xref ref-type="bibr" rid="R12">12</xref>], osteoporosis [<xref ref-type="bibr" rid="R13">13</xref>], COVID-19 [<xref ref-type="bibr" rid="R14">14</xref>], and bipolar disorder [<xref ref-type="bibr" rid="R15">15</xref>], and some studies have utilized CMap positive connections to identify mimetics inducing a specific phenotype e.g. new caloric restriction mimetics [<xref ref-type="bibr" rid="R16">16</xref>]. Although many studies have taken advantage of CMap in drug discovery, due to the multiplicity of factors (including cell type, duration, dose, etc.) it is still a challenge to increase the predictive performance of the methodologies used for ranking the interventions [<xref ref-type="bibr" rid="R17">17</xref>].</p><p id="P4">In this study, we aimed to discover new senolytics and senolytic targets and gain insight into the underlying mechanism of apoptosis resistance in senescent cells using bioinformatic methodologies and publicly available data. To overcome the heterogeneity problem of different senescent cell types we focused on senescent fibroblasts of lung origin which had numerous RNA sequencing datasets availably deposited in the Gene Expression Omnibus (GEO) database. In addition, administration of senolytics in clinical study of idiopathic lung fibrosis (IPF) has shown to be safe and to at least increase gait speed and 6-min walk distance (6MWD) of IPF patients [<xref ref-type="bibr" rid="R18">18</xref>]. IPF was chosen for the clinical trial due to a clear increase of senescent cells in pre-clinical mouse models as well as in human tissue samples [<xref ref-type="bibr" rid="R19">19</xref>]. However, also other lung diseases qualify as senopathies, including chronic obstructive pulmonary disease (COPD) and lung aging [<xref ref-type="bibr" rid="R20">20</xref>].</p><p id="P5">Therefore, we here report that by compilation of differential gene expression datasets, we acquired a consensus senescence signature of human lung fibroblasts. We then performed a massive interpretation of this senescence signature using bioinformatic gene-set enrichment analysis coupled with a gene-by-gene literature review. Then we extracted the anti-apoptotic module of the signature and scrutinized its association with the pool of transcriptional effects of small-molecule and genetic perturbations attained by CMap. As senolysis is mainly driven by induction of cell death and apoptosis in senescent cells, we further consolidated our CMap-based prediction of senolytic activity with the real large-scale cell viability assessments of the perturbed cells, obtained from the cancer dependency map (DepMap) portal. DepMap which is an online platform for systematic identification of genetic dependencies and small molecule sensitivities [<xref ref-type="bibr" rid="R21">21</xref>], has provided the datasets of genetic loss of function sensitivities from the project Achilles [<xref ref-type="bibr" rid="R21">21</xref>] and small molecule sensitivities from The Cancer Therapeutics Response Portal v2 (CTRP v2) [<xref ref-type="bibr" rid="R22">22</xref>]. Finally, we tested one resulting and promising candidate class, MEK inhibitors, for their potential activity as senolytics using human lung fibroblasts (HLFs).</p></sec><sec id="S2" sec-type="results"><title>Results</title><sec id="S3"><title>Unraveling the consensus senescence signature</title><p id="P6">Differential gene expression was analyzed in 14 datasets from 10 different studies of senescence induction using 3 different senescence inducers (Ras-oncogene induced - OIS, irradiation-induced - IRIS, and replicative senescence - RS) versus proliferating control cells in 2 fibroblast cell lines of lung origin, WI-38 and IMR-90 (<xref ref-type="supplementary-material" rid="SD1">Dataset S1</xref>. <xref ref-type="supplementary-material" rid="SD1">Sheet1</xref>). We performed principal component analysis (PCA) to see how the main principal components of these differential gene expression profiles distribute against each other in a simplified two-dimensional space (<xref ref-type="fig" rid="F2">Fig. 2A</xref>). Differential gene expression profiles in consequence to the 3 different senescence inducers show low inter-cellular variations, while variations due to different inducers were larger. This makes senescent cells of the same origin classifiable based on their mode of induction. Still, we speculated that several of the gene expression levels of these cells including cell cycle arrest, resistance against apoptosis, or their secretory profile must be independent of the senescence inducer. Therefore, we calculated a consensus signature independent of the senescence inducer including 384 upregulated genes and 605 downregulated genes (overall 989 genes) (<xref ref-type="supplementary-material" rid="SD1">Dataset S1</xref>. <xref ref-type="supplementary-material" rid="SD1">Sheet2</xref>). An overview of the bioinformatic workflow is shown in <xref ref-type="fig" rid="F1">Fig. 1</xref>.</p><p id="P7">CDKN1A (p21), one of the prominent markers of senescence, that enforces cell cycle arrest, was included in the signature of upregulated genes of HLFs, while surprisingly, CDKN2A (p16) or TP53 (p53) two other well-known genes involved in the regulation of the cell cycle in senescence were not included. By examining each differential gene expression dataset individually for a consensus senescence signature, we found that p16 was unanimously upregulated, and p53 unexpectedly was downregulated in all OIS datasets. However, this unanimity in either upregulation or downregulation was not observed in RS or IRIS datasets. These emphasize p21 as a better transcriptional diagnostic marker in senescent lung fibroblasts. It must be taken into account that we are just noting the transcription quantity; the protein levels might be determined by post-transcriptional control, too. Moreover, alternative splicing/reading of CDKN2A gene might have affected its undelineated transcriptional level. MSigDB Hallmarks 2020 enrichment analysis of the consensus signature by the Enrichr R tool demonstrated that the upregulated genes were significantly overrepresented in “TNF-alpha Signaling via NF-κB”, “p53 Pathway”, and “KRAS Signaling Up” (<xref ref-type="fig" rid="F2">Fig 2. B</xref>). All three pathways are well connected to senescence: activation of the NF-κB pathway not only induces the SASP, but is also implicated in senescent cell survival [<xref ref-type="bibr" rid="R23">23</xref>], p53 signaling plays a role in directing the fate of cells towards senescence or apoptosis upon cellular stress [<xref ref-type="bibr" rid="R24">24</xref>, <xref ref-type="bibr" rid="R25">25</xref>], while upregulation of RAS in senescence can ensure cellular survival or lead to developing a senescence-associated phenotype by two distinct but interconnected pathways - the RAF/MEK/ERK signaling cascade and the PI3K/AKT pathway [<xref ref-type="bibr" rid="R26">26</xref>, <xref ref-type="bibr" rid="R27">27</xref>].</p><p id="P8">KEGG pathways enrichment analysis of the consensus underexpressed signature, represents the deactivation of pathways related to “Cell cycle”, “DNA replication”, “Fanconi Anemia pathway” and DNA repair mechanisms including “Homologous recombination”, “Mismatch repair”, “Base excision repair”, and “Nucleotide excision repair”. Gene ontology (GO) overrepresentation analysis of the downregulated signature beyond the processes involved in cell cycle, DNA repair, and replication manifests downregulation of the genes which control the epigenome and packaging of the DNA (<xref ref-type="supplementary-material" rid="SD4">Fig. S1</xref> and <xref ref-type="supplementary-material" rid="SD1">Dataset S1</xref>. <xref ref-type="supplementary-material" rid="SD1">Sheet3</xref>).</p></sec><sec id="S4"><title>Manually curated senescence anti-apoptotic signature and its connectivity map</title><p id="P9">The consensus senescence signature was then reduced to only the anti-apoptotic module of the whole signature (anti-apoptotic signature, ASS). On a cautious note, it needs to be taken into account that the attained anti-apoptotic signature does not represent all the genes involved in resistance to cell death or apoptosis, since the method we utilized was designed in a way to decrease the effort needed to manually select (through vast literature mining) the genes with potential anti-apoptotic role in senescence and to reduce the risk of error in our selections. This became true by initially sorting the genes related to apoptosis using Genecards’ algorithmic gene scoring system which helped us to omit the genes that did not have enough evidence in the scientific literature to support their inclusion. However, in order not to miss important genes related to cell survival, prior to the manual literature-mining step, we appended the genes which were annotated by GO to be involved in regulation of cell death, to the list of the genes. Still, there is the possibility that some of the genes which were not well discussed in regard to apoptosis in the literature have been missed. Ultimately, we defined a signature including 59 upregulated genes and 57 downregulated genes whose inverse regulation have been shown to be potentially fatal or sensitize cells to apoptosis (<xref ref-type="table" rid="T1">table. 1</xref>). The evidence for and against the inclusion decision of the selected genes are provided as supplementary document (<xref ref-type="supplementary-material" rid="SD5">Supplementary file 1</xref>). A transcriptional connectivity map of the anti-apoptotic signature was attained by entering up and downregulated signature into the CLUE Query platform.</p></sec><sec id="S5"><title>Discovering potential senolytics utilizing CMap and compound sensitivity assessment</title><p id="P10">CMap retrieved the connectivity of 136460 small-molecule perturbations. Excluding perturbations in negatively correlated cell lines, 116128 perturbations relating to 21858 specific small molecules (compounds) were reached. To perform our analysis, we eliminated data of small molecules which had less than 10 perturbations each and their median TAS was less than 0.1 (TAS has been proposed as a factor representing the transcriptional strength and inter-sample correlation of each perturbation [<xref ref-type="bibr" rid="R10">10</xref>]) which left perturbational data related to 3628 unique compounds (<xref ref-type="supplementary-material" rid="SD2">Dataset S2</xref>. <xref ref-type="supplementary-material" rid="SD2">Sheet1-4</xref>). In order to sort small molecules over their association with the anti-apoptotic signature, we calculated the mean of normalized connectivity scores (NCSs) of each small-molecule entity over its different perturbations (in different cell types, or used concentration, even some were fully replicated in different institutes) and the percentile of this mean connectivity score (MCS) among the scores of all 3628 unique compounds. Previously we used mean squared distance (MSD) scoring to increase the cost of outliers in the final ranking of compounds [<xref ref-type="bibr" rid="R4">4</xref>]. However, this time we suspected that some of the NCS outliers appeared by the extremely different genetic context in which perturbations were exerted. Thus, we removed the perturbations in cell types whose gene signatures were negatively correlated with the anti-apoptotic signature (these cells were: 'HL60', 'JURKAT', 'KMS34', 'MINO', 'NALM6', 'NOMO1', 'OCILY10', 'OCILY3', 'SHSY5Y', 'THP1', 'U2OS' and 'U937') and we did not include their NCSs for calculating the MCS. Thus, we included the remaining data equally (even if any outliers remained after neutralizing the context dependency of the scores) and we further did not think that we needed to penalize the NCSs that were far from the expected result. The MCSs were further used for ranking the compounds.</p><p id="P11">The gene signature, which was used as the representative of each cell line was taken from the standardized gene expression matrix of the Cancer Cell Line Encyclopedia (CCLE) gene expression profiles obtained from the Harmonizome database. The positive MCS of a compound represents direct connectivity of its transcriptional impact with the signature of interest, which would implicate a potential senescence inductive effect. However, the negative MCS of a compound represents inverse connectivity of its transcriptional impact with the signature of interest, which we expect to exert a pro-apoptotic effect on the corresponding cells.</p><p id="P12">The top 10 percentile of the MCSs, with the lowest score of 0.68, included many of the compounds previously indicated to be senescence inducers e.g., etoposide, palbociclib (which is a CDK4/6 inhibitor), vincristine, topotecan, bortezomib, camptothecin, and vinblastine [<xref ref-type="bibr" rid="R28">28</xref>] (<xref ref-type="supplementary-material" rid="SD2">Dataset S2</xref>. <xref ref-type="supplementary-material" rid="SD2">Sheet6</xref>). Carfilzomib, which yet has not been studied for its association with senescence emergence, and bortezomib both are proteasome inhibitors that we previously mentioned to force-overexpress the genes involved in autophagosome formation, mimicking the anti-apoptotic senescence phenotype. Bortezomib and carfilzomib with MCSs of 0.99 and 1.46, placed at the 96.52 and 99.99 percentile of the global MCSs, respectively. It must be remarked that doxorubicin which is widely used as a senescence inducer got an MCS of 0.61 and posed at the 87.95 percentile of MCSs. Intriguingly, thapsigargin which we speculated to simulate senescence transcriptional signaling through endoplasmic calcium regulation, has got an MCS of 0.8 which is placed at the 92.88 percentile of MCSs pool. Since there was not a sufficient number of compounds that have CMap profiles and have been experimentally confirmed to have senolytic effects in lung fibroblasts (even some like fisetin have failed to show senolytic activity against senescent lung fibroblasts [<xref ref-type="bibr" rid="R29">29</xref>]), we were not able to validate in silico whether having an inverse connection has any association with senolytic effects. However, by assuming that the least connected compounds might potentially be senolytic, we selected the bottom 10 percentile of the compounds (MCSs were in the range of -1.07 to -0.52) for a more detailed analysis in the rest of the study (<xref ref-type="supplementary-material" rid="SD2">Dataset S2</xref>. <xref ref-type="supplementary-material" rid="SD2">Sheet7</xref>).</p><p id="P13">Among the 363 selected compounds which were inversely connected to the anti-apoptotic signature, we sought to see if any of these compounds would be known to selectively kill cancer cell lines of similar signatures (directly correlated with both the whole consensus senescence signature and the antiapoptotic signature) against cell lines with dissimilar signature (inversely correlated with both the whole consensus senescence signature and the antiapoptotic signature). Therefore, the standardized CCLE gene expression data were used for identifying the most and the least correlated cell lines’ signatures. We used the standardized CTD<sup>2</sup> drug sensitivity dataset for comparing the compound lethality in correlated cell lines vs inversely correlated ones. The cell lines should have been shared between the CCLE dataset and the CTD<sup>2</sup> sensitivity dataset. In addition, to avoid bias towards any specific lineage of cancer cell lines, at most the two most correlated cell lines in each lineage were included in the analysis). Selected cell lines with respect to their lineage are represented in the <xref ref-type="table" rid="T2">table. 2</xref>.</p><p id="P14">Sensitivity data of merely 11 out of the 363 previously selected compounds were available from CTD<sup>2</sup> dataset (<xref ref-type="supplementary-material" rid="SD2">Dataset S2</xref>. <xref ref-type="supplementary-material" rid="SD2">Sheet8</xref>). Of these 11 compounds, 2 compounds – selumetinib which is a MEK inhibitor, and SJ-172550 which is an MDMX inhibitor – were demonstrated to exert higher toxicity in correlated cell lines vs inversely correlated ones with p-values of 0.00002 and 0.0046, respectively, whereby significance was analyzed by permutation test.</p><p id="P15">To better gain insight into the compound sensitivities in the selected cell lines with respect to all other CTD<sup>2</sup> cell lines, we calculated the percentile of the mean sensitivity in correlated cell lines and inversely correlated cell lines separately. Data is reported in <xref ref-type="table" rid="T3">table. 3</xref>. Next, we evaluated replicate level viability data (replicate-level viability dataset which is provided by DepMap, includes the detailed measured viabilities of cells in exposure to different concentrations of the compounds, each in replicates, which are all reported) of selumetinib and SJ-172550 to ensure that the effects of the compounds on cell numbers in correlated cell lines vs inversely correlated cell lines is indeed due to toxicity and would not be confounded by a potential proliferation-enhancing effect in inversely correlated cell lines (<xref ref-type="supplementary-material" rid="SD2">Dataset S2</xref>. <xref ref-type="supplementary-material" rid="SD2">Sheet9</xref>). The mean viability of both correlated and inversely correlated cell lines exposed to SJ-172550 were more than 1 which was indicative of a proliferation-enhancing effect mostly toward inversely correlated cell lines. Therefore, through our bioinformatics assessments, selumetinib remained the only compound that we identified as a candidate senolytic for experimental testing.</p></sec><sec id="S6"><title>Bioinformatic uncovering of the gene regulatory system underlying senescence resistance to apoptosis</title><p id="P16">We utilized similar methodologies as we used for bioinformatic analysis of small molecules with some modifications, to find out the underlying signaling which might contribute to the senescence apoptosis resistance. By gaining knowledge about the master regulators of this cellular anti-apoptotic trait, researchers would be able to target these genes or processes to discover high efficiency senolytics. Genetic perturbations in the CMap, contrary to the small-molecule perturbations, are bi-directional, which means that the direction of the regulation of the gene had to be taken into account in our analyses. We used two different approaches to evaluate the connectivity of single gene regulation with the emergence of the anti-apoptotic signature (schematically represented in <xref ref-type="fig" rid="F1">Fig. 1</xref>). First, we applied the same MCS-based ranking for the perturbations that negatively regulate the gene direction of expression in the anti-apoptotic signature. It means that for the overexpressed genes in the anti-apoptotic signature we employed the NCSs of the loss of function perturbations (including CRISPR and shRNA knockdown) and for the underexpressed genes we used the NCSs of the gain of function perturbations (overexpression). The more negative MCS would hypothetically demonstrate that the inverse regulation of the corresponding gene can potentially counteract the whole anti-apoptotic signature, leading to cell death. Genes with the 5 smallest MCSs are represented based on 3 different functions of their perturbations (overexpression, CRISPR knockdown, and shRNA knockdown) (<xref ref-type="supplementary-material" rid="SD3">Dataset S3</xref>. <xref ref-type="supplementary-material" rid="SD2">Sheet2-4</xref>). We also pooled the data of both CRISPR and shRNA knockdown perturbations and calculated the MCSs based on the NCSs of the whole pooled loss of function perturbations (gene interventions with the 10 least MCSs are represented in the <xref ref-type="supplementary-material" rid="SD3">Dataset S3</xref>. <xref ref-type="supplementary-material" rid="SD3">Sheet5</xref>). Second, regardless of the ranking of the genes, we looked if the regulation of each gene in two opposite directions could differentially drive the cells towards two significantly distinct transcriptional fates: the one with the same direction as the direction of the gene in the anti-apoptotic signature, towards senescence induction (more specifically, towards raising the senescence apoptosis-resistance machinery), and the other one against the direction of the gene in the anti-apoptotic signature, towards undermining the pro-survival signalings. To carry it out, for the genes in the overexpressed anti-apoptotic signature we examined if the MCS of their overexpression is significantly larger than the MCS of their pooled loss of function, and for the genes in the underexpressed anti-apoptotic signature we examined if the MCS of their pooled loss of function is significantly greater than the MCS of the overexpression (significance was evaluated by permutation test).</p><p id="P17">The results of this analysis are shown in the <xref ref-type="supplementary-material" rid="SD3">Dataset S3</xref>. <xref ref-type="supplementary-material" rid="SD3">Sheet6-7</xref>. Collectively, based on the rankings and the impact of single genes in the active shaping of the anti-apoptotic vs the alleged apoptotic signature, we identified potential key players of this system. According to our data, we suggest that EZH2 and PCNA are the two most determining genes in the underexpressed anti-apoptotic signature. Among the upregulated genes, JUNB, SQSTM1, PRDX2, and CDKN1A (p21) are the master transcriptional regulators whose impairment of each might presumably be a powerful tool to induce apoptosis in senescent cells (especially lung fibroblasts). In the next step, similar to the bioinformatic test that we designed for analyzing cell death upon exposure of the senescence-mimicking cell lines to small molecules, due to the availability of gene LOF sensitivity data in cell lines (sensitivity data related to gene gain of function were not available), we could inspect through real sensitivity data to identify that the depletion of which overexpressed genes would be potentially fatal in senescent fibroblasts. Correlated cell lines and inversely correlated cell lines which were used for comparative sensitivity analysis of the CRISPR and RNAi knockdowns are shown in <xref ref-type="supplementary-material" rid="SD1">Dataset S1</xref>. <xref ref-type="supplementary-material" rid="SD1">Sheet5</xref>. Our bioinformatic assessments demonstrate that JUNB loss by either CRISPR or RNAi depletion led to a significantly increased cell death in correlated cell lines in comparison to the inversely correlated ones (<xref ref-type="supplementary-material" rid="SD3">Dataset S3</xref>. <xref ref-type="supplementary-material" rid="SD3">Sheet8-9</xref>).</p><p id="P18">In addition, RNAi LOF perturbation hints towards the expression of SQSTM1, LIF, and AREG as important genes in counteracting apoptosis in cell lines mimicking the here identified senescence signature and its anti-apoptotic module (<xref ref-type="table" rid="T4">Table. 4</xref>).</p></sec><sec id="S7"><title>MEK inhibitors are senolytic in human lung fibroblasts in vitro</title><p id="P19">To confirm the bioinformatic prediction regarding the senolytic activity of selumetinib in senescent lung fibroblasts, quiescent versus senescent human lung fibroblasts, HLF102, were treated with selumetinib. Stress-induced premature senescence (SIPS) was triggered using doxorubicin as shown in the scheme (<xref ref-type="fig" rid="F3">Fig. 3A</xref>) as well established in previous works [<xref ref-type="bibr" rid="R30">30</xref>–<xref ref-type="bibr" rid="R32">32</xref>]. Interestingly, selumetinib selectively killed senescent cells with an IC50 of around 8.35 µM, while quiescent control IC50 values were at 51.82 µM (<xref ref-type="fig" rid="F3">Fig. 3B</xref>). To test, if the senolytic activity can be generalized to the whole class of MEK inhibitors, we selected four additional MEK inhibitors: Binimetinib, Cobimetinib, Mirdametinib and Tramentinib. Indeed, all here tested MEK inhibitors displayed senolytic activity (<xref ref-type="fig" rid="F3">Fig. 3C-F</xref>), with Trametinib showing an IC50 in the nanomolar range with 0.06 µM and a fold difference to quiescent control cells of around 70 fold with an IC50 of 4.14 µM.</p></sec></sec><sec id="S8" sec-type="discussion"><title>Discussion</title><p id="P20">Here we report an innovative in silico approach to identify pathways and gene networks involved in making senescent human lung fibroblasts refractory to apoptosis and to identify potential drugs that can act as senolytic in this context. This analysis was based on re-using publicly available data and resulted in identification of a senescence signature that fits very well into current knowledge of the field, as outlined in detail below. In addition, it resulted in identification of MEK inhibitors as indeed senolytic in the context of in vitro lung fibroblast senescence.</p><sec id="S9"><title>Senescence signature: cell cycle, and DNA repair and replication</title><p id="P21">Cell cycle arrest besides DNA replication and repair defects as represented in the KEGG pathways enrichment analysis of the obtained consensus senescence signature have been widely accepted as hallmarks of senescence [<xref ref-type="bibr" rid="R30">30</xref>, <xref ref-type="bibr" rid="R31">31</xref>], also in vivo [<xref ref-type="bibr" rid="R32">32</xref>]. A large number of DNA repair genes are listed in downregulated signature, however, a study showed inhibiting two of the genes, BRCA1, and BLM (both are in the underexpressed signature) might contribute to the downregulation of most other DNA repair genes and eventually cause senescence [<xref ref-type="bibr" rid="R31">31</xref>]. Fanconi Anemia proteins are mostly involved in DNA repair processes, and their overexpression has been shown to counteract oncogene-induced senescence [<xref ref-type="bibr" rid="R33">33</xref>, <xref ref-type="bibr" rid="R34">34</xref>]. Proliferating cell nuclear antigen (PCNA) is one of the downregulated genes that encodes a protein that interacts with a large network of proteins involved in DNA replication and repair and its downregulation probably impacts a large number of associated processes [<xref ref-type="bibr" rid="R35">35</xref>]. PCNA expression is inversely regulated by p21 which is congruent with our signature [<xref ref-type="bibr" rid="R36">36</xref>]. Similarly, nucleotide metabolism is changed due to decrease of RRM1 and RRM2 which provide the nucleotide pool for DNA replication. Surprisingly, RRM2B is overexpressed and probably provides basal levels of deoxyribonucleoside triphosphates (dNTPs) for the remainder of DNA repair activity in senescent cells similar to hypoxic cells, preventing their death [<xref ref-type="bibr" rid="R37">37</xref>]. Elevated expression of RRM2B in senescent cells [<xref ref-type="bibr" rid="R38">38</xref>] and a causal role of RRM2 depletion in senescence induction [<xref ref-type="bibr" rid="R39">39</xref>] were previously reported.</p></sec><sec id="S10"><title>Senescence signature: epigenetic modifications</title><p id="P22">GO overrepresentation analysis of the senescence signature as demonstrated in the Results section represent epigenetic changes and chromatin remodeling taking place in senescent lung fibroblasts. GO biological processes of “chromatin organization”, “positive regulation of histone H3-K4 methylation” and “negative regulation of histone H3-K9 methylation” are enriched in the downregulated signature. Both DNA methylation by downregulation of DNMT1 and DNMT3B and DNA demethylation by downregulation of TET1 and TET2 are at least transcriptionally decreased according to the consensus senescence signature. Consistently, it was shown that knockdown of DNMT1 triggers premature senescence, however, DNMT3B has been reported to be elevated at the protein level in senescent fibroblast cells of lung origin [<xref ref-type="bibr" rid="R40">40</xref>]. This controversy may arise from the post-transcriptional regulation and metabolism of DNMT3B which needs to be investigated. The authors further reported that congruent with their findings, replicative senescent human cells characteristically exhibit widespread DNA hypomethylation and focal hypermethylation [<xref ref-type="bibr" rid="R40">40</xref>]. Global DNA hypomethylation has been shown to be induced by the impaired function of BRCA1 through regulation of DNMT1 expression [<xref ref-type="bibr" rid="R41">41</xref>], therefore BRCA1 decrease as it is observed in the consensus signature might be regarded as one of the main culprits of large-scale chromatin remodeling and consequently senescence induction [<xref ref-type="bibr" rid="R42">42</xref>].</p><p id="P23">SETD2, SETMAR, and EZH2 are the genes that encode proteins with histone methyltransferase activity, and they are all in the underexpressed signature.</p><p id="P24">CBX1, CBX2, CBX5, ASF1B, SMCH1, High-Mobility Group genes (including HMGB1, HMGB2, HMGB3, and HMGN2) and condensin/cohesion complex genes (condensing I subunits including SMC2, SMC4, NCAPD2, NCAPH, and NCAPG; condensing II subunits including SMC2, SMC4, and NCAPG2; cohesion subunits including SMC1a and RAD21) are other genes that are all downregulated and are involved in epigenetic control or remodeling of the chromatin. CBX1 encodes Heterochromatin Protein 1-Beta (HP1 beta), and CBX5 encodes Heterochromatin Protein 1-Alpha (HP1 alpha). It is shown that high-level HP1 proteins, which are involved in heterochromatin formation, are not required for evolving the senescence-associated heterochromatin foci (SAHF) and other hallmarks of senescence, such as the expression of senescence-associated β-galactosidase activity. However, how its decrease might contribute to SAHF needs to be examined [<xref ref-type="bibr" rid="R43">43</xref>]. Similarly, ASF1B which is a histone chaperone has been argued to have failed to induce SAHF stems, at least in part, from its failure to bind HIRA [<xref ref-type="bibr" rid="R44">44</xref>], still, whether endogenous downregulation of this gene in senescent lung fibroblasts has anything to do with SAHF needs to be investigated.</p><p id="P25">SETMAR enhances nonhomologous end-joining (NHEJ) DNA repair by di-methylating H3K36 at DNA double-strand breaks (DSBs) [<xref ref-type="bibr" rid="R45">45</xref>], hence its downregulation might impair DSB repair in senescence. Similarly, SETD2 is reported to be responsible for methylation of H3K36, however, it only confers its tri-methylation, not mono- or di-methylation [<xref ref-type="bibr" rid="R46">46</xref>, <xref ref-type="bibr" rid="R47">47</xref>]. To our knowledge depletion of SETMAR and SETD2 genes in senescence have not been investigated properly yet, this necessitates further studies to decipher their effect on chromatin organization and the gene expression regulation or DNA damage or replication responses in senescent cells.</p><p id="P26">EZH2 is the catalytic core protein of polycomb repressor complex 2 (PRC2) which transfers methyl to histone H3 at the lysine 27 (H3K27). Furthermore, CBX2 and SCMH1 which are among the core proteins in polycomb repressor complex 1 (PRC1) participate in transcriptional repression of the downstream genes by targeting the tri-methylated H3K27 residue (H3K27me3) after the methylation by PRC2 [<xref ref-type="bibr" rid="R48">48</xref>, <xref ref-type="bibr" rid="R49">49</xref>]. It is shown that the downregulation of EZH2 promotes senescence through the initiation of a DNA damage response independent of the loss of H3K27me3 and then by the overexpression of the p16 (CDKN2A) which is induced by the subsequent depletion of H3K27me3 [<xref ref-type="bibr" rid="R50">50</xref>]. In another study, repression of H3K27 methylation with the EZH2 inhibition provided survival benefit and conferred chemotherapy resistance in testicular germ cell tumors while induction of H3K27 methylation with the histone lysine demethylase inhibition resulted in increased cisplatin sensitivity [<xref ref-type="bibr" rid="R51">51</xref>]. Interestingly, EZH2 downregulation has also been reported as one of the main drivers of UVB-induced senescence program in dermal fibroblasts [<xref ref-type="bibr" rid="R52">52</xref>]. Similarly, the SCMH1 transcription defect has been shown to induce premature senescence in mouse embryonic fibroblasts [<xref ref-type="bibr" rid="R53">53</xref>]. In addition, depletion of PHF19 which regulates PRC2 function has been shown to strongly reduce the global levels of H3K27me3 [<xref ref-type="bibr" rid="R54">54</xref>]. In a distinct study, it is demonstrated that PHF19 depletion causes an increase in the accumulation of H3K27me3 in genes associated with differentiation (not all genes) of hematopoietic stem cells [<xref ref-type="bibr" rid="R55">55</xref>], hence it can be deduced that PHF19 depletion is a cellular mean for abortion of differentiation capability of cells, probably the same thing as what happens in senescence.</p><p id="P27">Consistent with what gene ontology analysis of the signature denotes on the enrichment of the downregulated genes in the biological process of negative regulation of histone H3K9 methylation, it is previously reported that the depletion of PHF2, which is a histone demethylase, leads to the accumulation of H3K9me3 and causes an increase in heterochromatin-related marks at global levels [<xref ref-type="bibr" rid="R56">56</xref>]. Interestingly, TET1-depleted lung cancer cells demonstrated a reduction of dimethylated histone H3K9 (H3K9me2). This depletion sensitized the cells for therapy-induced senescence. The effect was shown to be independent of the defect in the demethylation of CpG islands [<xref ref-type="bibr" rid="R57">57</xref>]. Regarding the aforementioned studies on the role of chromatin remodeling players we hypothesize that in senescence, histone H3K9s proceed toward more tri-methylation and less di-methylation. Previous studies support this hypothesis. One study manifested that H3K9me3 mediates epigenetic regulation of senescence [<xref ref-type="bibr" rid="R58">58</xref>]. Another study approved the global decline of H3K9me2 in senescent cells. This decline contributed to the escalation of inflammatory responses which resembled characteristics of SASP [<xref ref-type="bibr" rid="R59">59</xref>]. It has been suggested that reduced H3K9me2 enhances the binding of NFκB and AP-1 (activator protein-1) transcription factors at specific inflammation-responsive genes to augment proinflammatory stimuli [<xref ref-type="bibr" rid="R60">60</xref>]. Therefore, epigenetic changes can elucidate the underlying event which gives rise to the prominent characteristics of senescence including SAHF and SASP. It has to be taken into account that histone methylation profiles may differ on a local scale compared to a global scale. As it is shown that the loss of Lamin B Receptor (LBR) in fibroblasts of lung origin, reduced H3K9me3 heterochromatin marks in lamina-associated domains (LADs) region of DNA and heightened transcription of LAD-associated repetitive elements. The loss led to senescence in the cells [<xref ref-type="bibr" rid="R61">61</xref>].</p><p id="P28">Among downregulated non-histone proteins that modify the chromatin organization, two proteins of HMGB1 and HMGB2 have been studied in terms of their association with senescence. HMGB1 and HMGB2 bind to distinct genomic loci, however, target loci of both HMGB1 and HMGB2 are usually upregulated once relieved of HMGB1 and HMGB2 binding, respectively. The loss of HMGB1 has been demonstrated to trigger p21 activation or SASP induction, in contrast, the loss of HMGB2 does not induce senescence but triggers senescence-induced CTCF clustering and loop reshuffling which act as a primer for the ensuing senescent program [<xref ref-type="bibr" rid="R62">62</xref>, <xref ref-type="bibr" rid="R63">63</xref>]. The only gene that has been proven to affect chromatin organization and was upregulated in the consensus signature is TERF2IP. TERF2IP overexpression in senescence has been shown to protect critically short telomeres and its depletion in senescent cells that return to growth upon p21 inhibition caused higher levels of apoptosis [<xref ref-type="bibr" rid="R64">64</xref>]. TERF2IP interacts directly with H3/H4 histone tetramers and mediates chromatin opening required for new gene expressions in senescence [<xref ref-type="bibr" rid="R65">65</xref>]. In addition, TERF2IP has been demonstrated to repress histone gene expression and contribute to the global downregulation of histones in senescent cells [<xref ref-type="bibr" rid="R66">66</xref>]. In a different study, the depletion of total histone content in senescent cells was shown to be dependent on lysosomal-mediated proteolytic processing [<xref ref-type="bibr" rid="R67">67</xref>]. The nuclear leakage of chromatin is proposed to be caused by Lamin B1 (LMNB1) nuclear membrane protein loss in senescence and thereafter ubiquitinated chromatin is carried by adaptor protein, p62, to lysosomes for digestion [<xref ref-type="bibr" rid="R67">67</xref>]. Interestingly the consensus signature direction of gene expression is in agreement with these phenomena including LMNB1 and LMNB2 downregulation and p62 and cathepsins (CTSB and CTSS) upregulation.</p></sec><sec id="S11"><title>Senescence signature: Acidity, proteostasis and calcium regulation</title><p id="P29">Cytosolic decrease in acidity has been proposed as one of the drivers of apoptosis [<xref ref-type="bibr" rid="R68">68</xref>]. A study demonstrated that cardiac glycosides probably by induction of a dramatic drop in cytosolic pH of senescent cells contribute to apoptosis, so-called senolysis, of these cells [<xref ref-type="bibr" rid="R69">69</xref>]. In a recent study glutaminolysis by senescent cells has been presented as these cells’ defense tool against apoptosis which increases intracellular pH or at least counteracts pH drop by producing ammonia [<xref ref-type="bibr" rid="R70">70</xref>]. GLS gene expression is not increased in our consensus signature, however, analysis of gene ontology (<xref ref-type="supplementary-material" rid="SD4">Fig. S1</xref>) shows a reduction in intracellular organelles’ pH by an increase in genes involved in proton transport mainly by V-ATPases (ATP6AP1, ATP6AP2, ATP6V0A1, ATP6V0B, ATP6V0C, ATP6V1C1, ATP6V1E1, ATP6V1F, ATP6V1G1, ATP6V1H), and chloride transport by Chloride Voltage-Gated Channel 3 (CLCN3) [<xref ref-type="bibr" rid="R71">71</xref>], this theoretically accompanies the increase in cytosolic pH. It was shown that the granulocyte colony-stimulating factor (G-CSF) by upregulating the V-ATPase delays apoptosis in neutrophils through abolishing cytosolic acidification during the early stages of apoptosis [<xref ref-type="bibr" rid="R72">72</xref>]. Also, the NHE1 channel (SLC9A1) which has been shown to elicit an anti-apoptotic effect by cellular outport of protons has been upregulated in the signature [<xref ref-type="bibr" rid="R73">73</xref>, <xref ref-type="bibr" rid="R74">74</xref>]. Contrary to previous reports of lysosomal alkalinization in senescent cells which had been deduced from observations in aging-related studies, upregulation of V-ATPases and CLCN3 beside MCOLN1 (TRPML1) [<xref ref-type="bibr" rid="R75">75</xref>] and OSTM1 might contribute to increased acidity of lysosomal lumina at least from transcriptional perspective. It must be noted that the increase in expression of genes involved in the regulation of intracellular pH might just be a compensatory response to the disrupted permeability of the lysosomal membrane that contributes to lysosomal leakage of protons in senescent cells. This cross-compartmental maintenance of pH balance rescues the senescent cells from apoptosis [<xref ref-type="bibr" rid="R76">76</xref>]. Moreover, GO biological processes involved in phagosome acidification and maturation have been enriched in the upregulated signature. Further digging into the signature, we found out that the expression of SQSTM1 (P62), MAP1LC3B (LC3B), GABARAPL2, and ATG4A which are the genes involved in autophagosome formation and biogenesis are elevated. Intriguingly proteasome inhibition has been demonstrated to induce a similar phenotype and rapidly elevate the expression of p62, LC3B, and ATG4A regardless of activation of other compartments of autophagy [<xref ref-type="bibr" rid="R77">77</xref>]. This has been shown to have a survival benefit for the cells even before the commencement of autophagy [<xref ref-type="bibr" rid="R77">77</xref>]. In this sense, distinct proteasome subunits were downregulated in differential gene expression datasets of replicative and RAS-induced senescence which we employed in this study; however, none were included in the consensus signature. In replicative senescence proteasome subunits of PSMA4, PSMA7, PSMB1, PSMB7, PSMC3, PSMD11, PSMD14, PSME3, PSMG1, and PSMG3 were downregulated, and in RAS-induced senescence, PSME1 and PSMB9 were downregulated. Some of the subunits of proteasome were overexpressed in RAS-induced senescence but none in replicative senescence (data not shown). The reduced proteasomal activity was previously reported in replicative senescence [<xref ref-type="bibr" rid="R78">78</xref>], however, whether the response to proteotoxic stress is similar in differently triggered senescent cells, has to be investigated. In addition, there are some conflicting results over the autophagy activation in senescent cells. Some of the most comprehensive studies confirm the activation of autophagy in fully executed RAS-induced senescence [<xref ref-type="bibr" rid="R79">79</xref>, <xref ref-type="bibr" rid="R80">80</xref>]. Surprisingly, besides the autophagy-related genes that we noted, ATG101, ULK3, and ATG4D were exclusively overexpressed in datasets of RAS-induced senescence that we employed, but not in other forms of senescence. Studies that are denying the activation of autophagy in senescence mostly studied the role of autophagy in senescence induction rather than evaluating the effect on fully senescent cells. We speculate that impaired autophagy, as it happens during aging or direct stress to the compartments of autophagy, is a risk factor for senescence induction [<xref ref-type="bibr" rid="R81">81</xref>–<xref ref-type="bibr" rid="R83">83</xref>]. However, it seems when a cell is fully senescent, activation of different forms of autophagy including chaperone-mediated and selective autophagy might be crucial for confronting proteotoxic stresses and maintaining cell survival [<xref ref-type="bibr" rid="R84">84</xref>]. TPCN1 which is encoding a two-pore channel and TRPML1 regulate intracellular Ca<sup>2+</sup> through endolysosomal system [<xref ref-type="bibr" rid="R85">85</xref>, <xref ref-type="bibr" rid="R86">86</xref>]. Overexpression of these two genes probably increase calcium release to cytosol. In line with the increased cytosolic calcium and consequent altered signaling, TRPML1 expression has been shown to upregulate autophagic genes, increase autophagosomal biogenesis, and autophagosome-lysosome fusion [<xref ref-type="bibr" rid="R85">85</xref>]. Beside TPCN1 and TRPML1 two other genes of ITPR1 and TRPA1 are also included in the consensus upregulated signature which is enriched for GO molecular function of “calcium-release channel activity” (<xref ref-type="supplementary-material" rid="SD4">Fig. S1</xref> and <xref ref-type="supplementary-material" rid="SD1">Dataset S1</xref>. <xref ref-type="supplementary-material" rid="SD1">Sheet3</xref>). ITPR1 is responsible for the release of calcium from the endoplasmic reticulum upon activation by cytosolic Ca<sup>2+</sup> and IP3. TNF-α signaling and subsequent increase in PKC-α (PRKCA), have been demonstrated to contribute to ITPR1 (IP3R1) overexpression and an increase in cytosolic Ca<sup>2+</sup> release. In the study, RNAi targeting PKC-α inhibited TNF-α-induced IP3R1 overexpression and restored cytosolic Ca<sup>2+</sup> concentration [<xref ref-type="bibr" rid="R87">87</xref>]. The increased calcium release activates a number of pathways which consequently leads to the development of some of the phenotypes of senescence, like the inflammatory ones [<xref ref-type="bibr" rid="R88">88</xref>]. IP3R1 knockdown has been shown to promote escape from OIS [<xref ref-type="bibr" rid="R89">89</xref>]. Cytosolic calcium release has also been discussed in many studies as the driver of apoptotic cell death [<xref ref-type="bibr" rid="R90">90</xref>]. However, simultaneous activation of unfolded protein response (UPR) mediated by ERN1 (IRE1) has been shown to protect cells from apoptosis as ERN1 knockdown led to apoptosis by IP3R1-mediated calcium release [<xref ref-type="bibr" rid="R91">91</xref>]. UPR is the cell reaction to the accumulation of misfolded proteins above a critical threshold, in order to restore the defect in protein homeostasis [<xref ref-type="bibr" rid="R92">92</xref>]. GO analysis confirms enrichment of the upregulated signature in the biological process of “IRE1-mediated unfolded protein response”. IRE1 overexpression was previously reported to be implicated in promoting HRas-induced senescence [<xref ref-type="bibr" rid="R93">93</xref>]. We hypothesize that in ER of senescent cells, UPR and calcium homeostasis are finely balanced so that the outcome is evasion from apoptotic cell death despite the proteostasis fragility in senescent cells [<xref ref-type="bibr" rid="R94">94</xref>]. Transcriptional increase of the co-chaperone, DNAJB9, the downstream of ERN1-mediated UPR activation [<xref ref-type="bibr" rid="R95">95</xref>] not only regulates ERN1 activation in a feedback manner [<xref ref-type="bibr" rid="R96">96</xref>] but also has been shown to exert an antiapoptotic effect by physical interaction with p53; therefore, it is one of the possible routes how ERN1 activation might abolish apoptosis [<xref ref-type="bibr" rid="R97">97</xref>]. We speculate that ERN1 upregulation in the signature is the consequence of demethylation of histone H3K27-me3 at the promoter region of ERN1 enforced by EZH2 downregulation [<xref ref-type="bibr" rid="R98">98</xref>] in senescent cells. ER calcium depletion by genetic ablation of sarco/endoplasmic reticulum Ca<sup>2+</sup>-ATPase (SERCA2) or by its inhibition using thapsigargin has been demonstrated to induce senescence phenotype [<xref ref-type="bibr" rid="R99">99</xref>]. Intriguingly, thapsigargin not only simulates ER stress and UPR, but also enhance autophagosome formation, similar to our findings through the consensus signature of senescence. However, thapsigargin probably due to the vast alteration of intracellular calcium signaling disrupts autophagosome-lysosomal fusion and ultimate autophagy flux [<xref ref-type="bibr" rid="R100">100</xref>]. A more thorough mechanistic evaluation of the senescence-mimetic effect of thapsigargin may help enlighten the root causes of transcriptional changes in senescence.</p></sec><sec id="S12"><title>Senescence signature: Lipid metabolism</title><p id="P30">The other concurrently activated pathway that took our attention while interpreting the consensus signature is the increased metabolism of sphingolipids which is enriched in both KEGG pathways and GO biological processes. KDSR upregulation is at the forefront of the pathway involved in the de novo production of ceramide and sphingosine [<xref ref-type="bibr" rid="R101">101</xref>]. The balance between the accumulation of ceramides by overexpression of GBA and CERS2, and the accumulation of sphingosine and sphingosine-1-phosphate (S1P) by upregulation of ACER2 presumably have led the cells to preferably go toward senescence state rather than apoptosis. It is shown in a study, that ACER2 upregulation increases the levels of both sphingosine and S1P while decreases the levels of ceramides in cells. They have manifested that a moderate upregulation of ACER2 in an interplay with p53 signaling gives rise to cellular senescence by elevating S1P, a pro-proliferative and pro-survival bioactive lipid [<xref ref-type="bibr" rid="R102">102</xref>]. Consistently, knockout of NSMAF (FAN), which is downregulated in our signature and was reported to mediate tumor necrosis factor-induced activation of neutral sphingomyelinase, has been demonstrated to reduce cellular ceramide level by inhibiting CD40 ligand-induced sphingomyelinase stimulation. The changes eventually abrogated apoptosis of human fibroblasts [<xref ref-type="bibr" rid="R103">103</xref>]. In this regard, cleavage of ceramide into sphingosine by acid ceramidase (ASAH1) has been reported to potentiate resistance of senescent cells against senolytics. ASAH1 was not included in our consensus signature, however, surprisingly, we noticed that it has been upregulated in all datasets of RS and IRIS (not OIS) [<xref ref-type="bibr" rid="R104">104</xref>]. The other overexpressed gene involved in the metabolism of sphingolipids is prosaposin (PSAP) which facilitates the catabolism of glycosphingolipids. Overexpression of this gene was demonstrated to mediate inflammatory responses [<xref ref-type="bibr" rid="R105">105</xref>] which may associate with SASP. Furthermore, ADIPOR1 overexpression which is linked with ceramide catabolism might have contributed to skewing the balance toward an enhanced formation of S1P, ultimately exerting an antiapoptotic effect [<xref ref-type="bibr" rid="R106">106</xref>].</p></sec><sec id="S13"><title>Senescence signature: ERK</title><p id="P31">GO analysis of the molecular functions of the overexpressed signature also indicates enrichment of “MAP kinase phosphatase activity” via 3 Dual-specificity phosphatases (DUSP3, DUSP4, and DUSP6) which dephosphorylate active mitogen-activated protein kinases (MAPKs) including ERK1/2. It is shown that DUSP4 ablation of gene expression or expression of the phosphatase-resistant ERK2 postpones replicative senescence [<xref ref-type="bibr" rid="R107">107</xref>]. Another study reported reduced phosphorylated ERK representing the impaired ERK activation in senescence and pointed to the increased DUSP6 expression as the culprit of this defect. Their investigation has also shown that the loss of DUSP6 activity in senescent cells restores ERK1/2 phosphorylation and promoted cell proliferation [<xref ref-type="bibr" rid="R108">108</xref>], however, they have not studied any other hallmarks of senescence. We hypothesize that the DUSP6 transcriptional activation is probably the apoptotic-rescue response of the prolonged overactivation of ERK1/2 which if persisted could lead to cell death [<xref ref-type="bibr" rid="R109">109</xref>, <xref ref-type="bibr" rid="R110">110</xref>].</p></sec><sec id="S14"><title>Senescence signature: Mitochondrial homeostasis</title><p id="P32">The consensus signature also reflects changes in mitochondrial homeostasis. It has been indicated that while ATP production through glycolysis increases in senescent cells, the overall production of ATP mainly through impaired oxidative phosphorylation is reduced [<xref ref-type="bibr" rid="R111">111</xref>–<xref ref-type="bibr" rid="R113">113</xref>]. However, it turns out that in the signature, mitochondrial genes involved in oxidative phosphorylation, which is overrepresented in KEGG pathways, are upregulated. The upregulated genes including ND1, ND2, ND3, ND4, ND4L, ND5, COQ10B, and CYTB are enrolling in the respiratory electron transport chain. This overexpression, besides the underlying increase in mitochondrial gene copy number in senescent cells (due to increased mitochondrial biogenesis), might be representative of the effort of the cells to repair the defect in ATP production through oxidative phosphorylation. By exploring the signature, we found out that the directions of regulation of some of the genes are in agreement with the notion of the failure in the electron respiratory chain. One of the genes is MTFR2 (DUFD1) which is involved in mitochondrial fission, and its expression is ameliorated in the consensus senescence signature. It is shown that its Inhibition severely impairs O2 consumption which is indicative of its importance in mitochondrial respiration [<xref ref-type="bibr" rid="R114">114</xref>]. Similar to cytosolic and ER calcium homeostasis that we discussed mitochondrial calcium homeostasis has a crucial role in the induction of cellular senescence. Loss of FUS1, which is a DNA/RNA-binding protein with multiple functions, in a study (also downregulated in the signature) caused inefficient accumulation of Ca<sup>2+</sup> in mitochondria and decreased respiratory reserve capacity [<xref ref-type="bibr" rid="R115">115</xref>]. MCUB encodes a protein that negatively regulates the activity of the mitochondrial inner membrane calcium uniporter (MCU) [<xref ref-type="bibr" rid="R116">116</xref>]. MCU mediates calcium uptake into the mitochondria [<xref ref-type="bibr" rid="R117">117</xref>]. Therefore, the downregulation of MCUB in the senescence signature must have brought about the increase in mitochondrial calcium level [<xref ref-type="bibr" rid="R118">118</xref>]. It has been shown that during OIS, ITPR2 (most probably the same role for IP3R1) triggers calcium release from the endoplasmic reticulum, followed by mitochondrial calcium accumulation through MCU channels. Mitochondrial calcium accumulation has been claimed to lead to a subsequent decrease in mitochondrial membrane potential, reactive oxygen species accumulation, and senescence perse [<xref ref-type="bibr" rid="R89">89</xref>].</p><p id="P33">SLC25A40 (Solute Carrier Family 25 Member 40) which is a paralog of the gene SLC25A39, is probably involved in the mitochondrial import of glutathione. Mitochondrial glutathione by detoxifying ROS is required for the activity and stability of proteins that contain iron-sulfur clusters, involved in respiratory electron transport [<xref ref-type="bibr" rid="R119">119</xref>]. Thus, downregulation of this gene in the signature put mitochondrial respiration more prone to ROS-induced damage. CISD1 (MitoNEET) is another gene whose expression is enhanced according to the senescence signature. MitoNEET is a protein that contains a 2Fe–2S cluster and is located at the outer mitochondrial membrane. It is involved in the regulation of electron transport and oxidative phosphorylation [<xref ref-type="bibr" rid="R120">120</xref>]. Also, it regulates cellular iron and ROS homeostasis [<xref ref-type="bibr" rid="R121">121</xref>]. The expression brings about resistance to iron-mediated cell death (ferroptosis) [<xref ref-type="bibr" rid="R122">122</xref>] which is congruent with the previous reports of increased resistance to ferroptosis in senescent cells [<xref ref-type="bibr" rid="R123">123</xref>]. Looking through the signature, sideroflexin 2 (SFXN2) is another downregulated gene that is associated with mitochondrial transmembrane transport. knockout (KO) of SFXN2 in a study has been shown to increase mitochondrial iron content, which is suggested to be associated with decreases in the heme content. The authors claimed the abnormal iron metabolism impaired mitochondrial respiration in SFXN2-KO cells which can be similar to the phenomena in the senescent cells [<xref ref-type="bibr" rid="R124">124</xref>]. We hypothesize that the increase in expression of the compartments of the mitochondrial electron transport system, concurrent with the flawed oxidative phosphorylation might have given rise to the increase in reactive oxygen species (ROS) generation as it was previously shown that inhibiting the expression of the Rieske iron-sulfur protein of complex III (containing 2Fe–2S cluster) or its pharmacological inhibition elevated ROS level and decreased ATP and consequently was sufficient to trigger senescence [<xref ref-type="bibr" rid="R125">125</xref>]. To deal with this high-level ROS production without bringing the cell into apoptosis, cells seem to utilize thiol-specific peroxidases to protect the cell against oxidative stress by detoxifying peroxides [<xref ref-type="bibr" rid="R126">126</xref>]. Peroxiredoxin 2 (PRDX2) is among the family of these genes which is upregulated in the signature and undertakes this role [<xref ref-type="bibr" rid="R127">127</xref>]. It is probably one of the mechanisms in senescent cells under our study which provokes resistance against apoptosis due to the high level of ROS.</p></sec><sec id="S15"><title>Senescence signature: RNA splicing</title><p id="P34">15 genes related to RNA splicing have been represented in the underexpressed signature; None have been upregulated. GO biological process of “regulation of RNA splicing” has been overrepresented (<xref ref-type="supplementary-material" rid="SD1">Dataset S1</xref>. <xref ref-type="supplementary-material" rid="SD1">Sheet3</xref>). Genetic depletion of SRSF2 [<xref ref-type="bibr" rid="R128">128</xref>, <xref ref-type="bibr" rid="R129">129</xref>], SRSF3 [<xref ref-type="bibr" rid="R130">130</xref>, <xref ref-type="bibr" rid="R131">131</xref>], HNRNPA1 [<xref ref-type="bibr" rid="R132">132</xref>], HNRNPD [<xref ref-type="bibr" rid="R129">129</xref>], HNRNPU [<xref ref-type="bibr" rid="R133">133</xref>] and TRA2B [<xref ref-type="bibr" rid="R134">134</xref>] have previously been shown to bring about or associate with senescence through regulating different pathways including p21 and/or p53 [<xref ref-type="bibr" rid="R128">128</xref>, <xref ref-type="bibr" rid="R130">130</xref>, <xref ref-type="bibr" rid="R131">131</xref>, <xref ref-type="bibr" rid="R133">133</xref>, <xref ref-type="bibr" rid="R134">134</xref>].</p><sec id="S16"><title>Key elements of senescence signature conferring pro-survival effect</title><p id="P35">The senescence inductive effect of p21 overexpression which is a cell cycle inhibitor has been evident for quite a long time, however, its role in guaranteeing the viability of senescent cells has also been manifested recently which is consistent with our findings analyzing CMap data [<xref ref-type="bibr" rid="R135">135</xref>]. We previously noted the hypothetical role of PRDX2 in protecting senescent cells against high-level mitochondrial ROS [<xref ref-type="bibr" rid="R127">127</xref>]. Our transcriptional connectivity findings also support this pro-survival role.</p><p id="P36">The computational analysis of RNAi LOF perturbation in cancer cell lines that mimic senescence mechanisms of survival, revealed JUNB, SQSTM1, LIF, and AREG as critical genes in senescent cell survival. JUNB expression has been shown to be responsible for the induction of a large portion of the senescence phenotype including cell cycle arrest [<xref ref-type="bibr" rid="R136">136</xref>] and proinflammatory traits [<xref ref-type="bibr" rid="R137">137</xref>]. JUNB overexpression has been indicated to be protective against ER stress (which is observed in senescence) through activating AKT pathway [<xref ref-type="bibr" rid="R138">138</xref>]. It was claimed by a study that JUNB has repressive effect on expression of p62 [<xref ref-type="bibr" rid="R139">139</xref>], however, at least in senescence this repressive effect has been overcome by other factors causing overexpression of this gene. P62 has been demonstrated to be prosurvival factor in senescence through the NF-κB pathway, and its knockdown, incongruent to our speculation, has increased apoptotic cell death of senescent cells [<xref ref-type="bibr" rid="R140">140</xref>]. Moreover, the deubiquitinating enzyme USP20 which is also overexpressed in the consensus senescence signature, by stabilizing SQSTM1 contributes to TNFα /NF-κB-mediated cell survival [<xref ref-type="bibr" rid="R141">141</xref>]. A positive feedback loop between p62 expression and NF-κB activation has been reported elsewhere [<xref ref-type="bibr" rid="R142">142</xref>].</p><p id="P37">Amphiregulin (AREG) is overexpressed as a consequence of mitochondrial dysfunction [<xref ref-type="bibr" rid="R143">143</xref>] and its expression has been shown to be a part of a pathway that leads to senescence in BRAFV600E transduced melanocytes; The inhibition of AREG caused a reduction in promyelocytic leukemia protein (PML), p21, and gamma-H2AX protein expression, characteristics of senescence, suggesting an association of the senescence induction process to amphiregulin [<xref ref-type="bibr" rid="R144">144</xref>]. However, whether its decrease in senescent cells promotes cell apoptosis has not been investigated and remains to be determined. Our current knowledge of leukemia inhibitory factor (LIF) in regard to senescence is still insufficient. It contributes to radio-resistance in nasopharyngeal carcinoma [<xref ref-type="bibr" rid="R145">145</xref>] which could indicate an anti-apoptotic role, while its induction by TGFβ is required for TGFβ-mediated overexpression of p21 and consequently cell cycle arrest [<xref ref-type="bibr" rid="R146">146</xref>] as a hint towards a role in senescence induction or maintenance.</p><p id="P38">All these reports are well in line with our bioinformatic findings using transcriptional connectivity and genetic perturbation sensitivity as well as the gene set enrichment and literature-based interpretations of the whole consensus senescence signature.</p><p id="P39">Moreover, we bioinformatically identified selumetinib, which is a MEK inhibitor, alongside other MEK inhibitors as a class of senolytics. MEK inhibitors have been claimed to induce autophagy flux and diminish the abundance of p62 in BRAF and RAS mutant cancer cell lines [<xref ref-type="bibr" rid="R147">147</xref>]. A previous study has shown that MEK inhibitors impair autophagosome-lysosome fusion and generally autophagy flux when simultaneously used with senescence inducer in RAS mutant rat embryonic fibroblasts thereby restraining cell survival [<xref ref-type="bibr" rid="R148">148</xref>].This must be noted that senescence program was not fully implemented at the time of the administration of the MEK inhibitor. Surprisingly, such activity was indeed observed in adult human lung fibroblasts in which senescence was definitive as predicted by our computational model. MEK has been shown to activate Heat Shock Transcription Factor 1 (HSF1) to enhance the proteostasis in cells by increasing the chaperoning capacity required for selective autophagy and confronting the proteotoxic stress [<xref ref-type="bibr" rid="R149">149</xref>, <xref ref-type="bibr" rid="R150">150</xref>]. Surprisingly, HSF1 inhibition has been shown to impair aggregate-induced autophagosome formation and p62-mediated proteostasis [<xref ref-type="bibr" rid="R151">151</xref>]. Therefore, we speculate that MEK inhibitors might exert their senolytic effect through alterations in p62 and molecular chaperones including heat shock proteins which are at the downstream of MEK/HSF1 axis. Accordingly, knockdown of p62 [<xref ref-type="bibr" rid="R140">140</xref>] and inhibition of HSP90 [<xref ref-type="bibr" rid="R152">152</xref>], a molecular chaperone, have been manifested to induce apoptosis in senescent cells. Further, we propose p62 and molecular chaperones as potential target hubs for future development of potent senolytics. Moreover, the MEK/ERK axis has been implicated in promotion of ERN1-mediated OIS [<xref ref-type="bibr" rid="R93">93</xref>]. As we noted above, ERN1-mediated UPR and calcium signaling, together, participate in provoking resistance against apoptosis. However, to our knowledge whether MEK/ERK axis inhibition can induce apoptosis through this pathway has not been explored nor in general nor in senescence.</p><p id="P40">There are some limitations to our study. As our study was a vertical propagation of steps each being performed one after another, we were losing data in each step depending on the availability of the shared data in the databases. A number of the data losses include but are limited to: not utilization of a few queried genes by CMap in the calculation of NCSs; CCLE gene expression profiles did not contain all genes in the consensus senescence signature which might have affected our cell line correlation analyses; Cell lines were not identical between CCLE and sensitivity datasets, thus we used merely the shared ones for the analyses. Sensitivity data related to the majority of the small-molecules and gene LOF perturbations were not available, also sensitivity data of gene overexpression interventions were fully lacking. Validation of CMap-based prediction of senolytic effect due to the rareness of well-identified senolytics which exert their impact on senescent lung fibroblasts, was not possible for our team. Moreover, subjective curation of the anti-apoptotic signature alongside the evidence-based ranking and extracting of the genes might have caused us to falsely classify or lose some important genes which are not well-studied up to the time of this study. Still, since our final gene signatures were quite large, we are optimistic that results are not overly skewed.</p><p id="P41">One of the things that might have flawed our interpretations through the CMap data, which was also warned by the CMap team, is that gene overexpression does not always enhance the function of the targeted gene and pathways, sometimes due to the cellular compensatory responses. The last concern we would like to mention is the Groups’ sample size variation in the permutation tests which might have affected the results.</p></sec></sec></sec><sec id="S17" sec-type="conclusions"><title>Conclusion</title><p id="P42">To sum up, in the current study we identified a consensus senescence signature specifically related to fibroblasts of lung origin and semi-manually extracted its genetic module which functions as the anti-apoptotic compartment of the senescence phenotype. Afterward, with this assumption that we might be able to employ datasets related to cancer cell lines which are quite large nowadays, and extrapolate them to other fields, we tried to take advantage of these valuable deposited data to discover new senolytics which are now hotspots of cancer and aging sciences. In this way, using CMap transcriptional connectivity data we filtered several compounds and genetic interventions that could at least transcriptionally counteract the apoptosis-resistance signature which is exploited by the senescent cells to survive. Ultimately, by transcriptional connectivity-based analyses alongside the evaluation of cell survival response (all in cancer cell lines) in exposure to the compounds or genetic interventions, we suggested a MEK inhibitor and p62 or JUNB depletion as potential inducers of apoptosis in senescent lung fibroblasts. The senolytic effect of a range of MEK inhibitors was confirmed in vitro.</p></sec><sec id="S18" sec-type="methods"><title>Methods</title><sec id="S19"><title>Obtaining the consensus senescence signature in fibroblasts of lung origin</title><p id="P43">In the beginning, we gathered 19 RNA-sequencing gene expression datasets (from 10 different studies) of senescence induced by different triggers in IMR90 and WI38 cells (both fibroblasts with lung origin) from GEO. Three datasets of oncogenic RAF, etoposide and doxorubicin induced senescence in lung fibroblasts were removed because we could find just one dataset for each, making us unable to validate its accuracy through comparison with their counterparts. Remaining datasets were related to Ras, replicative exhaustion, and Irradiation induced senescence. Differential gene expression analysis was performed by the Grein app. All datasets are analyzed through the same method by the app (TMM normalization). Using principal component analysis (PCA), 2 remote datasets were removed, leaving 14 datasets. In addition, using hierarchical clustering, remote samples for differential expression analysis were removed (detailed metadata of the final used datasets and their samples are available in <xref ref-type="supplementary-material" rid="SD1">Dataset S1</xref>. <xref ref-type="supplementary-material" rid="SD1">Sheet1</xref>). To reach a unified signature from these 14 datasets, which does not exclude any gene with a critical role in the core senescence phenotype, instead of conducting a conventional meta-analysis, we innovated our own approach. Here is the method (python script is available in the <xref ref-type="supplementary-material" rid="SD5">supplementary files</xref>):</p><p id="P44">For including any gene in the core senescence signature, the gene should have been expressed in the same direction in all datasets or not significantly (FDR adjusted p-value cut-off strictly set at 0.1) inversely expressed in any dataset. Moreover, the gene should have been significantly differentially expressed (FDR adjusted P-value cut-off= 0.05) in more than 75% of the datasets.</p></sec><sec id="S20"><title>Deriving the anti-apoptotic signature from the obtained senescence signature</title><p id="P45">Genecards’ term-scoring system and Gene Ontology (GO) annotations alongside literature reviewing were the tools we utilized to find out the core gene system resisting apoptosis in senescent cells. The “apoptosis” term was searched in the Genecards database (searched at 2022/01/22) [<xref ref-type="bibr" rid="R153">153</xref>]. The output was a list of genes that were ranked based on their association with the “apoptosis” term which was obtained by Genecards’ algorithmic searching through scientific literature and bioinformatics databases. Genes with a score of more than 1 were filtered (we excluded the rest of the genes because the manual curation of the whole genes had minimal benefit regarding its time cost). Moreover, genes annotated for GO of “Regulation of Cell Death”, which were obtained from the AmiGO web application, were appended to the previously filtered genes and were included in our manual evaluation and curation of the genes. Around 300 genes related to apoptosis and cell death were extracted. Afterward, we manually searched the publications for the relation of these genes with apoptosis regarding the direction of the expression (more than 1500 articles were read). To find out the association of these genes with apoptosis we searched if their modulation in the same direction as expressed in the senescence signature has shown an anti-apoptotic effect or raised resistance against chemotherapeutics or if their inverse modulation could lead to an apoptotic effect in different studies (most studies were related to cancer cell lines). Overall, 116 genes (57 downregulated and 59 upregulated) were extracted. The table of the anti-apoptotic signature (also we call it the signature of interest throughout the study) and the references based on which we established our decision are available in <xref ref-type="supplementary-material" rid="SD5">Supplementary file 1</xref>.</p></sec><sec id="S21"><title>Overrepresentation analysis of the signatures</title><p id="P46">Gene signatures enrichment analyses for KEGG pathways, GO biological processes, and GO molecular functions were performed in R (version 4.2.0) using ClusterProfiler library (v4.4.1) [<xref ref-type="bibr" rid="R154">154</xref>]. Significance was reported by p-value, adjusted by Benjamini-Hochberg FDR correction. Enrichment analysis for MSigDB hallmark gene sets (2020) was conducted using EnrichR library [<xref ref-type="bibr" rid="R155">155</xref>].We used p-value for the analysis of significance.</p></sec><sec id="S22"><title>Cell lines with the most similar and dissimilar gene expression profiles regarding the senescence signature and the anti-apoptotic signature</title><p id="P47">The dataset of the standardized gene expression profiles of Cancer Cell Line Encyclopedia (CCLE) [<xref ref-type="bibr" rid="R156">156</xref>] was downloaded from Harmonizome [<xref ref-type="bibr" rid="R157">157</xref>] to find out the most positively and inversely (most negatively) correlated cell lines with the senescence signature and the anti-apoptotic signature of interest. For analysis of the correlation, we used the point biserial correlation function from the SciPy statistical tool (version 1.8.0) in python (3.9.12). Upregulated genes were annotated as “1” and downregulated ones were annotated as “-1”. Cut-offs for correlation scores were determined differently and separately explained in the dedicated sections. The p-value for significance was set at 0.05.</p></sec><sec id="S23"><title>Connectivity map of the anti-apoptotic signature</title><p id="P48">The anti-apoptotic signature was submitted into the CLUE Query platform to obtain the Connectivity Map (CMap) of the small-molecules and genetic perturbations [<xref ref-type="bibr" rid="R10">10</xref>]. Genes and compounds were ranked using the mean of the normalized connectivity scores (NCSs) of the genes or compounds in their different perturbations (different doses, perturbation time, perturbed cell lines, and perturbation-type for the genes). We excluded perturbations in cell types whose gene expression signatures were negatively correlated with the anti-apoptotic signature (point-biserial correlation coefficient &lt;-0.2 and p-value&lt;0.05) from the calculation of the mean of the NCSs (MCS). Compound entities with less than 10 perturbations and a median TAS score of less than 0.1 were excluded from further rankings and selections. We used CMap to identify and rank the contribution of each gene in the anti-apoptotic signature to the development of the whole anti-apoptotic module. For analysis of the transcriptional effect of the inhibition of the upregulated genes, we measured the MCSs of the CRISPR loss of functions (which was annotated as “trt_xpr” in the perturbation-type column of the dataset) and the MCSs of the short hairpin RNA (shRNA) loss of functions (we only used NCSs of the consensus signature from shRNAs targeting the same gene which was annotated as “trt_sh.cgs” in the perturbation-type column of the dataset). For analyzing the transcriptional effect of the inverse modulation of the downregulated genes, we calculated the MCS of the gene overexpression (which was annotated as “trt_oe” in the perturbation-type column of the dataset). Gene entities of the same perturbation type with less than 4 perturbations and a median TAS score of less than 0.1 were excluded from the rest of the study analyses to reduce errors due to the low sample number and lack of reproducibility. Furthermore, the significance of the differences between the NCSs of the gene LOF (scores of perturbations with “trt_sh.cgs” and “trt_xpr” perturbation type, were pooled) and the NCSs of the gene GOF, was analyzed using the permutation test. The alternative hypothesis of the permutation test was set in a way that the mean of the NCSs of a set of gene perturbations corresponding to a single gene intervention that opposes the expression direction of that gene in our anti-apoptotic signature should have been less than the mean of NCSs of a set of gene perturbations corresponding to a gene intervention that its direction of regulation is similar with the one exists in the anti-apoptotic signature. P-values below 0.05 were considered to be significant.</p></sec><sec id="S24"><title>Analysis of drug and gene loss of function sensitivity in cell lines of similar gene expression profiles vs dissimilar ones</title><p id="P49">We evaluated the cell viability impact of the compounds and the gene loss of functions in cell lines with similar gene expression profiles (correlated cell lines) versus cell lines with the most dissimilar gene expression profiles (inversely correlated cell lines). The significance was measured using the permutation test. For compound perturbation, “drug sensitivity AUC (CTD^2)” dataset and for gene loss of function, “CRISPR (DepMap 22Q2 Public+Score, Chronos)” and “RNAi (Achilles+DRIVE+Marcotte, DEMETER2)” datasets were downloaded from the DepMap portal. The correlations of the CCLE standardized gene expression profile of each cell with senescence signature and anti-apoptotic signature were assessed and the cell lines with a correlation coefficient of &gt;0.4 with both senescence signature and the anti-apoptotic signature were considered as correlated cells (p-value&lt;0.05) and cell lines with the correlation coefficient of &lt;-0.4 for both senescence signature and the anti-apoptotic signature were considered as negatively correlated cells (p-value&lt;0.05)(correlation analyses were performed on cell lines which were shared between CCLE datasets and each of the sensitivity datasets). To avoid bias toward any specific lineage of cancer cell lines, we used at most the two most correlated (or inversely correlated) cell lines in each lineage. As the sensitivity of different cell lines to the same drugs varies in scale due to the different transcriptional contexts, we standardized the sensitivity data of each cell line prior to the permutation test to be able to compare the sensitivity data on a similar scale. Perturbations were considered to be more lethal in correlated cell lines than inversely correlated ones if the subtraction of the mean of the standardized sensitivity scores in the inversely correlated cell lines from the mean of the standardized sensitivity scores in the correlated cell lines yielded a negative value and the p-value of the permutation test was less than 0.05. In addition, to assure that the significance of the different effects of the drug in correlated cell lines vs inversely correlated cell lines is due to more lethality in correlated cell lines, not the more proliferation enhancing effect on inversely correlated cell lines, we evaluated replicate level viability data of the final selected compounds (Drug sensitivity replicate-level dose (CTD^2) was downloaded from DepMap portal) and those with the overall mean viability of more than 0.9 in both correlated and inversely correlated (not just one of them), were excluded.</p></sec><sec id="S25"><title>Other statistical and visualization tests and transformations</title><p id="P50">PCA was performed on log fold changes data of differential gene expression analysis using sklearn library (version 1.0.2), decomposition tool, and plotted using Plotly (version 5.6.0) in python. Standardization (z-score) was performed using sklearn library preprocessing tool. The number of repeats in all permutation tests was set at 10000. The sample size cut-off for analysis of significance using the permutation test was set at a minimum of 4 for each group.</p></sec><sec id="S26"><title>Cell isolation and culture</title><p id="P51">Human parenchymal lung fibroblasts were isolated and cultured as described previously [<xref ref-type="bibr" rid="R158">158</xref>, <xref ref-type="bibr" rid="R159">159</xref>].</p></sec></sec><sec sec-type="supplementary-material" id="SM"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>Dataset S1</label><media xlink:href="EMS200181-supplement-Dataset_S1.xlsx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" id="d92aAcFbB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD2"><label>Dataset S2</label><media xlink:href="EMS200181-supplement-Dataset_S2.xlsx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" id="d92aAcFcB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD3"><label>Dataset S3</label><media xlink:href="EMS200181-supplement-Dataset_S3.xlsx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" id="d92aAcFdB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD4"><label>Fig S1</label><media xlink:href="EMS200181-supplement-Fig_S1.jpg" mimetype="image" mime-subtype="jpeg" id="d92aAcFeB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD5"><label>Supplementary file 1</label><media xlink:href="EMS200181-supplement-Supplementary_file_1.pdf" mimetype="application" mime-subtype="pdf" id="d92aAcFfB" position="anchor"/></supplementary-material></sec></body><back><ack id="S27"><title>Acknowledgments</title><p>We gratefully acknowledge the Austrian Science Fund (Österreichischer Wissenschaftsfonds; FWF) grant DOI: 10.55776/P35268.</p></ack><fn-group><fn id="FN1" fn-type="con"><p id="P52"><bold>Author Contributions</bold></p><p id="P53">Conceptualization: ANR, JG; Software and data curation: ANR; Methodology: ANR, LMM, KH, IL, SS; Investigation: ANR, SS; Formal analysis: ANR, SS, IL, JG; Resources: LMM, KH; Writing – Original draft: ANR, JG Writing: Review &amp; Editing: all authors have edited, read and approved the submitted manuscript; Supervision: ANR, JG.</p></fn><fn id="FN2" fn-type="conflict"><p id="P54"><bold>Conflicts Of Interest</bold></p><p id="P55">IL and JG are co-founders and shareholders of Rockfish Bio AG. IL is employed by Rockfish Bio AG, while JG is member of the board and acts as scientific advisor.</p></fn></fn-group><ref-list><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>S</given-names></name><name><surname>Sharpless</surname><given-names>NE</given-names></name></person-group><article-title>Senescence in Health and Disease</article-title><source>Cell</source><year>2017</year><volume>169</volume><issue>6</issue><fpage>1000</fpage><lpage>1011</lpage><pub-id pub-id-type="pmcid">PMC5643029</pub-id><pub-id pub-id-type="pmid">28575665</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2017.05.015</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lushchak</surname><given-names>O</given-names></name><name><surname>Schosserer</surname><given-names>M</given-names></name><name><surname>Grillari</surname><given-names>J</given-names></name></person-group><article-title>Senopathies-Diseases Associated with Cellular Senescence</article-title><source>Biomolecules</source><year>2023</year><volume>13</volume><issue>6</issue><pub-id pub-id-type="pmcid">PMC10296713</pub-id><pub-id pub-id-type="pmid">37371545</pub-id><pub-id pub-id-type="doi">10.3390/biom13060966</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hernandez-Segura</surname><given-names>A</given-names></name><name><surname>de Jong</surname><given-names>TV</given-names></name><name><surname>Melov</surname><given-names>S</given-names></name><name><surname>Guryev</surname><given-names>V</given-names></name><name><surname>Campisi</surname><given-names>J</given-names></name><name><surname>Demaria</surname><given-names>M</given-names></name></person-group><article-title>Unmasking Transcriptional Heterogeneity in Senescent Cells</article-title><source>Curr Biol</source><year>2017</year><volume>27</volume><issue>17</issue><fpage>2652</fpage><lpage>2660</lpage><elocation-id>e2654</elocation-id><pub-id pub-id-type="pmcid">PMC5788810</pub-id><pub-id pub-id-type="pmid">28844647</pub-id><pub-id pub-id-type="doi">10.1016/j.cub.2017.07.033</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nayeri Rad</surname><given-names>A</given-names></name><name><surname>Shams</surname><given-names>G</given-names></name><name><surname>Avelar</surname><given-names>RA</given-names></name><name><surname>Morowvat</surname><given-names>MH</given-names></name><name><surname>Ghasemi</surname><given-names>Y</given-names></name></person-group><article-title>Potential senotherapeutic candidates and their combinations derived from transcriptional connectivity and network measures</article-title><source>Informatics in Medicine Unlocked</source><year>2022</year><volume>30</volume><elocation-id>100920</elocation-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Tchkonia</surname><given-names>T</given-names></name><name><surname>Pirtskhalava</surname><given-names>T</given-names></name><name><surname>Gower</surname><given-names>AC</given-names></name><name><surname>Ding</surname><given-names>H</given-names></name><name><surname>Giorgadze</surname><given-names>N</given-names></name><name><surname>Palmer</surname><given-names>AK</given-names></name><name><surname>Ikeno</surname><given-names>Y</given-names></name><name><surname>Hubbard</surname><given-names>GB</given-names></name><name><surname>Lenburg</surname><given-names>M</given-names></name><name><surname>O'Hara</surname><given-names>SP</given-names></name><etal/></person-group><article-title>The Achilles' heel of senescent cells: from transcriptome to senolytic drugs</article-title><source>Aging Cell</source><year>2015</year><volume>14</volume><issue>4</issue><fpage>644</fpage><lpage>658</lpage><pub-id pub-id-type="pmcid">PMC4531078</pub-id><pub-id pub-id-type="pmid">25754370</pub-id><pub-id pub-id-type="doi">10.1111/acel.12344</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yousefzadeh</surname><given-names>MJ</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>McGowan</surname><given-names>SJ</given-names></name><name><surname>Angelini</surname><given-names>L</given-names></name><name><surname>Fuhrmann-Stroissnigg</surname><given-names>H</given-names></name><name><surname>Xu</surname><given-names>M</given-names></name><name><surname>Ling</surname><given-names>YY</given-names></name><name><surname>Melos</surname><given-names>KI</given-names></name><name><surname>Pirtskhalava</surname><given-names>T</given-names></name><name><surname>Inman</surname><given-names>CL</given-names></name><name><surname>McGuckian</surname><given-names>C</given-names></name><etal/></person-group><article-title>Fisetin is a senotherapeutic that extends health and lifespan</article-title><source>EBioMedicine</source><year>2018</year><volume>36</volume><fpage>18</fpage><lpage>28</lpage><pub-id pub-id-type="pmcid">PMC6197652</pub-id><pub-id pub-id-type="pmid">30279143</pub-id><pub-id pub-id-type="doi">10.1016/j.ebiom.2018.09.015</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Tchkonia</surname><given-names>T</given-names></name><name><surname>Fuhrmann-Stroissnigg</surname><given-names>H</given-names></name><name><surname>Dai</surname><given-names>HM</given-names></name><name><surname>Ling</surname><given-names>YY</given-names></name><name><surname>Stout</surname><given-names>MB</given-names></name><name><surname>Pirtskhalava</surname><given-names>T</given-names></name><name><surname>Giorgadze</surname><given-names>N</given-names></name><name><surname>Johnson</surname><given-names>KO</given-names></name><name><surname>Giles</surname><given-names>CB</given-names></name><name><surname>Wren</surname><given-names>JD</given-names></name><etal/></person-group><article-title>Identification of a novel senolytic agent, navitoclax, targeting the Bcl-2 family of anti-apoptotic factors</article-title><source>Aging Cell</source><year>2016</year><volume>15</volume><issue>3</issue><fpage>428</fpage><lpage>435</lpage><pub-id pub-id-type="pmcid">PMC4854923</pub-id><pub-id pub-id-type="pmid">26711051</pub-id><pub-id pub-id-type="doi">10.1111/acel.12445</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rad</surname><given-names>AN</given-names></name><name><surname>Grillari</surname><given-names>J</given-names></name></person-group><article-title>Current senolytics: Mode of action, efficacy and limitations, and their future</article-title><source>Mech Ageing Dev</source><year>2024</year><volume>217</volume><elocation-id>111888</elocation-id><pub-id pub-id-type="pmid">38040344</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niedernhofer</surname><given-names>LJ</given-names></name><name><surname>Robbins</surname><given-names>PD</given-names></name></person-group><article-title>Senotherapeutics for healthy ageing</article-title><source>Nature Reviews Drug Discovery</source><year>2018</year><volume>17</volume><issue>5</issue><fpage>377</fpage><pub-id pub-id-type="pmid">29651106</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subramanian</surname><given-names>A</given-names></name><name><surname>Narayan</surname><given-names>R</given-names></name><name><surname>Corsello</surname><given-names>SM</given-names></name><name><surname>Peck</surname><given-names>DD</given-names></name><name><surname>Natoli</surname><given-names>TE</given-names></name><name><surname>Lu</surname><given-names>X</given-names></name><name><surname>Gould</surname><given-names>J</given-names></name><name><surname>Davis</surname><given-names>JF</given-names></name><name><surname>Tubelli</surname><given-names>AA</given-names></name><name><surname>Asiedu</surname><given-names>JK</given-names></name><name><surname>Lahr</surname><given-names>DL</given-names></name><etal/></person-group><article-title>A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles</article-title><source>Cell</source><year>2017</year><volume>171</volume><issue>6</issue><fpage>1437</fpage><lpage>1452</lpage><elocation-id>e1417</elocation-id><pub-id pub-id-type="pmcid">PMC5990023</pub-id><pub-id pub-id-type="pmid">29195078</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2017.10.049</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dönertaş</surname><given-names>HM</given-names></name><name><surname>Fuentealba Valenzuela</surname><given-names>M</given-names></name><name><surname>Partridge</surname><given-names>L</given-names></name><name><surname>Thornton</surname><given-names>JM</given-names></name></person-group><article-title>Gene expression-based drug repurposing to target aging</article-title><source>Aging Cell</source><year>2018</year><volume>17</volume><issue>5</issue><elocation-id>e12819</elocation-id><pub-id pub-id-type="pmcid">PMC6156541</pub-id><pub-id pub-id-type="pmid">29959820</pub-id><pub-id pub-id-type="doi">10.1111/acel.12819</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>Y</given-names></name><name><surname>Yuan</surname><given-names>M</given-names></name><name><surname>Xin</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name></person-group><article-title>Screening novel drug candidates for Alzheimer’s disease by an integrated network and transcriptome analysis</article-title><source>Bioinformatics</source><year>2020</year><volume>36</volume><issue>17</issue><fpage>4626</fpage><lpage>4632</lpage><pub-id pub-id-type="pmid">32516365</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brum</surname><given-names>AM</given-names></name><name><surname>van de Peppel</surname><given-names>J</given-names></name><name><surname>van der Leije</surname><given-names>CS</given-names></name><name><surname>Schreuders-Koedam</surname><given-names>M</given-names></name><name><surname>Eijken</surname><given-names>M</given-names></name><name><surname>van der Eerden</surname><given-names>BCJ</given-names></name><name><surname>van Leeuwen</surname><given-names>JPTM</given-names></name></person-group><article-title>Connectivity Map-based discovery of parbendazole reveals targetable human osteogenic pathway</article-title><source>Proceedings of the National Academy of Sciences</source><year>2015</year><volume>112</volume><issue>41</issue><fpage>12711</fpage><lpage>12716</lpage><pub-id pub-id-type="pmcid">PMC4611615</pub-id><pub-id pub-id-type="pmid">26420877</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1501597112</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonnet</surname><given-names>R</given-names></name><name><surname>Mariault</surname><given-names>L</given-names></name><name><surname>Peyron</surname><given-names>J-F</given-names></name></person-group><article-title>Identification of potentially anti-COVID-19 active drugs using the connectivity MAP</article-title><source>PLOS ONE</source><year>2022</year><volume>17</volume><issue>1</issue><elocation-id>e0262751</elocation-id><pub-id pub-id-type="pmcid">PMC8794112</pub-id><pub-id pub-id-type="pmid">35085325</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0262751</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kidnapillai</surname><given-names>S</given-names></name><name><surname>Bortolasci</surname><given-names>CC</given-names></name><name><surname>Udawela</surname><given-names>M</given-names></name><name><surname>Panizzutti</surname><given-names>B</given-names></name><name><surname>Spolding</surname><given-names>B</given-names></name><name><surname>Connor</surname><given-names>T</given-names></name><name><surname>Sanigorski</surname><given-names>A</given-names></name><name><surname>Dean</surname><given-names>OM</given-names></name><name><surname>Crowley</surname><given-names>T</given-names></name><name><surname>Jamain</surname><given-names>S</given-names></name><name><surname>Gray</surname><given-names>L</given-names></name><etal/></person-group><article-title>The use of a gene expression signature and connectivity map to repurpose drugs for bipolar disorder</article-title><source>The World Journal of Biological Psychiatry</source><year>2020</year><volume>21</volume><issue>10</issue><fpage>775</fpage><lpage>783</lpage><pub-id pub-id-type="pmid">29956574</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calvert</surname><given-names>S</given-names></name><name><surname>Tacutu</surname><given-names>R</given-names></name><name><surname>Sharifi</surname><given-names>S</given-names></name><name><surname>Teixeira</surname><given-names>R</given-names></name><name><surname>Ghosh</surname><given-names>P</given-names></name><name><surname>de Magalhães</surname><given-names>JP</given-names></name></person-group><article-title>A network pharmacology approach reveals new candidate caloric restriction mimetics in C. elegans</article-title><source>Aging Cell</source><year>2016</year><volume>15</volume><issue>2</issue><fpage>256</fpage><lpage>266</lpage><pub-id pub-id-type="pmcid">PMC4783339</pub-id><pub-id pub-id-type="pmid">26676933</pub-id><pub-id pub-id-type="doi">10.1111/acel.12432</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Qian</surname><given-names>R</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Qin</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><etal/></person-group><article-title>A survey of optimal strategy for signature-based drug repositioning and an application to liver cancer</article-title><source>eLife</source><year>2022</year><volume>11</volume><elocation-id>e71880</elocation-id><pub-id pub-id-type="pmcid">PMC8893721</pub-id><pub-id pub-id-type="pmid">35191375</pub-id><pub-id pub-id-type="doi">10.7554/eLife.71880</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Justice</surname><given-names>JN</given-names></name><name><surname>Nambiar</surname><given-names>AM</given-names></name><name><surname>Tchkonia</surname><given-names>T</given-names></name><name><surname>LeBrasseur</surname><given-names>NK</given-names></name><name><surname>Pascual</surname><given-names>R</given-names></name><name><surname>Hashmi</surname><given-names>SK</given-names></name><name><surname>Prata</surname><given-names>L</given-names></name><name><surname>Masternak</surname><given-names>MM</given-names></name><name><surname>Kritchevsky</surname><given-names>SB</given-names></name><name><surname>Musi</surname><given-names>N</given-names></name><name><surname>Kirkland</surname><given-names>JL</given-names></name></person-group><article-title>Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study</article-title><source>EBioMedicine</source><year>2019</year><volume>40</volume><fpage>554</fpage><lpage>563</lpage><pub-id pub-id-type="pmcid">PMC6412088</pub-id><pub-id pub-id-type="pmid">30616998</pub-id><pub-id pub-id-type="doi">10.1016/j.ebiom.2018.12.052</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schafer</surname><given-names>MJ</given-names></name><name><surname>White</surname><given-names>TA</given-names></name><name><surname>Iijima</surname><given-names>K</given-names></name><name><surname>Haak</surname><given-names>AJ</given-names></name><name><surname>Ligresti</surname><given-names>G</given-names></name><name><surname>Atkinson</surname><given-names>EJ</given-names></name><name><surname>Oberg</surname><given-names>AL</given-names></name><name><surname>Birch</surname><given-names>J</given-names></name><name><surname>Salmonowicz</surname><given-names>H</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Mazula</surname><given-names>DL</given-names></name><etal/></person-group><article-title>Cellular senescence mediates fibrotic pulmonary disease</article-title><source>Nature Communications</source><year>2017</year><volume>8</volume><issue>1</issue><elocation-id>14532</elocation-id><pub-id pub-id-type="pmcid">PMC5331226</pub-id><pub-id pub-id-type="pmid">28230051</pub-id><pub-id pub-id-type="doi">10.1038/ncomms14532</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aghali</surname><given-names>A</given-names></name><name><surname>Koloko Ngassie</surname><given-names>ML</given-names></name><name><surname>Pabelick</surname><given-names>CM</given-names></name><name><surname>Prakash</surname><given-names>YS</given-names></name></person-group><article-title>Cellular Senescence in Aging Lungs and Diseases</article-title><source>Cells</source><year>2022</year><pub-id pub-id-type="pmcid">PMC9179897</pub-id><pub-id pub-id-type="pmid">35681476</pub-id><pub-id pub-id-type="doi">10.3390/cells11111781</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsherniak</surname><given-names>A</given-names></name><name><surname>Vazquez</surname><given-names>F</given-names></name><name><surname>Montgomery</surname><given-names>PG</given-names></name><name><surname>Weir</surname><given-names>BA</given-names></name><name><surname>Kryukov</surname><given-names>G</given-names></name><name><surname>Cowley</surname><given-names>GS</given-names></name><name><surname>Gill</surname><given-names>S</given-names></name><name><surname>Harrington</surname><given-names>WF</given-names></name><name><surname>Pantel</surname><given-names>S</given-names></name><name><surname>Krill-Burger</surname><given-names>JM</given-names></name><name><surname>Meyers</surname><given-names>RM</given-names></name><etal/></person-group><article-title>Defining a Cancer Dependency Map</article-title><source>Cell</source><year>2017</year><volume>170</volume><issue>3</issue><fpage>564</fpage><lpage>576</lpage><elocation-id>e516</elocation-id><pub-id pub-id-type="pmcid">PMC5667678</pub-id><pub-id pub-id-type="pmid">28753430</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2017.06.010</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seashore-Ludlow</surname><given-names>B</given-names></name><name><surname>Rees</surname><given-names>MG</given-names></name><name><surname>Cheah</surname><given-names>JH</given-names></name><name><surname>Cokol</surname><given-names>M</given-names></name><name><surname>Price</surname><given-names>EV</given-names></name><name><surname>Coletti</surname><given-names>ME</given-names></name><name><surname>Jones</surname><given-names>V</given-names></name><name><surname>Bodycombe</surname><given-names>NE</given-names></name><name><surname>Soule</surname><given-names>CK</given-names></name><name><surname>Gould</surname><given-names>J</given-names></name><name><surname>Alexander</surname><given-names>B</given-names></name><etal/></person-group><article-title>Harnessing Connectivity in a Large-Scale Small-Molecule Sensitivity Dataset</article-title><source>Cancer Discovery</source><year>2015</year><volume>5</volume><issue>11</issue><fpage>1210</fpage><lpage>1223</lpage><pub-id pub-id-type="pmcid">PMC4631646</pub-id><pub-id pub-id-type="pmid">26482930</pub-id><pub-id pub-id-type="doi">10.1158/2159-8290.CD-15-0235</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chien</surname><given-names>Y</given-names></name><name><surname>Scuoppo</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Fang</surname><given-names>X</given-names></name><name><surname>Balgley</surname><given-names>B</given-names></name><name><surname>Bolden</surname><given-names>JE</given-names></name><name><surname>Premsrirut</surname><given-names>P</given-names></name><name><surname>Luo</surname><given-names>W</given-names></name><name><surname>Chicas</surname><given-names>A</given-names></name><name><surname>Lee</surname><given-names>CS</given-names></name><name><surname>Kogan</surname><given-names>SC</given-names></name><name><surname>Lowe</surname><given-names>SW</given-names></name></person-group><article-title>Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity</article-title><source>Genes Dev</source><year>2011</year><volume>25</volume><issue>20</issue><fpage>2125</fpage><lpage>2136</lpage><pub-id pub-id-type="pmcid">PMC3205583</pub-id><pub-id pub-id-type="pmid">21979375</pub-id><pub-id pub-id-type="doi">10.1101/gad.17276711</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mijit</surname><given-names>M</given-names></name><name><surname>Caracciolo</surname><given-names>V</given-names></name><name><surname>Melillo</surname><given-names>A</given-names></name><name><surname>Amicarelli</surname><given-names>F</given-names></name><name><surname>Giordano</surname><given-names>A</given-names></name></person-group><article-title>Role of p53 in the Regulation of Cellular Senescence</article-title><source>Biomolecules</source><year>2020</year><volume>10</volume><issue>3</issue><pub-id pub-id-type="pmcid">PMC7175209</pub-id><pub-id pub-id-type="pmid">32182711</pub-id><pub-id pub-id-type="doi">10.3390/biom10030420</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheekey</surname><given-names>E</given-names></name><name><surname>Narita</surname><given-names>M</given-names></name></person-group><article-title>p53 in senescence – it's a marathon not a sprint</article-title><source>The FEBS Journal</source><year>2021</year><comment>n/a(n/a)</comment><pub-id pub-id-type="pmid">34921507</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steelman</surname><given-names>LS</given-names></name><name><surname>Chappell</surname><given-names>WH</given-names></name><name><surname>Abrams</surname><given-names>SL</given-names></name><name><surname>Kempf</surname><given-names>CR</given-names></name><name><surname>Long</surname><given-names>J</given-names></name><name><surname>Laidler</surname><given-names>P</given-names></name><name><surname>Mijatovic</surname><given-names>S</given-names></name><name><surname>Maksimovic-Ivanic</surname><given-names>D</given-names></name><name><surname>Stivala</surname><given-names>F</given-names></name><name><surname>Mazzarino</surname><given-names>MC</given-names></name><name><surname>Donia</surname><given-names>M</given-names></name><etal/></person-group><article-title>Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging</article-title><source>Aging</source><year>2011</year><volume>3</volume><issue>3</issue><fpage>192</fpage><lpage>222</lpage><pub-id pub-id-type="pmcid">PMC3091517</pub-id><pub-id pub-id-type="pmid">21422497</pub-id><pub-id pub-id-type="doi">10.18632/aging.100296</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nussinov</surname><given-names>R</given-names></name><name><surname>Tsai</surname><given-names>C-J</given-names></name><name><surname>Jang</surname><given-names>H</given-names></name></person-group><article-title>Does Ras Activate Raf and PI3K Allosterically?</article-title><source>Frontiers in Oncology</source><year>2019</year><volume>9</volume><pub-id pub-id-type="pmcid">PMC6874141</pub-id><pub-id pub-id-type="pmid">31799192</pub-id><pub-id pub-id-type="doi">10.3389/fonc.2019.01231</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saleh</surname><given-names>T</given-names></name><name><surname>Bloukh</surname><given-names>S</given-names></name><name><surname>Carpenter</surname><given-names>VJ</given-names></name><name><surname>Alwohoush</surname><given-names>E</given-names></name><name><surname>Bakeer</surname><given-names>J</given-names></name><name><surname>Darwish</surname><given-names>S</given-names></name><name><surname>Azab</surname><given-names>B</given-names></name><name><surname>Gewirtz</surname><given-names>DA</given-names></name></person-group><article-title>Therapy-Induced Senescence: An "Old" Friend Becomes the Enemy</article-title><source>Cancers (Basel)</source><year>2020</year><volume>12</volume><issue>4</issue><pub-id pub-id-type="pmcid">PMC7226427</pub-id><pub-id pub-id-type="pmid">32235364</pub-id><pub-id pub-id-type="doi">10.3390/cancers12040822</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Doornebal</surname><given-names>EJ</given-names></name><name><surname>Pirtskhalava</surname><given-names>T</given-names></name><name><surname>Giorgadze</surname><given-names>N</given-names></name><name><surname>Wentworth</surname><given-names>M</given-names></name><name><surname>Fuhrmann-Stroissnigg</surname><given-names>H</given-names></name><name><surname>Niedernhofer</surname><given-names>LJ</given-names></name><name><surname>Robbins</surname><given-names>PD</given-names></name><name><surname>Tchkonia</surname><given-names>T</given-names></name><name><surname>Kirkland</surname><given-names>JL</given-names></name></person-group><article-title>New agents that target senescent cells: the flavone, fisetin, and the BCL-X(L) inhibitors, A1331852 and A1155463</article-title><source>Aging (Albany NY)</source><year>2017</year><volume>9</volume><issue>3</issue><fpage>955</fpage><lpage>963</lpage><pub-id pub-id-type="pmcid">PMC5391241</pub-id><pub-id pub-id-type="pmid">28273655</pub-id><pub-id pub-id-type="doi">10.18632/aging.101202</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hernandez-Segura</surname><given-names>A</given-names></name><name><surname>Nehme</surname><given-names>J</given-names></name><name><surname>Demaria</surname><given-names>M</given-names></name></person-group><article-title>Hallmarks of Cellular Senescence</article-title><source>Trends in Cell Biology</source><year>2018</year><volume>28</volume><issue>6</issue><fpage>436</fpage><lpage>453</lpage><pub-id pub-id-type="pmid">29477613</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collin</surname><given-names>G</given-names></name><name><surname>Huna</surname><given-names>A</given-names></name><name><surname>Warnier</surname><given-names>M</given-names></name><name><surname>Flaman</surname><given-names>J-M</given-names></name><name><surname>Bernard</surname><given-names>D</given-names></name></person-group><article-title>Transcriptional repression of DNA repair genes is a hallmark and a cause of cellular senescence</article-title><source>Cell Death &amp; Disease</source><year>2018</year><volume>9</volume><issue>3</issue><fpage>259</fpage><pub-id pub-id-type="pmcid">PMC5833687</pub-id><pub-id pub-id-type="pmid">29449545</pub-id><pub-id pub-id-type="doi">10.1038/s41419-018-0300-z</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogrodnik</surname><given-names>M</given-names></name><name><surname>Carlos Acosta</surname><given-names>J</given-names></name><name><surname>Adams</surname><given-names>PD</given-names></name><name><surname>d'Adda di Fagagna</surname><given-names>F</given-names></name><name><surname>Baker</surname><given-names>DJ</given-names></name><name><surname>Bishop</surname><given-names>CL</given-names></name><name><surname>Chandra</surname><given-names>T</given-names></name><name><surname>Collado</surname><given-names>M</given-names></name><name><surname>Gil</surname><given-names>J</given-names></name><name><surname>Gorgoulis</surname><given-names>V</given-names></name><name><surname>Gruber</surname><given-names>F</given-names></name><etal/></person-group><article-title>Guidelines for minimal information on cellular senescence experimentation in vivo</article-title><source>Cell</source><year>2024</year><volume>187</volume><issue>16</issue><fpage>4150</fpage><lpage>4175</lpage><pub-id pub-id-type="pmid">39121846</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helbling-Leclerc</surname><given-names>A</given-names></name><name><surname>Dessarps-Freichey</surname><given-names>F</given-names></name><name><surname>Evrard</surname><given-names>C</given-names></name><name><surname>Rosselli</surname><given-names>F</given-names></name></person-group><article-title>Fanconi anemia proteins counteract the implementation of the oncogene-induced senescence program</article-title><source>Scientific Reports</source><year>2019</year><volume>9</volume><issue>1</issue><elocation-id>17024</elocation-id><pub-id pub-id-type="pmcid">PMC6863893</pub-id><pub-id pub-id-type="pmid">31745226</pub-id><pub-id pub-id-type="doi">10.1038/s41598-019-53502-w</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helbling-Leclerc</surname><given-names>A</given-names></name><name><surname>Garcin</surname><given-names>C</given-names></name><name><surname>Rosselli</surname><given-names>F</given-names></name></person-group><article-title>Beyond DNA repair and chromosome instability—Fanconi anaemia as a cellular senescence-associated syndrome</article-title><source>Cell Death &amp; Differentiation</source><year>2021</year><volume>28</volume><issue>4</issue><fpage>1159</fpage><lpage>1173</lpage><pub-id pub-id-type="pmcid">PMC8026967</pub-id><pub-id pub-id-type="pmid">33723374</pub-id><pub-id pub-id-type="doi">10.1038/s41418-021-00764-5</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Boehm</surname><given-names>EM</given-names></name><name><surname>Gildenberg</surname><given-names>MS</given-names></name><name><surname>Washington</surname><given-names>MT</given-names></name></person-group><chapter-title>Chapter Seven - The Many Roles of PCNA in Eukaryotic DNA Replication</chapter-title><person-group person-group-type="editor"><name><surname>Kaguni</surname><given-names>LS</given-names></name><name><surname>Oliveira</surname><given-names>MT</given-names></name></person-group><source>The Enzymes</source><year>2016</year><publisher-name>Academic Press</publisher-name><fpage>231</fpage><lpage>254</lpage><pub-id pub-id-type="pmcid">PMC4890617</pub-id><pub-id pub-id-type="pmid">27241932</pub-id><pub-id pub-id-type="doi">10.1016/bs.enz.2016.03.003</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gehen</surname><given-names>SC</given-names></name><name><surname>Vitiello</surname><given-names>PF</given-names></name><name><surname>Bambara</surname><given-names>RA</given-names></name><name><surname>Keng</surname><given-names>PC</given-names></name><name><surname>O'Reilly</surname><given-names>MA</given-names></name></person-group><article-title>Downregulation of PCNA potentiates p21-mediated growth inhibition in response to hyperoxia</article-title><source>American Journal of Physiology-Lung Cellular and Molecular Physiology</source><year>2007</year><volume>292</volume><issue>3</issue><fpage>L716</fpage><lpage>L724</lpage><pub-id pub-id-type="pmid">17085526</pub-id></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foskolou</surname><given-names>IP</given-names></name><name><surname>Jorgensen</surname><given-names>C</given-names></name><name><surname>Leszczynska</surname><given-names>KB</given-names></name><name><surname>Olcina</surname><given-names>MM</given-names></name><name><surname>Tarhonskaya</surname><given-names>H</given-names></name><name><surname>Haisma</surname><given-names>B</given-names></name><name><surname>D’Angiolella</surname><given-names>V</given-names></name><name><surname>Myers</surname><given-names>WK</given-names></name><name><surname>Domene</surname><given-names>C</given-names></name><name><surname>Flashman</surname><given-names>E</given-names></name><name><surname>Hammond</surname><given-names>EM</given-names></name></person-group><article-title>Ribonucleotide Reductase Requires Subunit Switching in Hypoxia to Maintain DNA Replication</article-title><source>Molecular Cell</source><year>2017</year><volume>66</volume><issue>2</issue><fpage>206</fpage><lpage>220</lpage><elocation-id>e209</elocation-id><pub-id pub-id-type="pmcid">PMC5405111</pub-id><pub-id pub-id-type="pmid">28416140</pub-id><pub-id pub-id-type="doi">10.1016/j.molcel.2017.03.005</pub-id></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuo</surname><given-names>M-L</given-names></name><name><surname>Sy</surname><given-names>AJ</given-names></name><name><surname>Xue</surname><given-names>L</given-names></name><name><surname>Chi</surname><given-names>MC</given-names></name><name><surname>Lee</surname><given-names>MT</given-names></name><name><surname>Yen</surname><given-names>T</given-names></name><name><surname>Chiang</surname><given-names>M-I</given-names></name><name><surname>Chang</surname><given-names>L</given-names></name><name><surname>Chu</surname><given-names>P</given-names></name><name><surname>Yen</surname><given-names>Y</given-names></name></person-group><article-title>RRM2B Suppresses Activation of the Oxidative Stress Pathway and is Up-regulated by P53 During Senescence</article-title><source>Scientific Reports</source><year>2012</year><volume>2</volume><issue>1</issue><fpage>822</fpage><pub-id pub-id-type="pmcid">PMC3492868</pub-id><pub-id pub-id-type="pmid">23139867</pub-id><pub-id pub-id-type="doi">10.1038/srep00822</pub-id></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delfarah</surname><given-names>A</given-names></name><name><surname>Parrish</surname><given-names>S</given-names></name><name><surname>Junge</surname><given-names>JA</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Seo</surname><given-names>F</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Mac</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>P</given-names></name><name><surname>Fraser</surname><given-names>SE</given-names></name><name><surname>Graham</surname><given-names>NA</given-names></name></person-group><article-title>Inhibition of nucleotide synthesis promotes replicative senescence of human mammary epithelial cells</article-title><source>Journal of Biological Chemistry</source><year>2019</year><volume>294</volume><issue>27</issue><fpage>10564</fpage><lpage>10578</lpage><pub-id pub-id-type="pmcid">PMC6615688</pub-id><pub-id pub-id-type="pmid">31138644</pub-id><pub-id pub-id-type="doi">10.1074/jbc.RA118.005806</pub-id></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cruickshanks</surname><given-names>HA</given-names></name><name><surname>McBryan</surname><given-names>T</given-names></name><name><surname>Nelson</surname><given-names>DM</given-names></name><name><surname>VanderKraats</surname><given-names>ND</given-names></name><name><surname>Shah</surname><given-names>PP</given-names></name><name><surname>van Tuyn</surname><given-names>J</given-names></name><name><surname>Singh Rai</surname><given-names>T</given-names></name><name><surname>Brock</surname><given-names>C</given-names></name><name><surname>Donahue</surname><given-names>G</given-names></name><name><surname>Dunican</surname><given-names>DS</given-names></name><name><surname>Drotar</surname><given-names>ME</given-names></name><etal/></person-group><article-title>Senescent cells harbour features of the cancer epigenome</article-title><source>Nature Cell Biology</source><year>2013</year><volume>15</volume><issue>12</issue><fpage>1495</fpage><lpage>1506</lpage><pub-id pub-id-type="pmcid">PMC4106249</pub-id><pub-id pub-id-type="pmid">24270890</pub-id><pub-id pub-id-type="doi">10.1038/ncb2879</pub-id></element-citation></ref><ref id="R41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shukla</surname><given-names>V</given-names></name><name><surname>Coumoul</surname><given-names>X</given-names></name><name><surname>Lahusen</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>R-H</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Vassilopoulos</surname><given-names>A</given-names></name><name><surname>Xiao</surname><given-names>C</given-names></name><name><surname>Lee</surname><given-names>M-H</given-names></name><name><surname>Man</surname><given-names>Y-G</given-names></name><name><surname>Ouchi</surname><given-names>M</given-names></name><name><surname>Ouchi</surname><given-names>T</given-names></name><etal/></person-group><article-title>BRCA1 affects global DNA methylation through regulation of DNMT1</article-title><source>Cell Research</source><year>2010</year><volume>20</volume><issue>11</issue><fpage>1201</fpage><lpage>1215</lpage><pub-id pub-id-type="pmcid">PMC9423198</pub-id><pub-id pub-id-type="pmid">20820192</pub-id><pub-id pub-id-type="doi">10.1038/cr.2010.128</pub-id></element-citation></ref><ref id="R42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Brodie</surname><given-names>SG</given-names></name><name><surname>Deng</surname><given-names>CX</given-names></name></person-group><article-title>Senescence, aging, and malignant transformation mediated by p53 in mice lacking the Brca1 full-length isoform</article-title><source>Genes Dev</source><year>2003</year><volume>17</volume><issue>2</issue><fpage>201</fpage><lpage>213</lpage><pub-id pub-id-type="pmcid">PMC195980</pub-id><pub-id pub-id-type="pmid">12533509</pub-id><pub-id pub-id-type="doi">10.1101/gad.1050003</pub-id></element-citation></ref><ref id="R43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Adams Peter</surname><given-names>D</given-names></name></person-group><article-title>Molecular Dissection of Formation of Senescence-Associated Heterochromatin Foci</article-title><source>Molecular and Cellular Biology</source><year>2007</year><volume>27</volume><issue>6</issue><fpage>2343</fpage><lpage>2358</lpage><pub-id pub-id-type="pmcid">PMC1820509</pub-id><pub-id pub-id-type="pmid">17242207</pub-id><pub-id pub-id-type="doi">10.1128/MCB.02019-06</pub-id></element-citation></ref><ref id="R44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Poustovoitov</surname><given-names>MV</given-names></name><name><surname>Ye</surname><given-names>X</given-names></name><name><surname>Santos</surname><given-names>HA</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Daganzo</surname><given-names>SM</given-names></name><name><surname>Erzberger</surname><given-names>JP</given-names></name><name><surname>Serebriiskii</surname><given-names>IG</given-names></name><name><surname>Canutescu</surname><given-names>AA</given-names></name><name><surname>Dunbrack</surname><given-names>RL</given-names></name><name><surname>Pehrson</surname><given-names>JR</given-names></name><etal/></person-group><article-title>Formation of MacroH2A-Containing Senescence-Associated Heterochromatin Foci and Senescence Driven by ASF1a and HIRA</article-title><source>Developmental Cell</source><year>2005</year><volume>8</volume><issue>1</issue><fpage>19</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">15621527</pub-id></element-citation></ref><ref id="R45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fnu</surname><given-names>S</given-names></name><name><surname>Williamson</surname><given-names>EA</given-names></name><name><surname>De Haro</surname><given-names>LP</given-names></name><name><surname>Brenneman</surname><given-names>M</given-names></name><name><surname>Wray</surname><given-names>J</given-names></name><name><surname>Shaheen</surname><given-names>M</given-names></name><name><surname>Radhakrishnan</surname><given-names>K</given-names></name><name><surname>Lee</surname><given-names>S-H</given-names></name><name><surname>Nickoloff</surname><given-names>JA</given-names></name><name><surname>Hromas</surname><given-names>R</given-names></name></person-group><article-title>Methylation of histone H3 lysine 36 enhances DNA repair by nonhomologous end-joining</article-title><source>Proceedings of the National Academy of Sciences</source><year>2011</year><volume>108</volume><issue>2</issue><fpage>540</fpage><lpage>545</lpage><pub-id pub-id-type="pmcid">PMC3021059</pub-id><pub-id pub-id-type="pmid">21187428</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1013571108</pub-id></element-citation></ref><ref id="R46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>X-J</given-names></name><name><surname>Wei</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>X-Y</given-names></name><name><surname>Hu</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>H-H</given-names></name><name><surname>Zhang</surname><given-names>Q-H</given-names></name><name><surname>Chen</surname><given-names>S-J</given-names></name><name><surname>Huang</surname><given-names>Q-H</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name></person-group><article-title>Identification and Characterization of a Novel Human Histone H3 Lysine 36-specific Methyltransferase *&lt;sup&gt;&lt;/sup&gt;</article-title><source>Journal of Biological Chemistry</source><year>2005</year><volume>280</volume><issue>42</issue><fpage>35261</fpage><lpage>35271</lpage><pub-id pub-id-type="pmid">16118227</pub-id></element-citation></ref><ref id="R47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edmunds</surname><given-names>JW</given-names></name><name><surname>Mahadevan</surname><given-names>LC</given-names></name><name><surname>Clayton</surname><given-names>AL</given-names></name></person-group><article-title>Dynamic histone H3 methylation during gene induction: HYPB/Setd2 mediates all H3K36 trimethylation</article-title><source>The EMBO Journal</source><year>2008</year><volume>27</volume><issue>2</issue><fpage>406</fpage><lpage>420</lpage><pub-id pub-id-type="pmcid">PMC2168397</pub-id><pub-id pub-id-type="pmid">18157086</pub-id><pub-id pub-id-type="doi">10.1038/sj.emboj.7601967</pub-id></element-citation></ref><ref id="R48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Croce</surname><given-names>L</given-names></name><name><surname>Helin</surname><given-names>K</given-names></name></person-group><article-title>Transcriptional regulation by Polycomb group proteins</article-title><source>Nature Structural &amp; Molecular Biology</source><year>2013</year><volume>20</volume><issue>10</issue><fpage>1147</fpage><lpage>1155</lpage><pub-id pub-id-type="pmid">24096405</pub-id></element-citation></ref><ref id="R49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>S-J</given-names></name><name><surname>Chun</surname><given-names>T</given-names></name></person-group><article-title>Structural heterogeneity of the mammalian polycomb repressor complex in immune regulation</article-title><source>Experimental &amp; Molecular Medicine</source><year>2020</year><volume>52</volume><issue>7</issue><fpage>1004</fpage><lpage>1015</lpage><pub-id pub-id-type="pmcid">PMC8080698</pub-id><pub-id pub-id-type="pmid">32636442</pub-id><pub-id pub-id-type="doi">10.1038/s12276-020-0462-5</pub-id></element-citation></ref><ref id="R50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ito</surname><given-names>T</given-names></name><name><surname>Teo</surname><given-names>YV</given-names></name><name><surname>Evans</surname><given-names>SA</given-names></name><name><surname>Neretti</surname><given-names>N</given-names></name><name><surname>Sedivy</surname><given-names>JM</given-names></name></person-group><article-title>Regulation of Cellular Senescence by Polycomb Chromatin Modifiers through Distinct DNA Damage- and Histone Methylation-Dependent Pathways</article-title><source>Cell Reports</source><year>2018</year><volume>22</volume><issue>13</issue><fpage>3480</fpage><lpage>3492</lpage><pub-id pub-id-type="pmcid">PMC5915310</pub-id><pub-id pub-id-type="pmid">29590617</pub-id><pub-id pub-id-type="doi">10.1016/j.celrep.2018.03.002</pub-id></element-citation></ref><ref id="R51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>R</given-names></name><name><surname>Fazal</surname><given-names>Z</given-names></name><name><surname>Corbet</surname><given-names>AK</given-names></name><name><surname>Bikorimana</surname><given-names>E</given-names></name><name><surname>Rodriguez</surname><given-names>JC</given-names></name><name><surname>Khan</surname><given-names>EM</given-names></name><name><surname>Shahid</surname><given-names>K</given-names></name><name><surname>Freemantle</surname><given-names>SJ</given-names></name><name><surname>Spinella</surname><given-names>MJ</given-names></name></person-group><article-title>Epigenetic Remodeling through Downregulation of Polycomb Repressive Complex 2 Mediates Chemotherapy Resistance in Testicular Germ Cell Tumors</article-title><source>Cancers (Basel)</source><year>2019</year><volume>11</volume><issue>6</issue><pub-id pub-id-type="pmcid">PMC6627640</pub-id><pub-id pub-id-type="pmid">31181810</pub-id><pub-id pub-id-type="doi">10.3390/cancers11060796</pub-id></element-citation></ref><ref id="R52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greussing</surname><given-names>R</given-names></name><name><surname>Hackl</surname><given-names>M</given-names></name><name><surname>Charoentong</surname><given-names>P</given-names></name><name><surname>Pauck</surname><given-names>A</given-names></name><name><surname>Monteforte</surname><given-names>R</given-names></name><name><surname>Cavinato</surname><given-names>M</given-names></name><name><surname>Hofer</surname><given-names>E</given-names></name><name><surname>Scheideler</surname><given-names>M</given-names></name><name><surname>Neuhaus</surname><given-names>M</given-names></name><name><surname>Micutkova</surname><given-names>L</given-names></name><name><surname>Mueck</surname><given-names>C</given-names></name><etal/></person-group><article-title>Identification of microRNA-mRNA functional interactions in UVB-induced senescence of human diploid fibroblasts</article-title><source>BMC Genomics</source><year>2013</year><volume>14</volume><issue>1</issue><fpage>224</fpage><pub-id pub-id-type="pmcid">PMC4008267</pub-id><pub-id pub-id-type="pmid">23557329</pub-id><pub-id pub-id-type="doi">10.1186/1471-2164-14-224</pub-id></element-citation></ref><ref id="R53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takada</surname><given-names>Y</given-names></name><name><surname>Isono</surname><given-names>K-i</given-names></name><name><surname>Shinga</surname><given-names>J</given-names></name><name><surname>Turner</surname><given-names>JMA</given-names></name><name><surname>Kitamura</surname><given-names>H</given-names></name><name><surname>Ohara</surname><given-names>O</given-names></name><name><surname>Watanabe</surname><given-names>G</given-names></name><name><surname>Singh</surname><given-names>PB</given-names></name><name><surname>Kamijo</surname><given-names>T</given-names></name><name><surname>Jenuwein</surname><given-names>T</given-names></name><name><surname>Burgoyne</surname><given-names>PS</given-names></name><etal/></person-group><article-title>Mammalian Polycomb Scmh1 mediates exclusion of Polycomb complexes from the XY body in the pachytene spermatocytes</article-title><source>Development</source><year>2007</year><volume>134</volume><issue>3</issue><fpage>579</fpage><lpage>590</lpage><pub-id pub-id-type="pmid">17215307</pub-id></element-citation></ref><ref id="R54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ballaré</surname><given-names>C</given-names></name><name><surname>Lange</surname><given-names>M</given-names></name><name><surname>Lapinaite</surname><given-names>A</given-names></name><name><surname>Martin</surname><given-names>GM</given-names></name><name><surname>Morey</surname><given-names>L</given-names></name><name><surname>Pascual</surname><given-names>G</given-names></name><name><surname>Liefke</surname><given-names>R</given-names></name><name><surname>Simon</surname><given-names>B</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Gozani</surname><given-names>O</given-names></name><name><surname>Carlomagno</surname><given-names>T</given-names></name><etal/></person-group><article-title>Phf19 links methylated Lys36 of histone H3 to regulation of Polycomb activity</article-title><source>Nat Struct Mol Biol</source><year>2012</year><volume>19</volume><issue>12</issue><fpage>1257</fpage><lpage>1265</lpage><pub-id pub-id-type="pmcid">PMC3926938</pub-id><pub-id pub-id-type="pmid">23104054</pub-id><pub-id pub-id-type="doi">10.1038/nsmb.2434</pub-id></element-citation></ref><ref id="R55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vizán</surname><given-names>P</given-names></name><name><surname>Gutiérrez</surname><given-names>A</given-names></name><name><surname>Espejo</surname><given-names>I</given-names></name><name><surname>García-Montolio</surname><given-names>M</given-names></name><name><surname>Lange</surname><given-names>M</given-names></name><name><surname>Carretero</surname><given-names>A</given-names></name><name><surname>Lafzi</surname><given-names>A</given-names></name><name><surname>de Andrés-Aguayo</surname><given-names>L</given-names></name><name><surname>Blanco</surname><given-names>E</given-names></name><name><surname>Thambyrajah</surname><given-names>R</given-names></name><name><surname>Graf</surname><given-names>T</given-names></name><etal/></person-group><article-title>The Polycomb-associated factor PHF19 controls hematopoietic stem cell state and differentiation</article-title><source>Science Advances</source><volume>6</volume><issue>32</issue><elocation-id>eabb2745</elocation-id><pub-id pub-id-type="pmcid">PMC7406347</pub-id><pub-id pub-id-type="pmid">32821835</pub-id><pub-id pub-id-type="doi">10.1126/sciadv.abb2745</pub-id></element-citation></ref><ref id="R56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pappa</surname><given-names>S</given-names></name><name><surname>Padilla</surname><given-names>N</given-names></name><name><surname>Iacobucci</surname><given-names>S</given-names></name><name><surname>Vicioso</surname><given-names>M</given-names></name><name><surname>Álvarez de la Campa</surname><given-names>E</given-names></name><name><surname>Navarro</surname><given-names>C</given-names></name><name><surname>Marcos</surname><given-names>E</given-names></name><name><surname>de la Cruz</surname><given-names>X</given-names></name><name><surname>Martínez-Balbás</surname><given-names>MA</given-names></name></person-group><article-title>PHF2 histone demethylase prevents DNA damage and genome instability by controlling cell cycle progression of neural progenitors</article-title><source>Proceedings of the National Academy of Sciences</source><year>2019</year><volume>116</volume><issue>39</issue><fpage>19464</fpage><lpage>19473</lpage><pub-id pub-id-type="pmcid">PMC6765295</pub-id><pub-id pub-id-type="pmid">31488723</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1903188116</pub-id></element-citation></ref><ref id="R57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Filipczak</surname><given-names>PT</given-names></name><name><surname>Leng</surname><given-names>S</given-names></name><name><surname>Tellez</surname><given-names>CS</given-names></name><name><surname>Do</surname><given-names>KC</given-names></name><name><surname>Grimes</surname><given-names>MJ</given-names></name><name><surname>Thomas</surname><given-names>CL</given-names></name><name><surname>Walton-Filipczak</surname><given-names>SR</given-names></name><name><surname>Picchi</surname><given-names>MA</given-names></name><name><surname>Belinsky</surname><given-names>SA</given-names></name></person-group><article-title>p53-Suppressed Oncogene TET1 Prevents Cellular Aging in Lung Cancer</article-title><source>Cancer Research</source><year>2019</year><volume>79</volume><issue>8</issue><fpage>1758</fpage><lpage>1768</lpage><pub-id pub-id-type="pmcid">PMC6467797</pub-id><pub-id pub-id-type="pmid">30622117</pub-id><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-18-1234</pub-id></element-citation></ref><ref id="R58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schleich</surname><given-names>K</given-names></name><name><surname>Kase</surname><given-names>J</given-names></name><name><surname>Dörr</surname><given-names>JR</given-names></name><name><surname>Trescher</surname><given-names>S</given-names></name><name><surname>Bhattacharya</surname><given-names>A</given-names></name><name><surname>Yu</surname><given-names>Y</given-names></name><name><surname>Wailes</surname><given-names>EM</given-names></name><name><surname>Fan</surname><given-names>DNY</given-names></name><name><surname>Lohneis</surname><given-names>P</given-names></name><name><surname>Milanovic</surname><given-names>M</given-names></name><name><surname>Lau</surname><given-names>A</given-names></name><etal/></person-group><article-title>H3K9me3-mediated epigenetic regulation of senescence in mice predicts outcome of lymphoma patients</article-title><source>Nature Communications</source><year>2020</year><volume>11</volume><issue>1</issue><elocation-id>3651</elocation-id><pub-id pub-id-type="pmcid">PMC7371731</pub-id><pub-id pub-id-type="pmid">32686676</pub-id><pub-id pub-id-type="doi">10.1038/s41467-020-17467-z</pub-id></element-citation></ref><ref id="R59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>A</given-names></name><name><surname>Imai</surname><given-names>Y</given-names></name><name><surname>Yamakoshi</surname><given-names>K</given-names></name><name><surname>Kuninaka</surname><given-names>S</given-names></name><name><surname>Ohtani</surname><given-names>N</given-names></name><name><surname>Yoshimoto</surname><given-names>S</given-names></name><name><surname>Hori</surname><given-names>S</given-names></name><name><surname>Tachibana</surname><given-names>M</given-names></name><name><surname>Anderton</surname><given-names>E</given-names></name><name><surname>Takeuchi</surname><given-names>T</given-names></name><name><surname>Shinkai</surname><given-names>Y</given-names></name><etal/></person-group><article-title>DNA Damage Signaling Triggers Degradation of Histone Methyltransferases through APC/CCdh1 in Senescent Cells</article-title><source>Molecular Cell</source><year>2012</year><volume>45</volume><issue>1</issue><fpage>123</fpage><lpage>131</lpage><pub-id pub-id-type="pmid">22178396</pub-id></element-citation></ref><ref id="R60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harman</surname><given-names>JL</given-names></name><name><surname>Dobnikar</surname><given-names>L</given-names></name><name><surname>Chappell</surname><given-names>J</given-names></name><name><surname>Stokell</surname><given-names>BG</given-names></name><name><surname>Dalby</surname><given-names>A</given-names></name><name><surname>Foote</surname><given-names>K</given-names></name><name><surname>Finigan</surname><given-names>A</given-names></name><name><surname>FreirePritchett</surname><given-names>P</given-names></name><name><surname>Taylor</surname><given-names>AL</given-names></name><name><surname>Worssam</surname><given-names>MD</given-names></name><name><surname>Madsen</surname><given-names>RR</given-names></name><etal/></person-group><article-title>Epigenetic Regulation of Vascular Smooth Muscle Cells by Histone H3 Lysine 9 Dimethylation Attenuates Target Gene-Induction by Inflammatory Signaling</article-title><source>Arteriosclerosis, Thrombosis and Vascular Biology</source><year>2019</year><volume>39</volume><issue>11</issue><fpage>2289</fpage><lpage>2302</lpage><pub-id pub-id-type="pmcid">PMC6818986</pub-id><pub-id pub-id-type="pmid">31434493</pub-id><pub-id pub-id-type="doi">10.1161/ATVBAHA.119.312765</pub-id></element-citation></ref><ref id="R61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herman</surname><given-names>AB</given-names></name><name><surname>Anerillas</surname><given-names>C</given-names></name><name><surname>Harris</surname><given-names>SC</given-names></name><name><surname>Munk</surname><given-names>R</given-names></name><name><surname>Martindale Jennifer</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Mazan-Mamczarz</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Heckenbach Indra</surname><given-names>J</given-names></name><name><surname>Scheibye-Knudsen</surname><given-names>M</given-names></name><name><surname>De</surname><given-names>S</given-names></name><etal/></person-group><article-title>Reduction of lamin B receptor levels by miR-340-5p disrupts chromatin, promotes cell senescence and enhances senolysis</article-title><source>Nucleic Acids Research</source><year>2021</year><volume>49</volume><issue>13</issue><fpage>7389</fpage><lpage>7405</lpage><pub-id pub-id-type="pmcid">PMC8287953</pub-id><pub-id pub-id-type="pmid">34181735</pub-id><pub-id pub-id-type="doi">10.1093/nar/gkab538</pub-id></element-citation></ref><ref id="R62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zirkel</surname><given-names>A</given-names></name><name><surname>Nikolic</surname><given-names>M</given-names></name><name><surname>Sofiadis</surname><given-names>K</given-names></name><name><surname>Mallm</surname><given-names>J-P</given-names></name><name><surname>Brackley</surname><given-names>CA</given-names></name><name><surname>Gothe</surname><given-names>H</given-names></name><name><surname>Drechsel</surname><given-names>O</given-names></name><name><surname>Becker</surname><given-names>C</given-names></name><name><surname>Altmüller</surname><given-names>J</given-names></name><name><surname>Josipovic</surname><given-names>N</given-names></name><name><surname>Georgomanolis</surname><given-names>T</given-names></name><etal/></person-group><article-title>HMGB2 Loss upon Senescence Entry Disrupts Genomic Organization and Induces CTCF Clustering across Cell Types</article-title><source>Molecular Cell</source><year>2018</year><volume>70</volume><issue>4</issue><fpage>730</fpage><lpage>744</lpage><elocation-id>e736</elocation-id><pub-id pub-id-type="pmid">29706538</pub-id></element-citation></ref><ref id="R63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sofiadis</surname><given-names>K</given-names></name><name><surname>Josipovic</surname><given-names>N</given-names></name><name><surname>Nikolic</surname><given-names>M</given-names></name><name><surname>Kargapolova</surname><given-names>Y</given-names></name><name><surname>Übelmesser</surname><given-names>N</given-names></name><name><surname>VaramogianniMamatsi</surname><given-names>V</given-names></name><name><surname>Zirkel</surname><given-names>A</given-names></name><name><surname>Papadionysiou</surname><given-names>I</given-names></name><name><surname>Loughran</surname><given-names>G</given-names></name><name><surname>Keane</surname><given-names>J</given-names></name><name><surname>Michel</surname><given-names>A</given-names></name><etal/></person-group><article-title>HMGB1 coordinates SASP-related chromatin folding and RNA homeostasis on the path to senescence</article-title><source>Molecular Systems Biology</source><year>2021</year><volume>17</volume><issue>6</issue><elocation-id>e9760</elocation-id><pub-id pub-id-type="pmcid">PMC8224457</pub-id><pub-id pub-id-type="pmid">34166567</pub-id><pub-id pub-id-type="doi">10.15252/msb.20209760</pub-id></element-citation></ref><ref id="R64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lototska</surname><given-names>L</given-names></name><name><surname>Yue</surname><given-names>J-X</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Giraud-Panis</surname><given-names>M-J</given-names></name><name><surname>Songyang</surname><given-names>Z</given-names></name><name><surname>Royle</surname><given-names>NJ</given-names></name><name><surname>Liti</surname><given-names>G</given-names></name><name><surname>Ye</surname><given-names>J</given-names></name><name><surname>Gilson</surname><given-names>E</given-names></name><name><surname>Mendez-Bermudez</surname><given-names>A</given-names></name></person-group><article-title>Human RAP1 specifically protects telomeres of senescent cells from DNA damage</article-title><source>EMBO reports</source><year>2020</year><volume>21</volume><issue>4</issue><elocation-id>e49076</elocation-id><pub-id pub-id-type="pmcid">PMC7132343</pub-id><pub-id pub-id-type="pmid">32096305</pub-id><pub-id pub-id-type="doi">10.15252/embr.201949076</pub-id></element-citation></ref><ref id="R65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>S</given-names></name><name><surname>Perez</surname><given-names>JV</given-names></name><name><surname>Svitko</surname><given-names>W</given-names></name><name><surname>Ricketts</surname><given-names>MD</given-names></name><name><surname>Dean</surname><given-names>E</given-names></name><name><surname>Schultz</surname><given-names>D</given-names></name><name><surname>Marmorstein</surname><given-names>R</given-names></name><name><surname>Johnson</surname><given-names>FB</given-names></name></person-group><article-title>Rap1-mediated nucleosome displacement can regulate gene expression in senescent cells without impacting the pace of senescence</article-title><source>Aging Cell</source><year>2020</year><volume>19</volume><issue>1</issue><elocation-id>e13061</elocation-id><pub-id pub-id-type="pmcid">PMC6974733</pub-id><pub-id pub-id-type="pmid">31742863</pub-id><pub-id pub-id-type="doi">10.1111/acel.13061</pub-id></element-citation></ref><ref id="R66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Platt</surname><given-names>JM</given-names></name><name><surname>Ryvkin</surname><given-names>P</given-names></name><name><surname>Wanat</surname><given-names>JJ</given-names></name><name><surname>Donahue</surname><given-names>G</given-names></name><name><surname>Ricketts</surname><given-names>MD</given-names></name><name><surname>Barrett</surname><given-names>SP</given-names></name><name><surname>Waters</surname><given-names>HJ</given-names></name><name><surname>Song</surname><given-names>S</given-names></name><name><surname>Chavez</surname><given-names>A</given-names></name><name><surname>Abdallah</surname><given-names>KO</given-names></name><name><surname>Master</surname><given-names>SR</given-names></name><etal/></person-group><article-title>Rap1 relocalization contributes to the chromatin-mediated gene expression profile and pace of cell senescence</article-title><source>Genes Dev</source><year>2013</year><volume>27</volume><issue>12</issue><fpage>1406</fpage><lpage>1420</lpage><pub-id pub-id-type="pmcid">PMC3701195</pub-id><pub-id pub-id-type="pmid">23756653</pub-id><pub-id pub-id-type="doi">10.1101/gad.218776.113</pub-id></element-citation></ref><ref id="R67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ivanov</surname><given-names>A</given-names></name><name><surname>Pawlikowski</surname><given-names>J</given-names></name><name><surname>Manoharan</surname><given-names>I</given-names></name><name><surname>van Tuyn</surname><given-names>J</given-names></name><name><surname>Nelson</surname><given-names>DM</given-names></name><name><surname>Rai</surname><given-names>TS</given-names></name><name><surname>Shah</surname><given-names>PP</given-names></name><name><surname>Hewitt</surname><given-names>G</given-names></name><name><surname>Korolchuk</surname><given-names>VI</given-names></name><name><surname>Passos</surname><given-names>JF</given-names></name><name><surname>Wu</surname><given-names>H</given-names></name><etal/></person-group><article-title>Lysosome-mediated processing of chromatin in senescence</article-title><source>Journal of Cell Biology</source><year>2013</year><volume>202</volume><issue>1</issue><fpage>129</fpage><lpage>143</lpage><pub-id pub-id-type="pmcid">PMC3704985</pub-id><pub-id pub-id-type="pmid">23816621</pub-id><pub-id pub-id-type="doi">10.1083/jcb.201212110</pub-id></element-citation></ref><ref id="R68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lagadic-Gossmann</surname><given-names>D</given-names></name><name><surname>Huc</surname><given-names>L</given-names></name><name><surname>Lecureur</surname><given-names>V</given-names></name></person-group><article-title>Alterations of intracellular pH homeostasis in apoptosis: origins and roles</article-title><source>Cell Death &amp; Differentiation</source><year>2004</year><volume>11</volume><issue>9</issue><fpage>953</fpage><lpage>961</lpage><pub-id pub-id-type="pmid">15195071</pub-id></element-citation></ref><ref id="R69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Triana-Martínez</surname><given-names>F</given-names></name><name><surname>Picallos-Rabina</surname><given-names>P</given-names></name><name><surname>Da Silva-Álvarez</surname><given-names>S</given-names></name><name><surname>Pietrocola</surname><given-names>F</given-names></name><name><surname>Llanos</surname><given-names>S</given-names></name><name><surname>Rodilla</surname><given-names>V</given-names></name><name><surname>Soprano</surname><given-names>E</given-names></name><name><surname>Pedrosa</surname><given-names>P</given-names></name><name><surname>Ferreirós</surname><given-names>A</given-names></name><name><surname>Barradas</surname><given-names>M</given-names></name><name><surname>Hernández-González</surname><given-names>F</given-names></name><etal/></person-group><article-title>Identification and characterization of Cardiac Glycosides as senolytic compounds</article-title><source>Nature Communications</source><year>2019</year><volume>10</volume><issue>1</issue><elocation-id>4731</elocation-id><pub-id pub-id-type="pmcid">PMC6803708</pub-id><pub-id pub-id-type="pmid">31636264</pub-id><pub-id pub-id-type="doi">10.1038/s41467-019-12888-x</pub-id></element-citation></ref><ref id="R70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johmura</surname><given-names>Y</given-names></name><name><surname>Yamanaka</surname><given-names>T</given-names></name><name><surname>Omori</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>T-W</given-names></name><name><surname>Sugiura</surname><given-names>Y</given-names></name><name><surname>Matsumoto</surname><given-names>M</given-names></name><name><surname>Suzuki</surname><given-names>N</given-names></name><name><surname>Kumamoto</surname><given-names>S</given-names></name><name><surname>Yamaguchi</surname><given-names>K</given-names></name><name><surname>Hatakeyama</surname><given-names>S</given-names></name><name><surname>Takami</surname><given-names>T</given-names></name><etal/></person-group><article-title>Senolysis by glutaminolysis inhibition ameliorates various age-associated disorders</article-title><source>Science</source><year>2021</year><volume>371</volume><issue>6526</issue><fpage>265</fpage><lpage>270</lpage><pub-id pub-id-type="pmid">33446552</pub-id></element-citation></ref><ref id="R71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name><name><surname>Weinman</surname><given-names>SA</given-names></name></person-group><article-title>The ClC-3 chloride channel promotes acidification of lysosomes in CHO-K1 and Huh-7 cells</article-title><source>American Journal of Physiology-Cell Physiology</source><year>2002</year><volume>282</volume><issue>6</issue><fpage>C1483</fpage><lpage>C1491</lpage><pub-id pub-id-type="pmid">11997263</pub-id></element-citation></ref><ref id="R72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gottlieb</surname><given-names>RA</given-names></name><name><surname>Giesing</surname><given-names>HA</given-names></name><name><surname>Zhu</surname><given-names>JY</given-names></name><name><surname>Engler</surname><given-names>RL</given-names></name><name><surname>Babior</surname><given-names>BM</given-names></name></person-group><article-title>Cell acidification in apoptosis: granulocyte colony-stimulating factor delays programmed cell death in neutrophils by up-regulating the vacuolar H(+)-ATPase</article-title><source>Proceedings of the National Academy of Sciences</source><year>1995</year><volume>92</volume><issue>13</issue><fpage>5965</fpage><lpage>5968</lpage><pub-id pub-id-type="pmcid">PMC41622</pub-id><pub-id pub-id-type="pmid">7541139</pub-id><pub-id pub-id-type="doi">10.1073/pnas.92.13.5965</pub-id></element-citation></ref><ref id="R73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rebillard</surname><given-names>Al</given-names></name><name><surname>Tekpli</surname><given-names>X</given-names></name><name><surname>Meurette</surname><given-names>O</given-names></name><name><surname>Sergent</surname><given-names>O</given-names></name><name><surname>LeMoigne-Muller</surname><given-names>Gl</given-names></name><name><surname>Vernhet</surname><given-names>L</given-names></name><name><surname>Gorria</surname><given-names>M</given-names></name><name><surname>Chevanne</surname><given-names>M</given-names></name><name><surname>Christmann</surname><given-names>M</given-names></name><name><surname>Kaina</surname><given-names>B</given-names></name><name><surname>Counillon</surname><given-names>L</given-names></name><etal/></person-group><article-title>Cisplatin-Induced Apoptosis Involves Membrane Fluidification via Inhibition of NHE1 in Human Colon Cancer Cells</article-title><source>Cancer Research</source><year>2007</year><volume>67</volume><issue>16</issue><fpage>7865</fpage><lpage>7874</lpage><pub-id pub-id-type="pmid">17699793</pub-id></element-citation></ref><ref id="R74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hyun</surname><given-names>SY</given-names></name><name><surname>Kim</surname><given-names>YK</given-names></name><name><surname>Jang</surname><given-names>JE</given-names></name><name><surname>Kim</surname><given-names>Y</given-names></name><name><surname>Kim</surname><given-names>YR</given-names></name><name><surname>Cheong</surname><given-names>J-W</given-names></name><name><surname>Shim</surname><given-names>KY</given-names></name><name><surname>Min</surname><given-names>YH</given-names></name></person-group><article-title>Inhibition of NHE1 Induced Apoptosis in Cytarabine Resistant Leukemia Cell Lines and Primary Leukemia Cells from AML Patients, Which Showed Increased Intracellular pH and NHE1 Activity</article-title><source>Blood</source><year>2014</year><volume>124</volume><issue>21</issue><fpage>3614</fpage></element-citation></ref><ref id="R75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bae</surname><given-names>M</given-names></name><name><surname>Patel</surname><given-names>N</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Lee</surname><given-names>M</given-names></name><name><surname>Tominaga-Yamanaka</surname><given-names>K</given-names></name><name><surname>Nath</surname><given-names>A</given-names></name><name><surname>Geiger</surname><given-names>J</given-names></name><name><surname>Gorospe</surname><given-names>M</given-names></name><name><surname>Mattson</surname><given-names>MP</given-names></name><name><surname>Haughey</surname><given-names>NJ</given-names></name></person-group><article-title>Activation of TRPML1 clears intraneuronal Aβ in preclinical models of HIV infection</article-title><source>J Neurosci</source><year>2014</year><volume>34</volume><issue>34</issue><fpage>11485</fpage><lpage>11503</lpage><pub-id pub-id-type="pmcid">PMC4138351</pub-id><pub-id pub-id-type="pmid">25143627</pub-id><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0210-14.2014</pub-id></element-citation></ref><ref id="R76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patschan</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Gealekman</surname><given-names>O</given-names></name><name><surname>Krupincza</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Shu</surname><given-names>L</given-names></name><name><surname>Shayman</surname><given-names>JA</given-names></name><name><surname>Goligorsky</surname><given-names>MS</given-names></name></person-group><article-title>Mapping mechanisms and charting the time course of premature cell senescence and apoptosis: lysosomal dysfunction and ganglioside accumulation in endothelial cells</article-title><source>American Journal of Physiology-Renal Physiology</source><year>2008</year><volume>294</volume><issue>1</issue><fpage>F100</fpage><lpage>F109</lpage><pub-id pub-id-type="pmid">17928415</pub-id></element-citation></ref><ref id="R77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sha</surname><given-names>Z</given-names></name><name><surname>Schnell</surname><given-names>HM</given-names></name><name><surname>Ruoff</surname><given-names>K</given-names></name><name><surname>Goldberg</surname><given-names>A</given-names></name></person-group><article-title>Rapid induction of p62 and GABARAPL1 upon proteasome inhibition promotes survival before autophagy activation</article-title><source>Journal of Cell Biology</source><year>2018</year><volume>217</volume><issue>5</issue><fpage>1757</fpage><lpage>1776</lpage><pub-id pub-id-type="pmcid">PMC5940303</pub-id><pub-id pub-id-type="pmid">29535191</pub-id><pub-id pub-id-type="doi">10.1083/jcb.201708168</pub-id></element-citation></ref><ref id="R78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chondrogianni</surname><given-names>N</given-names></name><name><surname>Stratford</surname><given-names>FLL</given-names></name><name><surname>Trougakos</surname><given-names>IP</given-names></name><name><surname>Friguet</surname><given-names>B</given-names></name><name><surname>Rivett</surname><given-names>AJ</given-names></name><name><surname>Gonos</surname><given-names>ES</given-names></name></person-group><article-title>Central Role of the Proteasome in Senescence and Survival of Human Fibroblasts: INDUCTION OF A SENESCENCE-LIKE PHENOTYPE UPON ITS INHIBITION AND RESISTANCE TO STRESS UPON ITS ACTIVATION *</article-title><source>Journal of Biological Chemistry</source><year>2003</year><volume>278</volume><issue>30</issue><fpage>28026</fpage><lpage>28037</lpage><pub-id pub-id-type="pmid">12736271</pub-id></element-citation></ref><ref id="R79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>AR</given-names></name><name><surname>Narita</surname><given-names>M</given-names></name><name><surname>Ferreira</surname><given-names>M</given-names></name><name><surname>Kirschner</surname><given-names>K</given-names></name><name><surname>Sadaie</surname><given-names>M</given-names></name><name><surname>Darot</surname><given-names>JF</given-names></name><name><surname>Tavaré</surname><given-names>S</given-names></name><name><surname>Arakawa</surname><given-names>S</given-names></name><name><surname>Shimizu</surname><given-names>S</given-names></name><name><surname>Watt</surname><given-names>FM</given-names></name><name><surname>Narita</surname><given-names>M</given-names></name></person-group><article-title>Autophagy mediates the mitotic senescence transition</article-title><source>Genes Dev</source><year>2009</year><volume>23</volume><issue>7</issue><fpage>798</fpage><lpage>803</lpage><pub-id pub-id-type="pmcid">PMC2666340</pub-id><pub-id pub-id-type="pmid">19279323</pub-id><pub-id pub-id-type="doi">10.1101/gad.519709</pub-id></element-citation></ref><ref id="R80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rovira</surname><given-names>M</given-names></name><name><surname>Sereda</surname><given-names>R</given-names></name><name><surname>Pladevall-Morera</surname><given-names>D</given-names></name><name><surname>Ramponi</surname><given-names>V</given-names></name><name><surname>Marin</surname><given-names>I</given-names></name><name><surname>Maus</surname><given-names>M</given-names></name><name><surname>Madrigal-Matute</surname><given-names>J</given-names></name><name><surname>Díaz</surname><given-names>A</given-names></name><name><surname>García</surname><given-names>F</given-names></name><name><surname>Muñoz</surname><given-names>J</given-names></name><name><surname>Cuervo</surname><given-names>AM</given-names></name><etal/></person-group><article-title>The lysosomal proteome of senescent cells contributes to the senescence secretome</article-title><source>Aging Cell</source><year>2022</year><comment>n/a(n/a)</comment><elocation-id>e13707</elocation-id><pub-id pub-id-type="pmcid">PMC9577959</pub-id><pub-id pub-id-type="pmid">36087066</pub-id><pub-id pub-id-type="doi">10.1111/acel.13707</pub-id></element-citation></ref><ref id="R81"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>García-Prat</surname><given-names>L</given-names></name><name><surname>Martínez-Vicente</surname><given-names>M</given-names></name><name><surname>Perdiguero</surname><given-names>E</given-names></name><name><surname>Ortet</surname><given-names>L</given-names></name><name><surname>Rodríguez-Ubreva</surname><given-names>J</given-names></name><name><surname>Rebollo</surname><given-names>E</given-names></name><name><surname>Ruiz-Bonilla</surname><given-names>V</given-names></name><name><surname>Gutarra</surname><given-names>S</given-names></name><name><surname>Ballestar</surname><given-names>E</given-names></name><name><surname>Serrano</surname><given-names>AL</given-names></name><name><surname>Sandri</surname><given-names>M</given-names></name><etal/></person-group><article-title>Autophagy maintains stemness by preventing senescence</article-title><source>Nature</source><year>2016</year><volume>529</volume><issue>7584</issue><fpage>37</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">26738589</pub-id></element-citation></ref><ref id="R82"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>X</given-names></name><name><surname>Narzt</surname><given-names>MS</given-names></name><name><surname>Nagelreiter</surname><given-names>IM</given-names></name><name><surname>Hohensinner</surname><given-names>P</given-names></name><name><surname>Terlecki-Zaniewicz</surname><given-names>L</given-names></name><name><surname>Tschachler</surname><given-names>E</given-names></name><name><surname>Grillari</surname><given-names>J</given-names></name><name><surname>Gruber</surname><given-names>F</given-names></name></person-group><article-title>Autophagy deficient keratinocytes display increased DNA damage, senescence and aberrant lipid composition after oxidative stress in vitro and in vivo</article-title><source>Redox Biology</source><year>2017</year><volume>11</volume><fpage>219</fpage><lpage>230</lpage><pub-id pub-id-type="pmcid">PMC5192251</pub-id><pub-id pub-id-type="pmid">28012437</pub-id><pub-id pub-id-type="doi">10.1016/j.redox.2016.12.015</pub-id></element-citation></ref><ref id="R83"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto-Imoto</surname><given-names>H</given-names></name><name><surname>Minami</surname><given-names>S</given-names></name><name><surname>Shioda</surname><given-names>T</given-names></name><name><surname>Yamashita</surname><given-names>Y</given-names></name><name><surname>Sakai</surname><given-names>S</given-names></name><name><surname>Maeda</surname><given-names>S</given-names></name><name><surname>Yamamoto</surname><given-names>T</given-names></name><name><surname>Oki</surname><given-names>S</given-names></name><name><surname>Takashima</surname><given-names>M</given-names></name><name><surname>Yamamuro</surname><given-names>T</given-names></name><name><surname>Yanagawa</surname><given-names>K</given-names></name><etal/></person-group><article-title>Age-associated decline of MondoA drives cellular senescence through impaired autophagy and mitochondrial homeostasis</article-title><source>Cell Reports</source><year>2022</year><volume>38</volume><issue>9</issue><elocation-id>110444</elocation-id><pub-id pub-id-type="pmid">35235784</pub-id></element-citation></ref><ref id="R84"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>Y</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>M-S</given-names></name><name><surname>Kwon</surname><given-names>Y</given-names></name><name><surname>Shin</surname><given-names>S</given-names></name><name><surname>Yi</surname><given-names>H</given-names></name><name><surname>Kim</surname><given-names>H</given-names></name><name><surname>Chang</surname><given-names>MJ</given-names></name><name><surname>Chang</surname><given-names>CB</given-names></name><name><surname>Kang</surname><given-names>SB</given-names></name><name><surname>Kim</surname><given-names>VN</given-names></name><etal/></person-group><article-title>Coordinate regulation of the senescent state by selective autophagy</article-title><source>Developmental Cell</source><year>2021</year><volume>56</volume><issue>10</issue><fpage>1512</fpage><lpage>1525</lpage><elocation-id>e1517</elocation-id><pub-id pub-id-type="pmid">33915088</pub-id></element-citation></ref><ref id="R85"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scotto Rosato</surname><given-names>A</given-names></name><name><surname>Montefusco</surname><given-names>S</given-names></name><name><surname>Soldati</surname><given-names>C</given-names></name><name><surname>Di Paola</surname><given-names>S</given-names></name><name><surname>Capuozzo</surname><given-names>A</given-names></name><name><surname>Monfregola</surname><given-names>J</given-names></name><name><surname>Polishchuk</surname><given-names>E</given-names></name><name><surname>Amabile</surname><given-names>A</given-names></name><name><surname>Grimm</surname><given-names>C</given-names></name><name><surname>Lombardo</surname><given-names>A</given-names></name><name><surname>De Matteis</surname><given-names>MA</given-names></name><etal/></person-group><article-title>TRPML1 links lysosomal calcium to autophagosome biogenesis through the activation of the CaMKKβ/VPS34 pathway</article-title><source>Nature Communications</source><year>2019</year><volume>10</volume><issue>1</issue><elocation-id>5630</elocation-id><pub-id pub-id-type="pmcid">PMC6904751</pub-id><pub-id pub-id-type="pmid">31822666</pub-id><pub-id pub-id-type="doi">10.1038/s41467-019-13572-w</pub-id></element-citation></ref><ref id="R86"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruas</surname><given-names>M</given-names></name><name><surname>Davis</surname><given-names>LC</given-names></name><name><surname>Chen</surname><given-names>C-C</given-names></name><name><surname>Morgan</surname><given-names>AJ</given-names></name><name><surname>Chuang</surname><given-names>K-T</given-names></name><name><surname>Walseth</surname><given-names>TF</given-names></name><name><surname>Grimm</surname><given-names>C</given-names></name><name><surname>Garnham</surname><given-names>C</given-names></name><name><surname>Powell</surname><given-names>T</given-names></name><etal/></person-group><article-title>Expression of Ca2+-permeable two-pore channels rescues NAADP signalling in TPC-deficient cells</article-title><source>The EMBO Journal</source><year>2015</year><volume>34</volume><issue>13</issue><fpage>1743</fpage><lpage>1758</lpage><pub-id pub-id-type="pmcid">PMC4516428</pub-id><pub-id pub-id-type="pmid">25872774</pub-id><pub-id pub-id-type="doi">10.15252/embj.201490009</pub-id></element-citation></ref><ref id="R87"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>D-L</given-names></name><name><surname>Dai</surname><given-names>W-Y</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Wen</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>Y-T</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>P</given-names></name></person-group><article-title>Interfering RNA against PKC-α inhibits TNF-α-induced IP3R1 expression and improves glomerular filtration rate in rats with fulminant hepatic failure</article-title><source>American Journal of Physiology-Renal Physiology</source><year>2018</year><volume>314</volume><issue>5</issue><fpage>F942</fpage><lpage>F955</lpage><pub-id pub-id-type="pmid">29357415</pub-id></element-citation></ref><ref id="R88"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>N</given-names></name><name><surname>Bernard</surname><given-names>D</given-names></name></person-group><article-title>Calcium signaling and cellular senescence</article-title><source>Cell Calcium</source><year>2018</year><volume>70</volume><fpage>16</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">28410770</pub-id></element-citation></ref><ref id="R89"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiel</surname><given-names>C</given-names></name><name><surname>Lallet-Daher</surname><given-names>H</given-names></name><name><surname>Gitenay</surname><given-names>D</given-names></name><name><surname>Gras</surname><given-names>B</given-names></name><name><surname>Le Calvé</surname><given-names>B</given-names></name><name><surname>Augert</surname><given-names>A</given-names></name><name><surname>Ferrand</surname><given-names>M</given-names></name><name><surname>Prevarskaya</surname><given-names>N</given-names></name><name><surname>Simonnet</surname><given-names>H</given-names></name><name><surname>Vindrieux</surname><given-names>D</given-names></name><name><surname>Bernard</surname><given-names>D</given-names></name></person-group><article-title>Endoplasmic reticulum calcium release through ITPR2 channels leads to mitochondrial calcium accumulation and senescence</article-title><source>Nature Communications</source><year>2014</year><volume>5</volume><issue>1</issue><elocation-id>3792</elocation-id><pub-id pub-id-type="pmid">24797322</pub-id></element-citation></ref><ref id="R90"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kania</surname><given-names>E</given-names></name><name><surname>Roest</surname><given-names>G</given-names></name><name><surname>Vervliet</surname><given-names>T</given-names></name><name><surname>Parys</surname><given-names>JB</given-names></name><name><surname>Bultynck</surname><given-names>G</given-names></name></person-group><article-title>IP3 Receptor-Mediated Calcium Signaling and Its Role in Autophagy in Cancer</article-title><source>Frontiers in Oncology</source><year>2017</year><volume>7</volume><pub-id pub-id-type="pmcid">PMC5497685</pub-id><pub-id pub-id-type="pmid">28725634</pub-id><pub-id pub-id-type="doi">10.3389/fonc.2017.00140</pub-id></element-citation></ref><ref id="R91"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Son</surname><given-names>SM</given-names></name><name><surname>Byun</surname><given-names>J</given-names></name><name><surname>Roh</surname><given-names>SE</given-names></name><name><surname>Kim</surname><given-names>SJ</given-names></name><name><surname>Mook-Jung</surname><given-names>I</given-names></name></person-group><article-title>Reduced IRE1alpha mediates apoptotic cell death by disrupting calcium homeostasis via the InsP3 receptor</article-title><source>Cell Death Dis</source><year>2014</year><volume>5</volume><elocation-id>e1188</elocation-id><pub-id pub-id-type="pmcid">PMC4001297</pub-id><pub-id pub-id-type="pmid">24743743</pub-id><pub-id pub-id-type="doi">10.1038/cddis.2014.129</pub-id></element-citation></ref><ref id="R92"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hetz</surname><given-names>C</given-names></name><name><surname>Papa</surname><given-names>FR</given-names></name></person-group><article-title>The Unfolded Protein Response and Cell Fate Control</article-title><source>Molecular Cell</source><year>2018</year><volume>69</volume><issue>2</issue><fpage>169</fpage><lpage>181</lpage><pub-id pub-id-type="pmid">29107536</pub-id></element-citation></ref><ref id="R93"><label>93</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blazanin</surname><given-names>N</given-names></name><name><surname>Son</surname><given-names>J</given-names></name><name><surname>Craig-Lucas</surname><given-names>AB</given-names></name><name><surname>John</surname><given-names>CL</given-names></name><name><surname>Breech</surname><given-names>KJ</given-names></name><name><surname>Podolsky</surname><given-names>MA</given-names></name><name><surname>Glick</surname><given-names>AB</given-names></name></person-group><article-title>ER stress and distinct outputs of the IRE1α RNase control proliferation and senescence in response to oncogenic Ras</article-title><source>Proceedings of the National Academy of Sciences</source><year>2017</year><volume>114</volume><issue>37</issue><fpage>9900</fpage><lpage>9905</lpage><pub-id pub-id-type="pmcid">PMC5603998</pub-id><pub-id pub-id-type="pmid">28847931</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1701757114</pub-id></element-citation></ref><ref id="R94"><label>94</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sabath</surname><given-names>N</given-names></name><name><surname>Levy-Adam</surname><given-names>F</given-names></name><name><surname>Younis</surname><given-names>A</given-names></name><name><surname>Rozales</surname><given-names>K</given-names></name><name><surname>Meller</surname><given-names>A</given-names></name><name><surname>Hadar</surname><given-names>S</given-names></name><name><surname>Soueid-Baumgarten</surname><given-names>S</given-names></name><name><surname>Shalgi</surname><given-names>R</given-names></name></person-group><article-title>Cellular proteostasis decline in human senescence</article-title><source>Proceedings of the National Academy of Sciences</source><year>2020</year><volume>117</volume><issue>50</issue><fpage>31902</fpage><lpage>31913</lpage><pub-id pub-id-type="pmcid">PMC7749315</pub-id><pub-id pub-id-type="pmid">33257563</pub-id><pub-id pub-id-type="doi">10.1073/pnas.2018138117</pub-id></element-citation></ref><ref id="R95"><label>95</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>A-H</given-names></name><name><surname>Iwakoshi</surname><given-names>NN</given-names></name><name><surname>Glimcher</surname><given-names>LH</given-names></name></person-group><article-title>XBP-1 Regulates a Subset of Endoplasmic Reticulum Resident Chaperone Genes in the Unfolded Protein Response</article-title><source>Molecular and Cellular Biology</source><year>2003</year><volume>23</volume><issue>21</issue><fpage>7448</fpage><lpage>7459</lpage><pub-id pub-id-type="pmcid">PMC207643</pub-id><pub-id pub-id-type="pmid">14559994</pub-id><pub-id pub-id-type="doi">10.1128/MCB.23.21.7448-7459.2003</pub-id></element-citation></ref><ref id="R96"><label>96</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amin-Wetzel</surname><given-names>N</given-names></name><name><surname>Saunders</surname><given-names>RA</given-names></name><name><surname>Kamphuis</surname><given-names>MJ</given-names></name><name><surname>Rato</surname><given-names>C</given-names></name><name><surname>Preissler</surname><given-names>S</given-names></name><name><surname>Harding</surname><given-names>HP</given-names></name><name><surname>Ron</surname><given-names>D</given-names></name></person-group><article-title>A J-Protein Co-chaperone Recruits BiP to Monomerize IRE1 and Repress the Unfolded Protein Response</article-title><source>Cell</source><year>2017</year><volume>171</volume><issue>7</issue><fpage>1625</fpage><lpage>1637</lpage><elocation-id>e1613</elocation-id><pub-id pub-id-type="pmcid">PMC5733394</pub-id><pub-id pub-id-type="pmid">29198525</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2017.10.040</pub-id></element-citation></ref><ref id="R97"><label>97</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>HJ</given-names></name><name><surname>Kim</surname><given-names>JM</given-names></name><name><surname>Kim</surname><given-names>KH</given-names></name><name><surname>Heo</surname><given-names>JI</given-names></name><name><surname>Kwak</surname><given-names>SJ</given-names></name><name><surname>Han</surname><given-names>JA</given-names></name></person-group><article-title>Genotoxic stress/p53-induced DNAJB9 inhibits the pro-apoptotic function of p53</article-title><source>Cell Death &amp; Differentiation</source><year>2015</year><volume>22</volume><issue>1</issue><fpage>86</fpage><lpage>95</lpage><pub-id pub-id-type="pmcid">PMC4262772</pub-id><pub-id pub-id-type="pmid">25146923</pub-id><pub-id pub-id-type="doi">10.1038/cdd.2014.116</pub-id></element-citation></ref><ref id="R98"><label>98</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bujisic</surname><given-names>B</given-names></name><name><surname>De Gassart</surname><given-names>A</given-names></name><name><surname>Tallant</surname><given-names>R</given-names></name><name><surname>Demaria</surname><given-names>O</given-names></name><name><surname>Zaffalon</surname><given-names>L</given-names></name><name><surname>Chelbi</surname><given-names>S</given-names></name><name><surname>Gilliet</surname><given-names>M</given-names></name><name><surname>Bertoni</surname><given-names>F</given-names></name><name><surname>Martinon</surname><given-names>F</given-names></name></person-group><article-title>Impairment of both IRE1 expression and XBP1 activation is a hallmark of GCB DLBCL and contributes to tumor growth</article-title><source>Blood</source><year>2017</year><volume>129</volume><issue>17</issue><fpage>2420</fpage><lpage>2428</lpage><pub-id pub-id-type="pmid">28167662</pub-id></element-citation></ref><ref id="R99"><label>99</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weaver</surname><given-names>SA</given-names></name><name><surname>Kono</surname><given-names>T</given-names></name><name><surname>Syed</surname><given-names>F</given-names></name><name><surname>Bone</surname><given-names>RN</given-names></name><name><surname>Evans-Molina</surname><given-names>C</given-names></name></person-group><article-title>288-OR: Role of Endoplasmic Reticulum (ER) Calcium in ß-Cell Senescence and Type 1 Diabetes Pathophysiology</article-title><source>Diabetes</source><year>2021</year><volume>70</volume><issue>Supplement_1</issue><elocation-id>288-OR</elocation-id></element-citation></ref><ref id="R100"><label>100</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ganley Ian</surname><given-names>G</given-names></name><name><surname>Wong</surname><given-names>P-M</given-names></name><name><surname>Gammoh</surname><given-names>N</given-names></name><name><surname>Jiang</surname><given-names>X</given-names></name></person-group><article-title>Distinct Autophagosomal-Lysosomal Fusion Mechanism Revealed by Thapsigargin-Induced Autophagy Arrest</article-title><source>Molecular Cell</source><year>2011</year><volume>42</volume><issue>6</issue><fpage>731</fpage><lpage>743</lpage><pub-id pub-id-type="pmcid">PMC3124681</pub-id><pub-id pub-id-type="pmid">21700220</pub-id><pub-id pub-id-type="doi">10.1016/j.molcel.2011.04.024</pub-id></element-citation></ref><ref id="R101"><label>101</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takeichi</surname><given-names>T</given-names></name><name><surname>Torrelo</surname><given-names>A</given-names></name><name><surname>Lee</surname><given-names>JYW</given-names></name><name><surname>Ohno</surname><given-names>Y</given-names></name><name><surname>Lozano</surname><given-names>ML</given-names></name><name><surname>Kihara</surname><given-names>A</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Yasuda</surname><given-names>Y</given-names></name><name><surname>Ishikawa</surname><given-names>J</given-names></name><name><surname>Murase</surname><given-names>T</given-names></name><name><surname>Rodrigo</surname><given-names>AB</given-names></name><etal/></person-group><article-title>Biallelic Mutations in KDSR Disrupt Ceramide Synthesis and Result in a Spectrum of Keratinization Disorders Associated with Thrombocytopenia</article-title><source>Journal of Investigative Dermatology</source><year>2017</year><volume>137</volume><issue>11</issue><fpage>2344</fpage><lpage>2353</lpage><pub-id pub-id-type="pmcid">PMC5646945</pub-id><pub-id pub-id-type="pmid">28774589</pub-id><pub-id pub-id-type="doi">10.1016/j.jid.2017.06.028</pub-id></element-citation></ref><ref id="R102"><label>102</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>R</given-names></name><name><surname>Garcia-Barros</surname><given-names>M</given-names></name><name><surname>Wen</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>F</given-names></name><name><surname>Lin</surname><given-names>C-L</given-names></name><name><surname>Hannun</surname><given-names>YA</given-names></name><name><surname>Obeid</surname><given-names>LM</given-names></name><name><surname>Mao</surname><given-names>C</given-names></name></person-group><article-title>Tumor suppressor p53 links ceramide metabolism to DNA damage response through alkaline ceramidase 2</article-title><source>Cell Death &amp; Differentiation</source><year>2017</year><pub-id pub-id-type="pmcid">PMC5943524</pub-id><pub-id pub-id-type="pmid">29229990</pub-id><pub-id pub-id-type="doi">10.1038/s41418-017-0018-y</pub-id></element-citation></ref><ref id="R103"><label>103</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ségui</surname><given-names>B</given-names></name><name><surname>Andrieu-Abadie</surname><given-names>N</given-names></name><name><surname>Adam-Klages</surname><given-names>S</given-names></name><name><surname>Meilhac</surname><given-names>O</given-names></name><name><surname>Kreder</surname><given-names>D</given-names></name><name><surname>Garcia</surname><given-names>V</given-names></name><name><surname>Bruno</surname><given-names>AP</given-names></name><name><surname>Jaffrézou</surname><given-names>J-P</given-names></name><name><surname>Salvayre</surname><given-names>R</given-names></name><name><surname>Krönke</surname><given-names>M</given-names></name><name><surname>Levade</surname><given-names>T</given-names></name></person-group><article-title>CD40 Signals Apoptosis through FAN-regulated Activation of the Sphingomyelin-Ceramide Pathway *</article-title><source>Journal of Biological Chemistry</source><year>1999</year><volume>274</volume><issue>52</issue><fpage>37251</fpage><lpage>37258</lpage><pub-id pub-id-type="pmid">10601289</pub-id></element-citation></ref><ref id="R104"><label>104</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Munk</surname><given-names>R</given-names></name><name><surname>Anerillas</surname><given-names>C</given-names></name><name><surname>Rossi</surname><given-names>M</given-names></name><name><surname>Tsitsipatis</surname><given-names>D</given-names></name><name><surname>Martindale</surname><given-names>JL</given-names></name><name><surname>Herman</surname><given-names>AB</given-names></name><name><surname>Yang</surname><given-names>J-H</given-names></name><name><surname>Roberts</surname><given-names>JA</given-names></name><name><surname>Varma</surname><given-names>VR</given-names></name><name><surname>Pandey</surname><given-names>PR</given-names></name><name><surname>Thambisetty</surname><given-names>M</given-names></name><etal/></person-group><article-title>Acid ceramidase promotes senescent cell survival</article-title><source>Aging</source><year>2021</year><volume>13</volume><issue>12</issue><fpage>15750</fpage><lpage>15769</lpage><pub-id pub-id-type="pmcid">PMC8266329</pub-id><pub-id pub-id-type="pmid">34102611</pub-id><pub-id pub-id-type="doi">10.18632/aging.203170</pub-id></element-citation></ref><ref id="R105"><label>105</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leent</surname><given-names>MMTv</given-names></name><name><surname>Beldman</surname><given-names>TJ</given-names></name><name><surname>Toner</surname><given-names>YC</given-names></name><name><surname>Lameijer</surname><given-names>MA</given-names></name><name><surname>Rother</surname><given-names>N</given-names></name><name><surname>Bekkering</surname><given-names>S</given-names></name><name><surname>Teunissen</surname><given-names>AJP</given-names></name><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>Meel</surname><given-names>Rvd</given-names></name><name><surname>Malkus</surname><given-names>J</given-names></name><name><surname>Nauta</surname><given-names>SA</given-names></name><etal/></person-group><article-title>Prosaposin mediates inflammation in atherosclerosis</article-title><source>Science Translational Medicine</source><year>2021</year><volume>13</volume><issue>584</issue><elocation-id>eabe1433</elocation-id><pub-id pub-id-type="pmcid">PMC8209679</pub-id><pub-id pub-id-type="pmid">33692130</pub-id><pub-id pub-id-type="doi">10.1126/scitranslmed.abe1433</pub-id></element-citation></ref><ref id="R106"><label>106</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holland</surname><given-names>WL</given-names></name><name><surname>Miller</surname><given-names>RA</given-names></name><name><surname>Wang</surname><given-names>ZV</given-names></name><name><surname>Sun</surname><given-names>K</given-names></name><name><surname>Barth</surname><given-names>BM</given-names></name><name><surname>Bui</surname><given-names>HH</given-names></name><name><surname>Davis</surname><given-names>KE</given-names></name><name><surname>Bikman</surname><given-names>BT</given-names></name><name><surname>Halberg</surname><given-names>N</given-names></name><name><surname>Rutkowski</surname><given-names>JM</given-names></name><name><surname>Wade</surname><given-names>MR</given-names></name><etal/></person-group><article-title>Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin</article-title><source>Nature Medicine</source><year>2011</year><volume>17</volume><issue>1</issue><fpage>55</fpage><lpage>63</lpage><pub-id pub-id-type="pmcid">PMC3134999</pub-id><pub-id pub-id-type="pmid">21186369</pub-id><pub-id pub-id-type="doi">10.1038/nm.2277</pub-id></element-citation></ref><ref id="R107"><label>107</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tresini</surname><given-names>M</given-names></name><name><surname>Lorenzini</surname><given-names>A</given-names></name><name><surname>Torres</surname><given-names>C</given-names></name><name><surname>Cristofalo</surname><given-names>VJ</given-names></name></person-group><article-title>Modulation of Replicative Senescence of Diploid Human Cells by Nuclear ERK Signaling *&lt;sup&gt;&lt;/sup&gt;</article-title><source>Journal of Biological Chemistry</source><year>2007</year><volume>282</volume><issue>6</issue><fpage>4136</fpage><lpage>4151</lpage><pub-id pub-id-type="pmid">17145763</pub-id></element-citation></ref><ref id="R108"><label>108</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Chi</surname><given-names>Y</given-names></name><name><surname>Gao</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Yao</surname><given-names>J</given-names></name></person-group><article-title>p53 protein-mediated up-regulation of MAP kinase phosphatase 3 (MKP-3) contributes to the establishment of the cellular senescent phenotype through dephosphorylation of extracellular signal-regulated kinase 1/2 (ERK1/2)</article-title><source>J Biol Chem</source><year>2015</year><volume>290</volume><issue>2</issue><fpage>1129</fpage><lpage>1140</lpage><pub-id pub-id-type="pmcid">PMC4294480</pub-id><pub-id pub-id-type="pmid">25414256</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M114.590943</pub-id></element-citation></ref><ref id="R109"><label>109</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pérez-Sen</surname><given-names>R</given-names></name><name><surname>Queipo</surname><given-names>MJ</given-names></name><name><surname>Gil-Redondo</surname><given-names>JC</given-names></name><name><surname>Ortega</surname><given-names>F</given-names></name><name><surname>Gómez-Villafuertes</surname><given-names>R</given-names></name><name><surname>Miras-Portugal</surname><given-names>MT</given-names></name><name><surname>Delicado</surname><given-names>EG</given-names></name></person-group><article-title>Dual-Specificity Phosphatase Regulation in Neurons and Glial Cells</article-title><source>International Journal of Molecular Sciences</source><year>2019</year><volume>20</volume><issue>8</issue><pub-id pub-id-type="pmcid">PMC6514851</pub-id><pub-id pub-id-type="pmid">31018603</pub-id><pub-id pub-id-type="doi">10.3390/ijms20081999</pub-id></element-citation></ref><ref id="R110"><label>110</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>W</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Fang</surname><given-names>W</given-names></name><name><surname>Liao</surname><given-names>S</given-names></name><name><surname>Xiong</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Xiao</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name></person-group><article-title>Dual Specificity Phosphatase 6 Protects Neural Stem Cells from β-Amyloid-Induced Cytotoxicity through ERK1/2 Inactivation</article-title><source>Biomolecules</source><year>2018</year><volume>8</volume><issue>4</issue><pub-id pub-id-type="pmcid">PMC6315916</pub-id><pub-id pub-id-type="pmid">30572643</pub-id><pub-id pub-id-type="doi">10.3390/biom8040181</pub-id></element-citation></ref><ref id="R111"><label>111</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zwerschke</surname><given-names>W</given-names></name><name><surname>Mazurek</surname><given-names>S</given-names></name><name><surname>Stöckl</surname><given-names>P</given-names></name><name><surname>Hütter</surname><given-names>E</given-names></name><name><surname>Eigenbrodt</surname><given-names>E</given-names></name><name><surname>Jansen-Dürr</surname><given-names>P</given-names></name></person-group><article-title>Metabolic analysis of senescent human fibroblasts reveals a role for AMP in cellular senescence</article-title><source>Biochemical Journal</source><year>2003</year><volume>376</volume><issue>2</issue><fpage>403</fpage><lpage>411</lpage><pub-id pub-id-type="pmcid">PMC1223775</pub-id><pub-id pub-id-type="pmid">12943534</pub-id><pub-id pub-id-type="doi">10.1042/BJ20030816</pub-id></element-citation></ref><ref id="R112"><label>112</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hutter</surname><given-names>E</given-names></name><name><surname>Renner</surname><given-names>K</given-names></name><name><surname>Pfister</surname><given-names>G</given-names></name><name><surname>Stöckl</surname><given-names>P</given-names></name><name><surname>Jansen-Dürr</surname><given-names>P</given-names></name><name><surname>Gnaiger</surname><given-names>E</given-names></name></person-group><article-title>Senescence-associated changes in respiration and oxidative phosphorylation in primary human fibroblasts</article-title><source>Biochemical Journal</source><year>2004</year><volume>380</volume><issue>3</issue><fpage>919</fpage><lpage>928</lpage><pub-id pub-id-type="pmcid">PMC1224220</pub-id><pub-id pub-id-type="pmid">15018610</pub-id><pub-id pub-id-type="doi">10.1042/BJ20040095</pub-id></element-citation></ref><ref id="R113"><label>113</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>James</surname><given-names>EL</given-names></name><name><surname>Michalek</surname><given-names>RD</given-names></name><name><surname>Pitiyage</surname><given-names>GN</given-names></name><name><surname>de Castro</surname><given-names>AM</given-names></name><name><surname>Vignola</surname><given-names>KS</given-names></name><name><surname>Jones</surname><given-names>J</given-names></name><name><surname>Mohney</surname><given-names>RP</given-names></name><name><surname>Karoly</surname><given-names>ED</given-names></name><name><surname>Prime</surname><given-names>SS</given-names></name><name><surname>Parkinson</surname><given-names>EK</given-names></name></person-group><article-title>Senescent Human Fibroblasts Show Increased Glycolysis and Redox Homeostasis with Extracellular Metabolomes That Overlap with Those of Irreparable DNA Damage, Aging and Disease</article-title><source>Journal of Proteome Research</source><year>2015</year><volume>14</volume><issue>4</issue><fpage>1854</fpage><lpage>1871</lpage><pub-id pub-id-type="pmid">25690941</pub-id></element-citation></ref><ref id="R114"><label>114</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monticone</surname><given-names>M</given-names></name><name><surname>Panfoli</surname><given-names>I</given-names></name><name><surname>Ravera</surname><given-names>S</given-names></name><name><surname>Puglisi</surname><given-names>R</given-names></name><name><surname>Jiang</surname><given-names>M-M</given-names></name><name><surname>Morello</surname><given-names>R</given-names></name><name><surname>Candiani</surname><given-names>S</given-names></name><name><surname>Tonachini</surname><given-names>L</given-names></name><name><surname>Biticchi</surname><given-names>R</given-names></name><name><surname>Fabiano</surname><given-names>A</given-names></name><name><surname>Cancedda</surname><given-names>R</given-names></name><etal/></person-group><article-title>The nuclear genes Mtfr1 and Dufd1 regulate mitochondrial dynamic and cellular respiration</article-title><source>Journal of Cellular Physiology</source><year>2010</year><volume>225</volume><issue>3</issue><fpage>767</fpage><lpage>776</lpage><pub-id pub-id-type="pmid">20568109</pub-id></element-citation></ref><ref id="R115"><label>115</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uzhachenko</surname><given-names>R</given-names></name><name><surname>Boyd</surname><given-names>K</given-names></name><name><surname>Olivares-Villagomez</surname><given-names>D</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Goodwin</surname><given-names>JS</given-names></name><name><surname>Rana</surname><given-names>T</given-names></name><name><surname>Shanker</surname><given-names>A</given-names></name><name><surname>Tan</surname><given-names>WJ</given-names></name><name><surname>Bondar</surname><given-names>T</given-names></name><name><surname>Medzhitov</surname><given-names>R</given-names></name><name><surname>Ivanova</surname><given-names>AV</given-names></name></person-group><article-title>Mitochondrial protein Fus1/Tusc2 in premature aging and age-related pathologies: critical roles of calcium and energy homeostasis</article-title><source>Aging (Albany NY)</source><year>2017</year><volume>9</volume><issue>3</issue><fpage>627</fpage><lpage>649</lpage><pub-id pub-id-type="pmcid">PMC5391223</pub-id><pub-id pub-id-type="pmid">28351997</pub-id><pub-id pub-id-type="doi">10.18632/aging.101213</pub-id></element-citation></ref><ref id="R116"><label>116</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raffaello</surname><given-names>A</given-names></name><name><surname>De Stefani</surname><given-names>D</given-names></name><name><surname>Sabbadin</surname><given-names>D</given-names></name><name><surname>Teardo</surname><given-names>E</given-names></name><name><surname>Merli</surname><given-names>G</given-names></name><name><surname>Picard</surname><given-names>A</given-names></name><name><surname>Checchetto</surname><given-names>V</given-names></name><name><surname>Moro</surname><given-names>S</given-names></name><name><surname>Szabò</surname><given-names>I</given-names></name><name><surname>Rizzuto</surname><given-names>R</given-names></name></person-group><article-title>The mitochondrial calcium uniporter is a multimer that can include a dominant-negative pore-forming subunit</article-title><source>The EMBO Journal</source><year>2013</year><volume>32</volume><issue>17</issue><fpage>2362</fpage><lpage>2376</lpage><pub-id pub-id-type="pmcid">PMC3771344</pub-id><pub-id pub-id-type="pmid">23900286</pub-id><pub-id pub-id-type="doi">10.1038/emboj.2013.157</pub-id></element-citation></ref><ref id="R117"><label>117</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Jin</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>J</given-names></name><name><surname>Tan</surname><given-names>R</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Ji</surname><given-names>X</given-names></name><name><surname>Jin</surname><given-names>C</given-names></name><name><surname>Jia</surname><given-names>Y</given-names></name><name><surname>Ren</surname><given-names>T</given-names></name><name><surname>Xing</surname><given-names>J</given-names></name></person-group><article-title>MCU-induced mitochondrial calcium uptake promotes mitochondrial biogenesis and colorectal cancer growth</article-title><source>Signal Transduction and Targeted Therapy</source><year>2020</year><volume>5</volume><issue>1</issue><fpage>59</fpage><pub-id pub-id-type="pmcid">PMC7200750</pub-id><pub-id pub-id-type="pmid">32371956</pub-id><pub-id pub-id-type="doi">10.1038/s41392-020-0155-5</pub-id></element-citation></ref><ref id="R118"><label>118</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lambert</surname><given-names>JP</given-names></name><name><surname>Luongo</surname><given-names>TS</given-names></name><name><surname>Tomar</surname><given-names>D</given-names></name><name><surname>Jadiya</surname><given-names>P</given-names></name><name><surname>Gao</surname><given-names>E</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Lucchese</surname><given-names>AM</given-names></name><name><surname>Kolmetzky</surname><given-names>DW</given-names></name><name><surname>Shah</surname><given-names>NS</given-names></name><name><surname>Elrod</surname><given-names>JW</given-names></name></person-group><article-title>MCUB Regulates the Molecular Composition of the Mitochondrial Calcium Uniporter Channel to Limit Mitochondrial Calcium Overload During Stress</article-title><source>Circulation</source><year>2019</year><volume>140</volume><issue>21</issue><fpage>1720</fpage><lpage>1733</lpage><pub-id pub-id-type="pmcid">PMC6996560</pub-id><pub-id pub-id-type="pmid">31533452</pub-id><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.118.037968</pub-id></element-citation></ref><ref id="R119"><label>119</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Yen</surname><given-names>FS</given-names></name><name><surname>Zhu</surname><given-names>XG</given-names></name><name><surname>Timson</surname><given-names>RC</given-names></name><name><surname>Weber</surname><given-names>R</given-names></name><name><surname>Xing</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Allwein</surname><given-names>B</given-names></name><name><surname>Luo</surname><given-names>H</given-names></name><name><surname>Yeh</surname><given-names>H-W</given-names></name><name><surname>Heissel</surname><given-names>S</given-names></name><etal/></person-group><article-title>SLC25A39 is necessary for mitochondrial glutathione import in mammalian cells</article-title><source>Nature</source><year>2021</year><volume>599</volume><issue>7883</issue><fpage>136</fpage><lpage>140</lpage><pub-id pub-id-type="pmcid">PMC10981497</pub-id><pub-id pub-id-type="pmid">34707288</pub-id><pub-id pub-id-type="doi">10.1038/s41586-021-04025-w</pub-id></element-citation></ref><ref id="R120"><label>120</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiley</surname><given-names>SE</given-names></name><name><surname>Murphy</surname><given-names>AN</given-names></name><name><surname>Ross</surname><given-names>SA</given-names></name><name><surname>van der Geer</surname><given-names>P</given-names></name><name><surname>Dixon</surname><given-names>JE</given-names></name></person-group><article-title>MitoNEET is an iron-containing outer mitochondrial membrane protein that regulates oxidative capacity</article-title><source>Proc Natl Acad Sci U S A</source><year>2007</year><volume>104</volume><issue>13</issue><fpage>5318</fpage><lpage>5323</lpage><pub-id pub-id-type="pmcid">PMC1838440</pub-id><pub-id pub-id-type="pmid">17376863</pub-id><pub-id pub-id-type="doi">10.1073/pnas.0701078104</pub-id></element-citation></ref><ref id="R121"><label>121</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tamir</surname><given-names>S</given-names></name><name><surname>Paddock</surname><given-names>ML</given-names></name><name><surname>Darash-Yahana-Baram</surname><given-names>M</given-names></name><name><surname>Holt</surname><given-names>SH</given-names></name><name><surname>Sohn</surname><given-names>YS</given-names></name><name><surname>Agranat</surname><given-names>L</given-names></name><name><surname>Michaeli</surname><given-names>D</given-names></name><name><surname>Stofleth</surname><given-names>JT</given-names></name><name><surname>Lipper</surname><given-names>CH</given-names></name><name><surname>Morcos</surname><given-names>F</given-names></name><name><surname>Cabantchik</surname><given-names>IZ</given-names></name><etal/></person-group><article-title>Structure–function analysis of NEET proteins uncovers their role as key regulators of iron and ROS homeostasis in health and disease</article-title><source>Biochimica et Biophysica Acta (BBA) - Molecular Cell Research</source><year>2015</year><volume>1853</volume><issue>6</issue><fpage>1294</fpage><lpage>1315</lpage><pub-id pub-id-type="pmid">25448035</pub-id></element-citation></ref><ref id="R122"><label>122</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Kang</surname><given-names>R</given-names></name><name><surname>Tang</surname><given-names>D</given-names></name></person-group><article-title>CISD1 inhibits ferroptosis by protection against mitochondrial lipid peroxidation</article-title><source>Biochemical and Biophysical Research Communications</source><year>2016</year><volume>478</volume><issue>2</issue><fpage>838</fpage><lpage>844</lpage><pub-id pub-id-type="pmid">27510639</pub-id></element-citation></ref><ref id="R123"><label>123</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masaldan</surname><given-names>S</given-names></name><name><surname>Clatworthy</surname><given-names>SAS</given-names></name><name><surname>Gamell</surname><given-names>C</given-names></name><name><surname>Meggyesy</surname><given-names>PM</given-names></name><name><surname>Rigopoulos</surname><given-names>A-T</given-names></name><name><surname>Haupt</surname><given-names>S</given-names></name><name><surname>Haupt</surname><given-names>Y</given-names></name><name><surname>Denoyer</surname><given-names>D</given-names></name><name><surname>Adlard</surname><given-names>PA</given-names></name><name><surname>Bush</surname><given-names>AI</given-names></name><name><surname>Cater</surname><given-names>MA</given-names></name></person-group><article-title>Iron accumulation in senescent cells is coupled with impaired ferritinophagy and inhibition of ferroptosis</article-title><source>Redox Biology</source><year>2018</year><volume>14</volume><fpage>100</fpage><lpage>115</lpage><pub-id pub-id-type="pmcid">PMC5596264</pub-id><pub-id pub-id-type="pmid">28888202</pub-id><pub-id pub-id-type="doi">10.1016/j.redox.2017.08.015</pub-id></element-citation></ref><ref id="R124"><label>124</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mon</surname><given-names>EE</given-names></name><name><surname>Wei</surname><given-names>F-Y</given-names></name><name><surname>Ahmad</surname><given-names>RNR</given-names></name><name><surname>Yamamoto</surname><given-names>T</given-names></name><name><surname>Moroishi</surname><given-names>T</given-names></name><name><surname>Tomizawa</surname><given-names>K</given-names></name></person-group><article-title>Regulation of mitochondrial iron homeostasis by sideroflexin 2</article-title><source>The Journal of Physiological Sciences</source><year>2019</year><volume>69</volume><issue>2</issue><fpage>359</fpage><lpage>373</lpage><pub-id pub-id-type="pmcid">PMC6373408</pub-id><pub-id pub-id-type="pmid">30570704</pub-id><pub-id pub-id-type="doi">10.1007/s12576-018-0652-2</pub-id></element-citation></ref><ref id="R125"><label>125</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moiseeva</surname><given-names>O</given-names></name><name><surname>Bourdeau</surname><given-names>V</given-names></name><name><surname>Roux</surname><given-names>A</given-names></name><name><surname>Deschênes-Simard</surname><given-names>X</given-names></name><name><surname>Ferbeyre</surname><given-names>G</given-names></name></person-group><article-title>Mitochondrial Dysfunction Contributes to Oncogene-Induced Senescence</article-title><source>Molecular and Cellular Biology</source><year>2009</year><volume>29</volume><issue>16</issue><fpage>4495</fpage><lpage>4507</lpage><pub-id pub-id-type="pmcid">PMC2725737</pub-id><pub-id pub-id-type="pmid">19528227</pub-id><pub-id pub-id-type="doi">10.1128/MCB.01868-08</pub-id></element-citation></ref><ref id="R126"><label>126</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Na</surname><given-names>R</given-names></name><name><surname>Gu</surname><given-names>M</given-names></name><name><surname>Salmon</surname><given-names>AB</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Liang</surname><given-names>H</given-names></name><name><surname>Qi</surname><given-names>W</given-names></name><name><surname>Van Remmen</surname><given-names>H</given-names></name><name><surname>Richardson</surname><given-names>A</given-names></name><name><surname>Ran</surname><given-names>Q</given-names></name></person-group><article-title>Reduction of mitochondrial H2O2 by overexpressing peroxiredoxin 3 improves glucose tolerance in mice</article-title><source>Aging Cell</source><year>2008</year><volume>7</volume><issue>6</issue><fpage>866</fpage><lpage>878</lpage><pub-id pub-id-type="pmcid">PMC4431549</pub-id><pub-id pub-id-type="pmid">18778410</pub-id><pub-id pub-id-type="doi">10.1111/j.1474-9726.2008.00432.x</pub-id></element-citation></ref><ref id="R127"><label>127</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Zhu</surname><given-names>S</given-names></name><name><surname>Lu</surname><given-names>H</given-names></name><name><surname>Peng</surname><given-names>D</given-names></name><name><surname>Soutto</surname><given-names>M</given-names></name><name><surname>Naz</surname><given-names>H</given-names></name><name><surname>Peek</surname><given-names>R</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Zaika</surname><given-names>A</given-names></name><name><surname>Xu</surname><given-names>Z</given-names></name><etal/></person-group><article-title>PRDX2 protects against oxidative stress induced by H. pylori and promotes resistance to cisplatin in gastric cancer</article-title><source>Redox Biology</source><year>2020</year><volume>28</volume><elocation-id>101319</elocation-id><pub-id pub-id-type="pmcid">PMC6811995</pub-id><pub-id pub-id-type="pmid">31536951</pub-id><pub-id pub-id-type="doi">10.1016/j.redox.2019.101319</pub-id></element-citation></ref><ref id="R128"><label>128</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edmond</surname><given-names>V</given-names></name><name><surname>Brambilla</surname><given-names>C</given-names></name><name><surname>Brambilla</surname><given-names>E</given-names></name><name><surname>Gazzeri</surname><given-names>S</given-names></name><name><surname>Eymin</surname><given-names>B</given-names></name></person-group><article-title>SRSF2 is required for sodium butyrate-mediated p21(WAF1) induction and premature senescence in human lung carcinoma cell lines</article-title><source>Cell Cycle</source><year>2011</year><volume>10</volume><issue>12</issue><fpage>1968</fpage><lpage>1977</lpage><pub-id pub-id-type="pmid">21555914</pub-id></element-citation></ref><ref id="R129"><label>129</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Latorre</surname><given-names>E</given-names></name><name><surname>Torregrossa</surname><given-names>R</given-names></name><name><surname>Wood</surname><given-names>ME</given-names></name><name><surname>Whiteman</surname><given-names>M</given-names></name><name><surname>Harries</surname><given-names>LW</given-names></name></person-group><article-title>Mitochondria-targeted hydrogen sulfide attenuates endothelial senescence by selective induction of splicing factors HNRNPD and SRSF2</article-title><source>Aging (Albany NY)</source><year>2018</year><volume>10</volume><issue>7</issue><fpage>1666</fpage><lpage>1681</lpage><pub-id pub-id-type="pmcid">PMC6075431</pub-id><pub-id pub-id-type="pmid">30026406</pub-id><pub-id pub-id-type="doi">10.18632/aging.101500</pub-id></element-citation></ref><ref id="R130"><label>130</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Park</surname><given-names>RY</given-names></name><name><surname>Kee</surname><given-names>Y</given-names></name><name><surname>Jeong</surname><given-names>S</given-names></name><name><surname>Ohn</surname><given-names>T</given-names></name></person-group><article-title>Splicing factor SRSF3 represses translation of p21cip1/waf1 mRNA</article-title><source>Cell Death &amp; Disease</source><year>2022</year><volume>13</volume><issue>11</issue><fpage>933</fpage><pub-id pub-id-type="pmcid">PMC9640673</pub-id><pub-id pub-id-type="pmid">36344491</pub-id><pub-id pub-id-type="doi">10.1038/s41419-022-05371-x</pub-id></element-citation></ref><ref id="R131"><label>131</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>Y</given-names></name><name><surname>Horikawa</surname><given-names>I</given-names></name><name><surname>Ajiro</surname><given-names>M</given-names></name><name><surname>Robles</surname><given-names>AI</given-names></name><name><surname>Fujita</surname><given-names>K</given-names></name><name><surname>Mondal</surname><given-names>AM</given-names></name><name><surname>Stauffer</surname><given-names>JK</given-names></name><name><surname>Zheng</surname><given-names>ZM</given-names></name><name><surname>Harris</surname><given-names>CC</given-names></name></person-group><article-title>Downregulation of splicing factor SRSF3 induces p53β, an alternatively spliced isoform of p53 that promotes cellular senescence</article-title><source>Oncogene</source><year>2013</year><volume>32</volume><issue>22</issue><fpage>2792</fpage><lpage>2798</lpage><pub-id pub-id-type="pmcid">PMC6503963</pub-id><pub-id pub-id-type="pmid">22777358</pub-id><pub-id pub-id-type="doi">10.1038/onc.2012.288</pub-id></element-citation></ref><ref id="R132"><label>132</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Han</surname><given-names>L</given-names></name><name><surname>Zhao</surname><given-names>G</given-names></name><name><surname>Shen</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>P</given-names></name><name><surname>Sun</surname><given-names>Z</given-names></name><name><surname>Xu</surname><given-names>C</given-names></name><name><surname>Su</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Tong</surname><given-names>T</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name></person-group><article-title>hnRNP A1 antagonizes cellular senescence and senescence-associated secretory phenotype via regulation of SIRT1 mRNA stability</article-title><source>Aging Cell</source><year>2016</year><volume>15</volume><issue>6</issue><fpage>1063</fpage><lpage>1073</lpage><pub-id pub-id-type="pmcid">PMC6398525</pub-id><pub-id pub-id-type="pmid">27613566</pub-id><pub-id pub-id-type="doi">10.1111/acel.12511</pub-id></element-citation></ref><ref id="R133"><label>133</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Ma</surname><given-names>X</given-names></name><name><surname>Guo</surname><given-names>W</given-names></name><name><surname>Lu</surname><given-names>B</given-names></name><name><surname>Yue</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Wu</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Luo</surname><given-names>X</given-names></name></person-group><article-title>Deacetylation of HnRNP U mediated by sirtuin1 ameliorates aged rat with liver fibrosis via inhibiting p53-related senescence and NLRP3-related inflammation</article-title><source>International Immunopharmacology</source><year>2024</year><volume>141</volume><elocation-id>113026</elocation-id><pub-id pub-id-type="pmid">39216234</pub-id></element-citation></ref><ref id="R134"><label>134</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kajita</surname><given-names>K</given-names></name><name><surname>Kuwano</surname><given-names>Y</given-names></name><name><surname>Satake</surname><given-names>Y</given-names></name><name><surname>Kano</surname><given-names>S</given-names></name><name><surname>Kurokawa</surname><given-names>K</given-names></name><name><surname>Akaike</surname><given-names>Y</given-names></name><name><surname>Masuda</surname><given-names>K</given-names></name><name><surname>Nishida</surname><given-names>K</given-names></name><name><surname>Rokutan</surname><given-names>K</given-names></name></person-group><article-title>Ultraconserved region-containing Transformer 2β4 controls senescence of colon cancer cells</article-title><source>Oncogenesis</source><year>2016</year><volume>5</volume><issue>4</issue><elocation-id>e213</elocation-id><pub-id pub-id-type="pmcid">PMC4848834</pub-id><pub-id pub-id-type="pmid">27043659</pub-id><pub-id pub-id-type="doi">10.1038/oncsis.2016.18</pub-id></element-citation></ref><ref id="R135"><label>135</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yosef</surname><given-names>R</given-names></name><name><surname>Pilpel</surname><given-names>N</given-names></name><name><surname>Papismadov</surname><given-names>N</given-names></name><name><surname>Gal</surname><given-names>H</given-names></name><name><surname>Ovadya</surname><given-names>Y</given-names></name><name><surname>Vadai</surname><given-names>E</given-names></name><name><surname>Miller</surname><given-names>S</given-names></name><name><surname>Porat</surname><given-names>Z</given-names></name><name><surname>Ben-Dor</surname><given-names>S</given-names></name><name><surname>Krizhanovsky</surname><given-names>V</given-names></name></person-group><article-title>p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling</article-title><source>The EMBO Journal</source><year>2017</year><volume>36</volume><issue>15</issue><fpage>2280</fpage><lpage>2295</lpage><pub-id pub-id-type="pmcid">PMC5538795</pub-id><pub-id pub-id-type="pmid">28607003</pub-id><pub-id pub-id-type="doi">10.15252/embj.201695553</pub-id></element-citation></ref><ref id="R136"><label>136</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maity</surname><given-names>P</given-names></name><name><surname>Singh</surname><given-names>K</given-names></name><name><surname>Krug</surname><given-names>L</given-names></name><name><surname>Koroma</surname><given-names>A</given-names></name><name><surname>Hainzl</surname><given-names>A</given-names></name><name><surname>Bloch</surname><given-names>W</given-names></name><name><surname>Kochanek</surname><given-names>S</given-names></name><name><surname>Wlaschek</surname><given-names>M</given-names></name><name><surname>Schorpp-Kistner</surname><given-names>M</given-names></name><name><surname>Angel</surname><given-names>P</given-names></name><name><surname>Ignatius</surname><given-names>A</given-names></name><etal/></person-group><article-title>Persistent JunB activation in fibroblasts disrupts stem cell niche interactions enforcing skin aging</article-title><source>Cell Reports</source><year>2021</year><volume>36</volume><issue>9</issue><elocation-id>109634</elocation-id><pub-id pub-id-type="pmid">34469740</pub-id></element-citation></ref><ref id="R137"><label>137</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomard</surname><given-names>T</given-names></name><name><surname>Michaud</surname><given-names>HA</given-names></name><name><surname>Tempé</surname><given-names>D</given-names></name><name><surname>Thiolon</surname><given-names>K</given-names></name><name><surname>Pelegrin</surname><given-names>M</given-names></name><name><surname>Piechaczyk</surname><given-names>M</given-names></name></person-group><article-title>An NFkappaB-dependent role for JunB in the induction of proinflammatory cytokines in LPS-activated bone marrow-derived dendritic cells</article-title><source>PLoS One</source><year>2010</year><volume>5</volume><issue>3</issue><elocation-id>e9585</elocation-id><pub-id pub-id-type="pmcid">PMC2833204</pub-id><pub-id pub-id-type="pmid">20221401</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0009585</pub-id></element-citation></ref><ref id="R138"><label>138</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cunha</surname><given-names>DA</given-names></name><name><surname>Gurzov</surname><given-names>EN</given-names></name><name><surname>Naamane</surname><given-names>N</given-names></name><name><surname>Ortis</surname><given-names>F</given-names></name><name><surname>Cardozo</surname><given-names>AK</given-names></name><name><surname>Bugliani</surname><given-names>M</given-names></name><name><surname>Marchetti</surname><given-names>P</given-names></name><name><surname>Eizirik</surname><given-names>DL</given-names></name><name><surname>Cnop</surname><given-names>M</given-names></name></person-group><article-title>JunB protects β-cells from lipotoxicity via the XBP1–AKT pathway</article-title><source>Cell Death &amp; Differentiation</source><year>2014</year><volume>21</volume><issue>8</issue><fpage>1313</fpage><lpage>1324</lpage><pub-id pub-id-type="pmcid">PMC4085537</pub-id><pub-id pub-id-type="pmid">24786832</pub-id><pub-id pub-id-type="doi">10.1038/cdd.2014.53</pub-id></element-citation></ref><ref id="R139"><label>139</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Jin</surname><given-names>JY</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Qin</surname><given-names>X</given-names></name><name><surname>Streilein</surname><given-names>R</given-names></name><name><surname>Hall</surname><given-names>RP</given-names></name><name><surname>Zhang</surname><given-names>JY</given-names></name></person-group><article-title>RNA-Seq and ChIP-Seq Reveal SQSTM1/p62 as a Key Mediator of JunB Suppression of NF-κB-Dependent Inflammation</article-title><source>Journal of Investigative Dermatology</source><year>2015</year><volume>135</volume><issue>4</issue><fpage>1016</fpage><lpage>1024</lpage><pub-id pub-id-type="pmcid">PMC4366298</pub-id><pub-id pub-id-type="pmid">25501661</pub-id><pub-id pub-id-type="doi">10.1038/jid.2014.519</pub-id></element-citation></ref><ref id="R140"><label>140</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Yu</surname><given-names>W</given-names></name><name><surname>He</surname><given-names>Q</given-names></name><name><surname>He</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Han</surname><given-names>W</given-names></name></person-group><article-title>Autophagy facilitates age-related cell apoptosis—a new insight from senile cataract</article-title><source>Cell Death &amp; Disease</source><year>2022</year><volume>13</volume><issue>1</issue><fpage>37</fpage><pub-id pub-id-type="pmcid">PMC8748728</pub-id><pub-id pub-id-type="pmid">35013122</pub-id><pub-id pub-id-type="doi">10.1038/s41419-021-04489-8</pub-id></element-citation></ref><ref id="R141"><label>141</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ha</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>M</given-names></name><name><surname>Seo</surname><given-names>D</given-names></name><name><surname>Park</surname><given-names>JS</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Park</surname><given-names>SH</given-names></name></person-group><article-title>The Deubiquitinating Enzyme USP20 Regulates the TNFα-Induced NF-κB Signaling Pathway through Stabilization of p62</article-title><source>International Journal of Molecular Sciences</source><year>2020</year><volume>21</volume><issue>9</issue><pub-id pub-id-type="pmcid">PMC7247158</pub-id><pub-id pub-id-type="pmid">32354117</pub-id><pub-id pub-id-type="doi">10.3390/ijms21093116</pub-id></element-citation></ref><ref id="R142"><label>142</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>S</given-names></name><name><surname>Qiang</surname><given-names>L</given-names></name><name><surname>Sample</surname><given-names>A</given-names></name><name><surname>Shah</surname><given-names>P</given-names></name><name><surname>He</surname><given-names>YY</given-names></name></person-group><article-title>NF-κB Signaling Activation Induced by Chloroquine Requires Autophagosome, p62 Protein, and c-Jun N-terminal Kinase (JNK) Signaling and Promotes Tumor Cell Resistance</article-title><source>J Biol Chem</source><year>2017</year><volume>292</volume><issue>8</issue><fpage>3379</fpage><lpage>3388</lpage><pub-id pub-id-type="pmcid">PMC5336170</pub-id><pub-id pub-id-type="pmid">28082672</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M116.756536</pub-id></element-citation></ref><ref id="R143"><label>143</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hino</surname><given-names>Y</given-names></name><name><surname>Nagaoka</surname><given-names>K</given-names></name><name><surname>Oki</surname><given-names>S</given-names></name><name><surname>Etoh</surname><given-names>K</given-names></name><name><surname>Hino</surname><given-names>S</given-names></name><name><surname>Nakao</surname><given-names>M</given-names></name></person-group><article-title>Mitochondrial stress induces AREG expression and epigenomic remodeling through c-JUN and YAP-mediated enhancer activation</article-title><source>Nucleic Acids Research</source><year>2022</year><volume>50</volume><issue>17</issue><fpage>9765</fpage><lpage>9779</lpage><pub-id pub-id-type="pmcid">PMC9508833</pub-id><pub-id pub-id-type="pmid">36095121</pub-id><pub-id pub-id-type="doi">10.1093/nar/gkac735</pub-id></element-citation></ref><ref id="R144"><label>144</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pommer</surname><given-names>M</given-names></name><name><surname>Kuphal</surname><given-names>S</given-names></name><name><surname>Bosserhoff</surname><given-names>AK</given-names></name></person-group><article-title>Amphiregulin Regulates Melanocytic Senescence</article-title><source>Cells</source><year>2021</year><volume>10</volume><issue>2</issue><pub-id pub-id-type="pmcid">PMC7914549</pub-id><pub-id pub-id-type="pmid">33562468</pub-id><pub-id pub-id-type="doi">10.3390/cells10020326</pub-id></element-citation></ref><ref id="R145"><label>145</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>S-C</given-names></name><name><surname>Tsang</surname><given-names>N-M</given-names></name><name><surname>Chiang</surname><given-names>W-C</given-names></name><name><surname>Chang</surname><given-names>K-P</given-names></name><name><surname>Hsueh</surname><given-names>C</given-names></name><name><surname>Liang</surname><given-names>Y</given-names></name><name><surname>Juang</surname><given-names>J-L</given-names></name><name><surname>Chow</surname><given-names>K-PN</given-names></name><name><surname>Chang</surname><given-names>Y-S</given-names></name></person-group><article-title>Leukemia inhibitory factor promotes nasopharyngeal carcinoma progression and radioresistance</article-title><source>The Journal of Clinical Investigation</source><year>2013</year><volume>123</volume><issue>12</issue><fpage>5269</fpage><lpage>5283</lpage><pub-id pub-id-type="pmcid">PMC3859424</pub-id><pub-id pub-id-type="pmid">24270418</pub-id><pub-id pub-id-type="doi">10.1172/JCI63428</pub-id></element-citation></ref><ref id="R146"><label>146</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Humbert</surname><given-names>L</given-names></name><name><surname>Ghozlan</surname><given-names>M</given-names></name><name><surname>Canaff</surname><given-names>L</given-names></name><name><surname>Tian</surname><given-names>J</given-names></name><name><surname>Lebrun</surname><given-names>J-J</given-names></name></person-group><article-title>The leukemia inhibitory factor (LIF) and p21 mediate the TGFβ tumor suppressive effects in human cutaneous melanoma</article-title><source>BMC Cancer</source><year>2015</year><volume>15</volume><issue>1</issue><fpage>200</fpage><pub-id pub-id-type="pmcid">PMC4389797</pub-id><pub-id pub-id-type="pmid">25885043</pub-id><pub-id pub-id-type="doi">10.1186/s12885-015-1177-1</pub-id></element-citation></ref><ref id="R147"><label>147</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kinsey</surname><given-names>CG</given-names></name><name><surname>Camolotto</surname><given-names>SA</given-names></name><name><surname>Boespflug</surname><given-names>AM</given-names></name><name><surname>Guillen</surname><given-names>KP</given-names></name><name><surname>Foth</surname><given-names>M</given-names></name><name><surname>Truong</surname><given-names>A</given-names></name><name><surname>Schuman</surname><given-names>SS</given-names></name><name><surname>Shea</surname><given-names>JE</given-names></name><name><surname>Seipp</surname><given-names>MT</given-names></name><name><surname>Yap</surname><given-names>JT</given-names></name><name><surname>Burrell</surname><given-names>LD</given-names></name><etal/></person-group><article-title>Protective autophagy elicited by RAF↑MEK↑ERK inhibition suggests a treatment strategy for RAS-driven cancers</article-title><source>Nature Medicine</source><year>2019</year><volume>25</volume><issue>4</issue><fpage>620</fpage><lpage>627</lpage><pub-id pub-id-type="pmcid">PMC6452642</pub-id><pub-id pub-id-type="pmid">30833748</pub-id><pub-id pub-id-type="doi">10.1038/s41591-019-0367-9</pub-id></element-citation></ref><ref id="R148"><label>148</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kochetkova</surname><given-names>EY</given-names></name><name><surname>Blinova</surname><given-names>GI</given-names></name><name><surname>Bystrova</surname><given-names>OA</given-names></name><name><surname>Martynova</surname><given-names>MG</given-names></name><name><surname>Pospelov</surname><given-names>VA</given-names></name><name><surname>Pospelova</surname><given-names>TV</given-names></name></person-group><article-title>Targeted elimination of senescent Ras-transformed cells by suppression of MEK/ERK pathway</article-title><source>Aging (Albany NY)</source><year>2017</year><volume>9</volume><issue>11</issue><fpage>2352</fpage><lpage>2375</lpage><pub-id pub-id-type="pmcid">PMC5723691</pub-id><pub-id pub-id-type="pmid">29140794</pub-id><pub-id pub-id-type="doi">10.18632/aging.101325</pub-id></element-citation></ref><ref id="R149"><label>149</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>Z</given-names></name><name><surname>Dai</surname><given-names>S</given-names></name><name><surname>He</surname><given-names>Y</given-names></name><name><surname>Doty Rosalinda</surname><given-names>A</given-names></name><name><surname>Shultz Leonard</surname><given-names>D</given-names></name><name><surname>Sampson Stephen</surname><given-names>B</given-names></name><name><surname>Dai</surname><given-names>C</given-names></name></person-group><article-title>MEK Guards Proteome Stability and Inhibits Tumor-Suppressive Amyloidogenesis via HSF1</article-title><source>Cell</source><year>2015</year><volume>160</volume><issue>4</issue><fpage>729</fpage><lpage>744</lpage><pub-id pub-id-type="pmcid">PMC4564124</pub-id><pub-id pub-id-type="pmid">25679764</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2015.01.028</pub-id></element-citation></ref><ref id="R150"><label>150</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salamanca</surname><given-names>HH</given-names></name><name><surname>Antonyak</surname><given-names>MA</given-names></name><name><surname>Cerione</surname><given-names>RA</given-names></name><name><surname>Shi</surname><given-names>H</given-names></name><name><surname>Lis</surname><given-names>JT</given-names></name></person-group><article-title>Inhibiting heat shock factor 1 in human cancer cells with a potent RNA aptamer</article-title><source>PLoS One</source><year>2014</year><volume>9</volume><issue>5</issue><elocation-id>e96330</elocation-id><pub-id pub-id-type="pmcid">PMC4011729</pub-id><pub-id pub-id-type="pmid">24800749</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0096330</pub-id></element-citation></ref><ref id="R151"><label>151</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>Y</given-names></name><name><surname>Tsujimura</surname><given-names>A</given-names></name><name><surname>Taguchi</surname><given-names>K</given-names></name><name><surname>Tanaka</surname><given-names>M</given-names></name></person-group><article-title>HSF1 stress response pathway regulates autophagy receptor SQSTM1/p62-associated proteostasis</article-title><source>Autophagy</source><year>2017</year><volume>13</volume><issue>1</issue><fpage>133</fpage><lpage>148</lpage><pub-id pub-id-type="pmcid">PMC5240838</pub-id><pub-id pub-id-type="pmid">27846364</pub-id><pub-id pub-id-type="doi">10.1080/15548627.2016.1248018</pub-id></element-citation></ref><ref id="R152"><label>152</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuhrmann-Stroissnigg</surname><given-names>H</given-names></name><name><surname>Ling</surname><given-names>YY</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>McGowan</surname><given-names>SJ</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Brooks</surname><given-names>RW</given-names></name><name><surname>Grassi</surname><given-names>D</given-names></name><name><surname>Gregg</surname><given-names>SQ</given-names></name><name><surname>Stripay</surname><given-names>JL</given-names></name><name><surname>Dorronsoro</surname><given-names>A</given-names></name><name><surname>Corbo</surname><given-names>L</given-names></name><etal/></person-group><article-title>Identification of HSP90 inhibitors as a novel class of senolytics</article-title><source>Nature Communications</source><year>2017</year><volume>8</volume><issue>1</issue><fpage>422</fpage><pub-id pub-id-type="pmcid">PMC5583353</pub-id><pub-id pub-id-type="pmid">28871086</pub-id><pub-id pub-id-type="doi">10.1038/s41467-017-00314-z</pub-id></element-citation></ref><ref id="R153"><label>153</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Safran</surname><given-names>M</given-names></name><name><surname>Rosen</surname><given-names>N</given-names></name><name><surname>Twik</surname><given-names>M</given-names></name><name><surname>BarShir</surname><given-names>R</given-names></name><name><surname>Stein</surname><given-names>TI</given-names></name><name><surname>Dahary</surname><given-names>D</given-names></name><name><surname>Fishilevich</surname><given-names>S</given-names></name><name><surname>Lancet</surname><given-names>D</given-names></name></person-group><chapter-title>The GeneCards Suite</chapter-title><person-group person-group-type="editor"><name><surname>Abugessaisa</surname><given-names>I</given-names></name><name><surname>Kasukawa</surname><given-names>T</given-names></name></person-group><source>Practical Guide to Life Science Databases</source><year>2021</year><publisher-loc>Singapore</publisher-loc><publisher-name>Springer Nature Singapore</publisher-name><fpage>27</fpage><lpage>56</lpage></element-citation></ref><ref id="R154"><label>154</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>T</given-names></name><name><surname>Hu</surname><given-names>E</given-names></name><name><surname>Xu</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Guo</surname><given-names>P</given-names></name><name><surname>Dai</surname><given-names>Z</given-names></name><name><surname>Feng</surname><given-names>T</given-names></name><name><surname>Zhou</surname><given-names>L</given-names></name><name><surname>Tang</surname><given-names>W</given-names></name><name><surname>Zhan</surname><given-names>L</given-names></name><name><surname>Fu</surname><given-names>X</given-names></name><etal/></person-group><article-title>clusterProfiler 4.0: A universal enrichment tool for interpreting omics data</article-title><source>Innovation (N Y)</source><year>2021</year><volume>2</volume><issue>3</issue><elocation-id>100141</elocation-id><pub-id pub-id-type="pmcid">PMC8454663</pub-id><pub-id pub-id-type="pmid">34557778</pub-id><pub-id pub-id-type="doi">10.1016/j.xinn.2021.100141</pub-id></element-citation></ref><ref id="R155"><label>155</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuleshov</surname><given-names>MV</given-names></name><name><surname>Jones</surname><given-names>MR</given-names></name><name><surname>Rouillard</surname><given-names>AD</given-names></name><name><surname>Fernandez</surname><given-names>NF</given-names></name><name><surname>Duan</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Koplev</surname><given-names>S</given-names></name><name><surname>Jenkins</surname><given-names>SL</given-names></name><name><surname>Jagodnik</surname><given-names>KM</given-names></name><name><surname>Lachmann</surname><given-names>A</given-names></name><name><surname>McDermott</surname><given-names>MG</given-names></name><etal/></person-group><article-title>Enrichr: a comprehensive gene set enrichment analysis web server 2016 update</article-title><source>Nucleic Acids Res</source><year>2016</year><volume>44</volume><issue>W1</issue><fpage>W90</fpage><lpage>97</lpage><pub-id pub-id-type="pmcid">PMC4987924</pub-id><pub-id pub-id-type="pmid">27141961</pub-id><pub-id pub-id-type="doi">10.1093/nar/gkw377</pub-id></element-citation></ref><ref id="R156"><label>156</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barretina</surname><given-names>J</given-names></name><name><surname>Caponigro</surname><given-names>G</given-names></name><name><surname>Stransky</surname><given-names>N</given-names></name><name><surname>Venkatesan</surname><given-names>K</given-names></name><name><surname>Margolin</surname><given-names>AA</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Wilson</surname><given-names>CJ</given-names></name><name><surname>Lehar</surname><given-names>J</given-names></name><name><surname>Kryukov</surname><given-names>GV</given-names></name><name><surname>Sonkin</surname><given-names>D</given-names></name><name><surname>Reddy</surname><given-names>A</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Murray</surname><given-names>L</given-names></name><etal/></person-group><article-title>The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity</article-title><source>Nature</source><year>2012</year><volume>483</volume><issue>7391</issue><fpage>603</fpage><lpage>607</lpage><pub-id pub-id-type="pmcid">PMC3320027</pub-id><pub-id pub-id-type="pmid">22460905</pub-id><pub-id pub-id-type="doi">10.1038/nature11003</pub-id></element-citation></ref><ref id="R157"><label>157</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rouillard</surname><given-names>AD</given-names></name><name><surname>Gundersen</surname><given-names>GW</given-names></name><name><surname>Fernandez</surname><given-names>NF</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Monteiro</surname><given-names>CD</given-names></name><name><surname>McDermott</surname><given-names>MG</given-names></name><name><surname>Ma'ayan</surname><given-names>A</given-names></name></person-group><article-title>The harmonizome: a collection of processed datasets gathered to serve and mine knowledge about genes and proteins</article-title><source>Database (Oxford)</source><year>2016</year><volume>2016</volume><pub-id pub-id-type="pmcid">PMC4930834</pub-id><pub-id pub-id-type="pmid">27374120</pub-id><pub-id pub-id-type="doi">10.1093/database/baw100</pub-id></element-citation></ref><ref id="R158"><label>158</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Birnhuber</surname><given-names>A</given-names></name><name><surname>Crnkovic</surname><given-names>S</given-names></name><name><surname>Biasin</surname><given-names>V</given-names></name><name><surname>Marsh</surname><given-names>LM</given-names></name><name><surname>Odler</surname><given-names>B</given-names></name><name><surname>Sahu-Osen</surname><given-names>A</given-names></name><name><surname>Stacher-Priehse</surname><given-names>E</given-names></name><name><surname>Brcic</surname><given-names>L</given-names></name><name><surname>Schneider</surname><given-names>F</given-names></name><name><surname>Cikes</surname><given-names>N</given-names></name><name><surname>Ghanim</surname><given-names>B</given-names></name><etal/></person-group><article-title>IL-1 receptor blockade skews inflammation towards Th2 in a mouse model of systemic sclerosis</article-title><source>European Respiratory Journal</source><year>2019</year><volume>54</volume><issue>3</issue><elocation-id>1900154</elocation-id><pub-id pub-id-type="pmcid">PMC6860995</pub-id><pub-id pub-id-type="pmid">31320452</pub-id><pub-id pub-id-type="doi">10.1183/13993003.00154-2019</pub-id></element-citation></ref><ref id="R159"><label>159</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwapiszewska</surname><given-names>G</given-names></name><name><surname>Gungl</surname><given-names>A</given-names></name><name><surname>Wilhelm</surname><given-names>J</given-names></name><name><surname>Marsh</surname><given-names>LM</given-names></name><name><surname>Thekkekara Puthenparampil</surname><given-names>H</given-names></name><name><surname>Sinn</surname><given-names>K</given-names></name><name><surname>Didiasova</surname><given-names>M</given-names></name><name><surname>Klepetko</surname><given-names>W</given-names></name><name><surname>Kosanovic</surname><given-names>D</given-names></name><name><surname>Schermuly</surname><given-names>RT</given-names></name><name><surname>Wujak</surname><given-names>L</given-names></name><etal/></person-group><article-title>Transcriptome profiling reveals the complexity of pirfenidone effects in idiopathic pulmonary fibrosis</article-title><source>European Respiratory Journal</source><year>2018</year><volume>52</volume><issue>5</issue><elocation-id>1800564</elocation-id><pub-id pub-id-type="pmid">30166321</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Fig. 1</label><caption><title>Schematic of the bioinformatic pipeline of the study.</title></caption><graphic xlink:href="EMS200181-f001"/></fig><fig id="F2" position="float"><label>Fig. 2</label><caption><title>Principal component analysis of the differential gene expression profiles of the collected senescent models, and enrichment analysis of the consensus signature derived from all these datasets.</title><p>(A) The first two principal components of differential gene expression profiles, are labeled by the senescence induction model and the cell type. (B) KEGG pathways and MSigDB Hallmark gene set enrichment analysis for up and downregulated signature separately. OIS: oncogene-induced senescence, RS: replicative senescence, and IRIS: irradiation-induced senescence.</p></caption><graphic xlink:href="EMS200181-f002"/></fig><fig id="F3" position="float"><label>Fig. 3</label><caption><title>Senolytic effect of MEK inhibitors.</title><p>(A) Schematic of evaluating the senolytic effect of MEK inhibitors in the stress-induced premature senescence (SIPS) model triggered by doxorubicin. (B-F) Viability plots of SIPS cells versus Quiescent Human Lung Fibroblasts in the presence of 5 MEK inhibitors: Selumetinib, Binimetinib, Cobimetinib, Mirdametinib, and Trametinib.</p></caption><graphic xlink:href="EMS200181-f003"/></fig><table-wrap id="T1" position="float" orientation="portrait"><label>Table 1</label><caption><p>The anti-apoptotic module of the senescence signature (anti-apoptotic signature).</p></caption><table frame="void" rules="none"><thead><tr><th valign="top" align="center" colspan="2" style="background-color:#F7CAAC">Overexpressed genes</th><th valign="top" align="center" colspan="2" style="background-color:#B4C6E7">Underexpressed genes</th></tr><tr style="border-bottom: 1px solid"><th valign="top" align="left">Gene symbol</th><th valign="top" align="left">Gene full name</th><th valign="top" align="left">Gene symbol</th><th valign="top" align="left">Gene full name</th></tr></thead><tbody><tr><td valign="top" align="left">CDKN1A</td><td valign="top" align="left" style="border-right: 1px solid">Cyclin Dependent Kinase Inhibitor 1A</td><td valign="top" align="left">CASP2</td><td valign="top" align="left">Caspase 2</td></tr><tr><td valign="top" align="left">TNFRSF10C</td><td valign="top" align="left" style="border-right: 1px solid">TNF Receptor Superfamily Member
10c</td><td valign="top" align="left">CASP6</td><td valign="top" align="left">Caspase 6</td></tr><tr><td valign="top" align="left">TNFRSF10D</td><td valign="top" align="left" style="border-right: 1px solid">TNF Receptor Superfamily Member 10d</td><td valign="top" align="left">PARP1</td><td valign="top" align="left">Poly(ADP-Ribose) Polymerase 1</td></tr><tr><td valign="top" align="left">BCL2L2</td><td valign="top" align="left" style="border-right: 1px solid">BCL2 Like 2</td><td valign="top" align="left">CDK1</td><td valign="top" align="left">Cyclin Dependent Kinase 1</td></tr><tr><td valign="top" align="left">VEGFA</td><td valign="top" align="left" style="border-right: 1px solid">Vascular Endothelial Growth Factor A</td><td valign="top" align="left">TET2</td><td valign="top" align="left">Tet Methylcytosine Dioxygenase 2</td></tr><tr><td valign="top" align="left">IL6</td><td valign="top" align="left" style="border-right: 1px solid">Interleukin 6</td><td valign="top" align="left">CDKN1B</td><td valign="top" align="left">Cyclin Dependent Kinase Inhibitor 1B</td></tr><tr><td valign="top" align="left">SQSTM1</td><td valign="top" align="left" style="border-right: 1px solid">Sequestosome 1</td><td valign="top" align="left">PCNA</td><td valign="top" align="left">Proliferating Cell Nuclear Antigen</td></tr><tr><td valign="top" align="left">TIGAR</td><td valign="top" align="left" style="border-right: 1px solid">TP53 Induced Glycolysis Regulatory Phosphatase</td><td valign="top" align="left">BRCA1</td><td valign="top" align="left">BRCA1 DNA Repair Associated</td></tr><tr><td valign="top" align="left">ERN1</td><td valign="top" align="left" style="border-right: 1px solid">Endoplasmic Reticulum To Nucleus Signaling 1</td><td valign="top" align="left">PRKCA</td><td valign="top" align="left">Protein Kinase C Alpha</td></tr><tr><td valign="top" align="left">SHC1</td><td valign="top" align="left" style="border-right: 1px solid">SHC Adaptor Protein 1</td><td valign="top" align="left">CCNB1</td><td valign="top" align="left">Cyclin B1</td></tr><tr><td valign="top" align="left">PTRH2</td><td valign="top" align="left" style="border-right: 1px solid">Peptidyl-TRNA Hydrolase 2</td><td valign="top" align="left">CASP8AP2</td><td valign="top" align="left">Caspase 8 Associated Protein 2</td></tr><tr><td valign="top" align="left">CSF2</td><td valign="top" align="left" style="border-right: 1px solid">Colony Stimulating Factor 2</td><td valign="top" align="left">EZH2</td><td valign="top" align="left">Enhancer Of Zeste 2 Polycomb Repressive Complex 2 Subunit</td></tr><tr><td valign="top" align="left">HK2</td><td valign="top" align="left" style="border-right: 1px solid">Hexokinase 2</td><td valign="top" align="left">NOD1</td><td valign="top" align="left">Nucleotide Binding Oligomerization Domain Containing 1</td></tr><tr><td valign="top" align="left">GDNF</td><td valign="top" align="left" style="border-right: 1px solid">Glial Cell Derived Neurotrophic Factor</td><td valign="top" align="left">SET</td><td valign="top" align="left">SET Nuclear Proto-Oncogene</td></tr><tr><td valign="top" align="left">IGF2R</td><td valign="top" align="left" style="border-right: 1px solid">Insulin Like Growth Factor 2 Receptor</td><td valign="top" align="left">MLH1</td><td valign="top" align="left">MutL Homolog 1</td></tr><tr><td valign="top" align="left">NRG1</td><td valign="top" align="left" style="border-right: 1px solid">Neuregulin 1</td><td valign="top" align="left">HNRNPA1</td><td valign="top" align="left">Heterogeneous Nuclear Ribonucleoprotein A1</td></tr><tr><td valign="top" align="left">CD44</td><td valign="top" align="left" style="border-right: 1px solid">CD44 Molecule (Indian Blood Group)</td><td valign="top" align="left">ITGB3BP</td><td valign="top" align="left">Integrin Subunit Beta 3 Binding Protein</td></tr><tr><td valign="top" align="left">MXD1</td><td valign="top" align="left" style="border-right: 1px solid">MAX Dimerization Protein 1</td><td valign="top" align="left">SMAD4</td><td valign="top" align="left">SMAD Family Member 4</td></tr><tr><td valign="top" align="left">OSMR</td><td valign="top" align="left" style="border-right: 1px solid">Oncostatin M Receptor</td><td valign="top" align="left">MSH2</td><td valign="top" align="left">MutS Homolog 2</td></tr><tr><td valign="top" align="left">AREG</td><td valign="top" align="left" style="border-right: 1px solid">Amphiregulin</td><td valign="top" align="left">JADE1</td><td valign="top" align="left">Jade Family PHD Finger 1</td></tr><tr><td valign="top" align="left">PRDX2</td><td valign="top" align="left" style="border-right: 1px solid">Peroxiredoxin 2</td><td valign="top" align="left">TOP2A</td><td valign="top" align="left">DNA Topoisomerase II Alpha</td></tr><tr><td valign="top" align="left">BSG</td><td valign="top" align="left" style="border-right: 1px solid">Basigin (Ok Blood Group)</td><td valign="top" align="left">SRSF2</td><td valign="top" align="left">Serine And Arginine Rich Splicing Factor 2</td></tr><tr><td valign="top" align="left">CHMP5</td><td valign="top" align="left" style="border-right: 1px solid">Charged Multivesicular Body Protein 5</td><td valign="top" align="left">BARD1</td><td valign="top" align="left">BRCA1 Associated RING Domain 1</td></tr><tr><td valign="top" align="left">SLC9A1</td><td valign="top" align="left" style="border-right: 1px solid">Solute Carrier Family 9 Member A1</td><td valign="top" align="left">MCM2</td><td valign="top" align="left">Minichromosome Maintenance Complex Component 2</td></tr><tr><td valign="top" align="left">ANGPTL4</td><td valign="top" align="left" style="border-right: 1px solid">Angiopoietin Like 4</td><td valign="top" align="left">E2F2</td><td valign="top" align="left">E2F Transcription Factor 2</td></tr><tr><td valign="top" align="left">ADIPOR1</td><td valign="top" align="left" style="border-right: 1px solid">Adiponectin Receptor 1</td><td valign="top" align="left">SETD2</td><td valign="top" align="left">SET Domain Containing 2, Histone Lysine Methyltransferase</td></tr><tr><td valign="top" align="left">JUP</td><td valign="top" align="left" style="border-right: 1px solid">Junction Plakoglobin</td><td valign="top" align="left">ID4</td><td valign="top" align="left">Inhibitor Of DNA Binding 4, HLH Protein</td></tr><tr><td valign="top" align="left">DUSP6</td><td valign="top" align="left" style="border-right: 1px solid">Dual Specificity Phosphatase 6</td><td valign="top" align="left">TJP2</td><td valign="top" align="left">Tight Junction Protein 2</td></tr><tr><td valign="top" align="left">PROCR</td><td valign="top" align="left" style="border-right: 1px solid">Protein C Receptor</td><td valign="top" align="left">KLF2</td><td valign="top" align="left">Kruppel Like Factor 2</td></tr><tr><td valign="top" align="left">MAP1LC3B</td><td valign="top" align="left" style="border-right: 1px solid">Microtubule Associated Protein 1 Light Chain 3 Beta</td><td valign="top" align="left">SMARCA2</td><td valign="top" align="left">SWI/SNF Related, Matrix Associated, Actin Dependent Regulator Of Chromatin, Subfamily A, Member 2</td></tr><tr><td valign="top" align="left">LIF</td><td valign="top" align="left" style="border-right: 1px solid">LIF Interleukin 6 Family Cytokine</td><td valign="top" align="left">MCM3</td><td valign="top" align="left">Minichromosome Maintenance Complex Component 3</td></tr><tr><td valign="top" align="left">AKR1B1</td><td valign="top" align="left" style="border-right: 1px solid">Aldo-Keto Reductase Family 1 Member B</td><td valign="top" align="left">FUS</td><td valign="top" align="left">FUS RNA Binding Protein</td></tr><tr><td valign="top" align="left">GLRX</td><td valign="top" align="left" style="border-right: 1px solid">Glutaredoxin</td><td valign="top" align="left">SENP1</td><td valign="top" align="left">SUMO Specific Peptidase 1</td></tr><tr><td valign="top" align="left">FANK1</td><td valign="top" align="left" style="border-right: 1px solid">Fibronectin Type III And Ankyrin Repeat Domains 1</td><td valign="top" align="left">HNRNPD</td><td valign="top" align="left">Heterogeneous Nuclear Ribonucleoprotein D</td></tr><tr><td valign="top" align="left">RRM2B</td><td valign="top" align="left" style="border-right: 1px solid">Ribonucleotide Reductase Regulatory TP53 Inducible Subunit M2B</td><td valign="top" align="left">PKMYT1</td><td valign="top" align="left">Protein Kinase, Membrane Associated Tyrosine/Threonine 1</td></tr><tr><td valign="top" align="left">DNAJB9</td><td valign="top" align="left" style="border-right: 1px solid">DnaJ Heat Shock Protein Family (Hsp40) Member B9</td><td valign="top" align="left">FANCD2</td><td valign="top" align="left">FA Complementation Group D2</td></tr><tr><td valign="top" align="left">IL12A</td><td valign="top" align="left" style="border-right: 1px solid">Interleukin 12A</td><td valign="top" align="left">RBL1</td><td valign="top" align="left">RB Transcriptional Corepressor Like 1</td></tr><tr><td valign="top" align="left">CXCL1</td><td valign="top" align="left" style="border-right: 1px solid">C-X-C Motif Chemokine Ligand 1</td><td valign="top" align="left">GLUL</td><td valign="top" align="left">Glutamate-Ammonia Ligase</td></tr><tr><td valign="top" align="left">JUNB</td><td valign="top" align="left" style="border-right: 1px solid">JunB Proto-Oncogene, AP-1 Transcription Factor Subunit</td><td valign="top" align="left">RBMS3</td><td valign="top" align="left">RNA Binding Motif Single Stranded Interacting Protein 3</td></tr><tr><td valign="top" align="left">CD9</td><td valign="top" align="left" style="border-right: 1px solid">CD9 Molecule</td><td valign="top" align="left">TPM1</td><td valign="top" align="left">Tropomyosin 1</td></tr><tr><td valign="top" align="left">DDRGK1</td><td valign="top" align="left" style="border-right: 1px solid">DDRGK Domain Containing 1</td><td valign="top" align="left">CCDC8</td><td valign="top" align="left">Coiled-Coil Domain Containing 8</td></tr><tr><td valign="top" align="left">ABCA1</td><td valign="top" align="left" style="border-right: 1px solid">ATP Binding Cassette Subfamily A Member 1</td><td valign="top" align="left">MSH6</td><td valign="top" align="left">MutS Homolog 6</td></tr><tr><td valign="top" align="left">GABARAPL2</td><td valign="top" align="left" style="border-right: 1px solid">GABA Type A Receptor Associated Protein Like 2</td><td valign="top" align="left">MEIS1</td><td valign="top" align="left">Meis Homeobox 1</td></tr><tr><td valign="top" align="left">CTSS</td><td valign="top" align="left" style="border-right: 1px solid">Cathepsin S</td><td valign="top" align="left">NSMAF</td><td valign="top" align="left">Neutral Sphingomyelinase Activation Associated Factor</td></tr><tr><td valign="top" align="left">PSENEN</td><td valign="top" align="left" style="border-right: 1px solid">Presenilin Enhancer, Gamma-Secretase Subunit</td><td valign="top" align="left">MYH10</td><td valign="top" align="left">Myosin Heavy Chain 10</td></tr><tr><td valign="top" align="left">CXADR</td><td valign="top" align="left" style="border-right: 1px solid">CXADR Ig-Like Cell Adhesion Molecule</td><td valign="top" align="left">RBBP7</td><td valign="top" align="left">RB Binding Protein 7, Chromatin Remodeling Factor</td></tr><tr><td valign="top" align="left">DUSP4</td><td valign="top" align="left" style="border-right: 1px solid">Dual Specificity Phosphatase 4</td><td valign="top" align="left">TCF4</td><td valign="top" align="left">Transcription Factor 4</td></tr><tr><td valign="top" align="left">FNTA</td><td valign="top" align="left" style="border-right: 1px solid">Farnesyltransferase, CAAX Box, Alpha</td><td valign="top" align="left">TAF9B</td><td valign="top" align="left">TATA-Box Binding Protein Associated Factor 9b</td></tr><tr><td valign="top" align="left">PLAT</td><td valign="top" align="left" style="border-right: 1px solid">Plasminogen Activator, Tissue Type</td><td valign="top" align="left">HTR2B</td><td valign="top" align="left">5-Hydroxytryptamine Receptor 2B</td></tr><tr><td valign="top" align="left">LUCAT1</td><td valign="top" align="left" style="border-right: 1px solid">Lung Cancer Associated Transcript 1</td><td valign="top" align="left">CDKN2C</td><td valign="top" align="left">Cyclin Dependent Kinase Inhibitor 2C</td></tr><tr><td valign="top" align="left">CLN8</td><td valign="top" align="left" style="border-right: 1px solid">CLN8 Transmembrane ER And ERGIC Protein</td><td valign="top" align="left">LRIG3</td><td valign="top" align="left">Leucine Rich Repeats And Immunoglobulin Like Domains 3</td></tr><tr><td valign="top" align="left">CLCN3</td><td valign="top" align="left" style="border-right: 1px solid">Chloride Voltage-Gated Channel 3</td><td valign="top" align="left">EXO1</td><td valign="top" align="left">Exonuclease 1</td></tr><tr><td valign="top" align="left">PSAP</td><td valign="top" align="left" style="border-right: 1px solid">Prosaposin</td><td valign="top" align="left">PATZ1</td><td valign="top" align="left">POZ/BTB And AT Hook Containing Zinc Finger 1</td></tr><tr><td valign="top" align="left">CHST11</td><td valign="top" align="left" style="border-right: 1px solid">Carbohydrate Sulfotransferase 11</td><td valign="top" align="left">MXRA8</td><td valign="top" align="left">Matrix Remodeling Associated 8</td></tr><tr><td valign="top" align="left">CPEB4</td><td valign="top" align="left" style="border-right: 1px solid">Cytoplasmic Polyadenylation Element Binding Protein 4</td><td valign="top" align="left">RUNX1T1</td><td valign="top" align="left">RUNX1 Partner Transcriptional Co-Repressor 1</td></tr><tr><td valign="top" align="left">LRPAP1</td><td valign="top" align="left" style="border-right: 1px solid">LDL Receptor Related Protein Associated Protein 1</td><td valign="top" align="left">ARHGAP11A</td><td valign="top" align="left">Rho GTPase Activating Protein 11A</td></tr><tr><td valign="top" align="left">STXBP1</td><td valign="top" align="left" style="border-right: 1px solid">Syntaxin Binding Protein 1</td><td valign="top" align="left">SLFN11</td><td valign="top" align="left">Schlafen Family Member 11</td></tr><tr><td valign="top" align="left">TM7SF3</td><td valign="top" align="left" style="border-right: 1px solid">Transmembrane 7 Superfamily Member 3</td><td valign="top" align="left"/><td valign="top" align="left"/></tr><tr><td valign="top" align="left">TNFSF18</td><td valign="top" align="left" style="border-right: 1px solid">TNF Superfamily Member 18</td><td valign="top" align="left"/><td valign="top" align="left"/></tr></tbody></table></table-wrap><table-wrap id="T2" position="float" orientation="portrait"><label>Table 2</label><caption><p>The selected positively correlated cell lines and the inversely correlated cell lines, with respect to their cancer lineages, which were shared between CCLE and CTD<sup>2</sup> datasets and were utilized in the comparative assessment of small molecule sensitivities.</p></caption><table frame="void" rules="none"><thead><tr><th valign="top" align="left" colspan="3" style="background-color:#FBE4D5">Positively correlated cell lines</th><th valign="top" align="left" colspan="3" style="background-color:#D9E2F3">Negatively correlated cell lines</th></tr><tr style="border-bottom: 1px solid"><th valign="top" align="left">Lineage</th><th valign="top" align="left">Cell lines</th><th valign="top" align="center" style="border-right: 1px solid">Count</th><th valign="top" align="left">Lineage</th><th valign="top" align="left">Cell lines</th><th valign="top" align="center">Count</th></tr></thead><tbody><tr><td valign="top" align="left">Exocrine</td><td valign="top" align="left">'HPAFII', 'SU8686'</td><td valign="top" align="center" style="border-right: 1px solid">2</td><td valign="top" align="left">Osteosarcoma</td><td valign="top" align="left">'U2OS', 'HOS'</td><td valign="top" align="center">2</td></tr><tr><td valign="top" align="left">Renal Cell Carcinoma</td><td valign="top" align="left">'CAL54', 'KMRC3'</td><td valign="top" align="center" style="border-right: 1px solid">2</td><td valign="top" align="left">Non Hodgkin Lymphoma</td><td valign="top" align="left">'GA10', 'BL70'</td><td valign="top" align="center">2</td></tr><tr><td valign="top" align="left">Upper Aerodigestive Squamous</td><td valign="top" align="left">'BICR56', 'BICR22'</td><td valign="top" align="center" style="border-right: 1px solid">2</td><td valign="top" align="left">Ewing Sarcoma</td><td valign="top" align="left">'SKES1'</td><td valign="top" align="center">1</td></tr><tr><td valign="top" align="left">Thyroid Carcinoma</td><td valign="top" align="left">'BHT101', 'BCPAP'</td><td valign="top" align="center" style="border-right: 1px solid">2</td><td valign="top" align="left">ALL</td><td valign="top" align="left">'SUPT1', 'TALL1'</td><td valign="top" align="center">2</td></tr><tr><td valign="top" align="left">Melanoma</td><td valign="top" align="left">'HS294T', 'COLO829'</td><td valign="top" align="center" style="border-right: 1px solid">2</td><td valign="top" align="left">Neuroblastoma</td><td valign="top" align="left">'SKNDZ'</td><td valign="top" align="center">1</td></tr><tr><td valign="top" align="left">Rhabdomyosarcoma</td><td valign="top" align="left">'RH18'</td><td valign="top" align="center" style="border-right: 1px solid">1</td><td valign="top" align="left">Gastric Adenocarcinoma</td><td valign="top" align="left">'HGC27'</td><td valign="top" align="center">1</td></tr><tr><td valign="top" align="left">Ovary Adenocarcinoma</td><td valign="top" align="left">'OV56', 'RMGI'</td><td valign="top" align="center" style="border-right: 1px solid">2</td><td valign="top" align="left">SCLC</td><td valign="top" align="left">'NCIH1184'</td><td valign="top" align="center">1</td></tr><tr><td valign="top" align="left">Esophagus Squamous</td><td valign="top" align="left">'KYSE30', 'ECGI10'</td><td valign="top" align="center" style="border-right: 1px solid">2</td><td valign="top" align="left">Rhabdomyosarcoma</td><td valign="top" align="left">'RH41'</td><td valign="top" align="center">1</td></tr><tr><td valign="top" align="left">NSCLC</td><td valign="top" align="left">'RERFLCMS', 'NCIH1666'</td><td valign="top" align="center" style="border-right: 1px solid">2</td><td valign="top" align="left">Medulloblastoma</td><td valign="top" align="left">'D283MED'</td><td valign="top" align="center">1</td></tr><tr><td valign="top" align="left">Glioma</td><td valign="top" align="left">'KG1C'</td><td valign="top" align="center" style="border-right: 1px solid">1</td><td valign="top" align="left"/><td valign="top" align="left"/><td valign="top" align="left"/></tr></tbody></table></table-wrap><table-wrap id="T3" position="float" orientation="portrait"><label>Table 3</label><caption><p>Analysis of sensitivity to the shared bottom 10 percent connected compounds. The Mean Connectivity Score (MCS) and its percentile (MCS_percentile) alongside the median of TAS (TAS_median) are derived from Connectivity Map. The difference between the compound sensitivity in the correlated cell lines and the inversely correlated ones is defined by "Statistic" and "p-value". Moreover, the percentile of mean sensitivity in each group is represented.</p></caption><table frame="void" rules="none"><thead><tr style="background-color:#E7E6E6"><th valign="top" align="left">Compound</th><th valign="top" align="center">MCS_percentile</th><th valign="top" align="center">MCS</th><th valign="top" align="center">TAS_median</th><th valign="top" align="center">Statistic</th><th valign="top" align="center">p-value<xref ref-type="table-fn" rid="TFN1">*</xref></th><th valign="top" align="center">Percentile of mean sensitivity in positively correlated cells</th><th valign="top" align="center">Percentile of mean sensitivity in negatively correlated cells</th></tr></thead><tbody><tr style="border-top: 1px solid"><td valign="top" align="left" style="border-right: 1px solid">AC-55649</td><td valign="top" align="center">2.09</td><td valign="top" align="center">-0.71</td><td valign="top" align="center">0.14</td><td valign="top" align="center">0.11</td><td valign="top" align="center">0.80595</td><td valign="top" align="center">46.1</td><td valign="top" align="center">31.8</td></tr><tr><td valign="top" align="left" style="border-right: 1px solid">GMX-1778</td><td valign="top" align="center">2.81</td><td valign="top" align="center">-0.68</td><td valign="top" align="center">0.17</td><td valign="top" align="center">0.43</td><td valign="top" align="center">0.91083</td><td valign="top" align="center">38.3</td><td valign="top" align="center">23.1</td></tr><tr><td valign="top" align="left" style="border-right: 1px solid">PRIMA1</td><td valign="top" align="center">0.08</td><td valign="top" align="center">-1.04</td><td valign="top" align="center">0.15</td><td valign="top" align="center">0.63</td><td valign="top" align="center">0.99466</td><td valign="top" align="center">51.4</td><td valign="top" align="center">24.5</td></tr><tr><td valign="top" align="left" style="border-right: 1px solid">CX-4945</td><td valign="top" align="center">0.68</td><td valign="top" align="center">-0.83</td><td valign="top" align="center">0.325</td><td valign="top" align="center">-0.26</td><td valign="top" align="center">0.13075</td><td valign="top" align="center">20.6</td><td valign="top" align="center">35.6</td></tr><tr><td valign="top" align="left" style="border-right: 1px solid">evodiamine</td><td valign="top" align="center">5.15</td><td valign="top" align="center">-0.61</td><td valign="top" align="center">0.145</td><td valign="top" align="center">0.18</td><td valign="top" align="center">0.8767</td><td valign="top" align="center">53.6</td><td valign="top" align="center">39.5</td></tr><tr><td valign="top" align="left" style="border-right: 1px solid">zebularine</td><td valign="top" align="center">4.98</td><td valign="top" align="center">-0.62</td><td valign="top" align="center">0.15</td><td valign="top" align="center">0.12</td><td valign="top" align="center">0.74099</td><td valign="top" align="center">44.1</td><td valign="top" align="center">33.4</td></tr><tr><td valign="top" align="left" style="border-right: 1px solid">MK-0752</td><td valign="top" align="center">2.61</td><td valign="top" align="center">-0.69</td><td valign="top" align="center">0.14</td><td valign="top" align="center">-0.13</td><td valign="top" align="center">0.11836</td><td valign="top" align="center">55.2</td><td valign="top" align="center">62.15</td></tr><tr><td valign="top" align="left" style="border-right: 1px solid">prima-1-met</td><td valign="top" align="center">1.68</td><td valign="top" align="center">-0.74</td><td valign="top" align="center">0.13</td><td valign="top" align="center">0.08</td><td valign="top" align="center">0.63333</td><td valign="top" align="center">7.5</td><td valign="top" align="center">5.2</td></tr><tr style="background-color:#FFFF00"><td valign="top" align="left" style="border-right: 1px solid">SJ-172550</td><td valign="top" align="center">6.14</td><td valign="top" align="center">-0.59</td><td valign="top" align="center">0.17</td><td valign="top" align="center">-0.38</td><td valign="top" align="center">0.00468</td><td valign="top" align="center">34.3</td><td valign="top" align="center">64.3</td></tr><tr style="background-color:#FFFF00"><td valign="top" align="left" style="border-right: 1px solid">selumetinib</td><td valign="top" align="center">7.91</td><td valign="top" align="center">-0.55</td><td valign="top" align="center">0.23</td><td valign="top" align="center">-1.60</td><td valign="top" align="center">2.00E-05</td><td valign="top" align="center">26.81</td><td valign="top" align="center">68.20</td></tr><tr><td valign="top" align="left" style="border-right: 1px solid">darinaparsin</td><td valign="top" align="center">8.59</td><td valign="top" align="center">-0.54</td><td valign="top" align="center">0.16</td><td valign="top" align="center">-0.01</td><td valign="top" align="center">0.47096</td><td valign="top" align="center">27.5</td><td valign="top" align="center">28.3</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><label>*</label><p id="P56">p-value is determined by the permutation test</p></fn></table-wrap-foot></table-wrap><table-wrap id="T4" position="float" orientation="portrait"><label>Table 4</label><caption><p>Analysis of sensitivity to the RNAi loss of function (LOF) perturbations of the genes whose LOF were among the top 10 inversely connected interventions with the anti-apoptotic signature. The Mean Connectivity Score (MCS) and the median of TAS (TAS_median) are derived from Connectivity Map. The difference in the RNAi sensitivity in correlated cell lines vs inversely correlated ones is defined by "Statistic" and "p-value". Moreover the percentile of mean sensitivity in each group is represented</p></caption><table frame="void" rules="none"><thead><tr style="background-color:#DBDBDB"><th valign="top" align="center">RNAi</th><th valign="top" align="center">MCS</th><th valign="top" align="center">TAS_median</th><th valign="top" align="center">Statistic</th><th valign="top" align="center">p-value</th><th valign="top" align="center">Percentile of mean sensitivity in positively correlated cells</th><th valign="top" align="center">Percentile of mean sensitivity in negatively correlated cells</th></tr></thead><tbody><tr><td valign="top" align="left">CDKN1A</td><td valign="top" align="center">-0.498</td><td valign="top" align="center">0.185</td><td valign="top" align="center">0.975</td><td valign="top" align="center">0.999</td><td valign="top" align="center">79.718</td><td valign="top" align="center">24.225</td></tr><tr><td valign="top" align="left">STXBP1</td><td valign="top" align="center">-1.217</td><td valign="top" align="center">0.130</td><td valign="top" align="center">0.486</td><td valign="top" align="center">0.971</td><td valign="top" align="center">28.873</td><td valign="top" align="center">16.197</td></tr><tr style="background-color:#FFFF00"><td valign="top" align="left">SQSTM1</td><td valign="top" align="center">-0.770</td><td valign="top" align="center">0.140</td><td valign="top" align="center">-0.475</td><td valign="top" align="center">0.021</td><td valign="top" align="center">38.592</td><td valign="top" align="center">72.958</td></tr><tr style="background-color:#FFFF00"><td valign="top" align="left">JUNB</td><td valign="top" align="center">-1.068</td><td valign="top" align="center">0.165</td><td valign="top" align="center">-0.576</td><td valign="top" align="center">0.015</td><td valign="top" align="center">26.901</td><td valign="top" align="center">67.606</td></tr><tr><td valign="top" align="left">TNFSF18</td><td valign="top" align="center">-0.516</td><td valign="top" align="center">0.100</td><td valign="top" align="center">-0.483</td><td valign="top" align="center">0.057</td><td valign="top" align="center">26.620</td><td valign="top" align="center">54.648</td></tr><tr><td valign="top" align="left">IL12A</td><td valign="top" align="center">-0.516</td><td valign="top" align="center">0.140</td><td valign="top" align="center">0.061</td><td valign="top" align="center">0.599</td><td valign="top" align="center">35.915</td><td valign="top" align="center">32.676</td></tr><tr><td valign="top" align="left">PRDX2</td><td valign="top" align="center">-0.670</td><td valign="top" align="center">0.170</td><td valign="top" align="center">-0.377</td><td valign="top" align="center">0.149</td><td valign="top" align="center">27.465</td><td valign="top" align="center">45.634</td></tr><tr style="background-color:#FFFF00"><td valign="top" align="left">LIF</td><td valign="top" align="center">-0.499</td><td valign="top" align="center">0.200</td><td valign="top" align="center">-0.337</td><td valign="top" align="center">0.015</td><td valign="top" align="center">32.394</td><td valign="top" align="center">62.394</td></tr><tr style="background-color:#FFFF00"><td valign="top" align="left">AREG</td><td valign="top" align="center">-0.706</td><td valign="top" align="center">0.200</td><td valign="top" align="center">-0.712</td><td valign="top" align="center">0.020</td><td valign="top" align="center">21.408</td><td valign="top" align="center">41.972</td></tr><tr><td valign="top" align="left">MXD1</td><td valign="top" align="center">-0.773</td><td valign="top" align="center">0.185</td><td valign="top" align="center">0.070</td><td valign="top" align="center">0.624</td><td valign="top" align="center">56.338</td><td valign="top" align="center">51.268</td></tr></tbody></table><table-wrap-foot><fn id="TFN2"><label>*</label><p id="P57">p-value is determined by the permutation test</p></fn></table-wrap-foot></table-wrap></floats-group></article>